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RÉSUMÉ 
La culture de cellules de mammifères constitue à ce jour la plateforme d'expression la plus 
utilisée dans l'industrie biopharmaceutique, en raison de la capacité inégalée de ces cellules à 
réaliser les modifications post-traductionnelles essentielles à la fonctionnalité des produits 
complexes. En raison de la forte demande pour les produits biothérapeutiques, de la volonté de 
diminuer les coûts associés au développement des bioprocédés et du besoin de réduire les temps 
de mise en marché, plusieurs progrès réalisés au cours des dernières décennies ont permis des 
améliorations significative en termes de rendement et de qualité du produit. Ces avancées ont été 
effectuées surtout grâce au développement de meilleurs vecteurs d'expression, au développement 
de milieux de culture plus performants et à l'application de stratégies fed-batch permettant 
l'atteinte de très hautes densités cellulaires. Une autre avancée récente concerne le développement 
de systèmes d'expression inductibles, dont l'énorme avantage est de permettre de découpler les 
phases de croissance et de production, conférant ainsi la possibilité d'optimiser chacune des 
phases indépendamment, avec des conditions opératoires spécifiques à chacune d'elles. Par 
ailleurs, cela permet en principe de faire croître les cellules plus rapidement avant la phase 
d'induction, puisque ces dernières n'ont pas à supporter la charge métabolique additionnelle 
qu'impose la synthèse d'une protéine recombinante. Dans de tels procédés bi-phasiques, établir le 
moment propice pour procéder à l'induction et élaborer une stratégie d'alimentation post-
induction efficace sont deux facteurs cruciaux qui vont dicter la productivité du système. En 
raison de la complexité du métabolisme des cellules de mammifères, l'optimisation ciblée des 
procédés de culture demeure un défi, mais ce travail peut être grandement facilite par le biais de 
nouvelles approches du génie métabolique. C'est le cas notamment de la technique d'analyse des 
flux métaboliques avec traceurs isotopiques (
13
C-MFA), qui a démontré qu'elle permet une 
caractérisation de l'état physiologique à la fois plus fine et plus robuste, mais qui a toutefois 
encore peu été exploitée dans le contexte de la culture de cellules animales. 
L'objectif principal de cette thèse était donc d'appliquer la technique d'analyse des flux 
métaboliques avec traceurs isotopiques afin d'effectuer une caractérisation quantitative du 
métabolisme primaire de cellules CHO dotées d'un système d'expression inductible, afin de 
permettre l'établissement systématique des principales conditions de culture et le développement 
rationnel d'une stratégie d'alimentation post-induction. A cette fin, des protocoles expérimentaux 
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pour effectuer des expériences de marquage et des analyses par spectrométrie de masse, ainsi que 
les outils de calcul requis pour effectuer l'estimation des flux intracellulaires à partir de ces 
mesures ont du être développés ou adaptés à partir de méthodes décrites dans la littérature. 
En premier lieu, l'approche a été utilisée afin d'analyser le métabolisme central du carbone 
d'une lignée de cellules CHO en lien avec la productivité cellulaire spécifique. L'objectif était 
d'évaluer de façon quantitative la charge imposée par la synthèse d'une protéine recombinante sur 
le métabolisme primaire des cellules. Ceci a été accompli par le biais d'une analyse comparative 
des flux métaboliques pour des cellules induites et non-induites. Des cultures avec divers 
substrats marqués au C
13
 ont été réalisées et les distributions de masse résultantes de plusieurs  
métabolites extracellulaires (lactate et trois acides aminés) ont été mesurées. Ces données ont été 
utilisées, de concert avec des mesures de taux spécifiques de consommation et de production, 
pour calculer les flux métaboliques. Cette analyse a notamment révélé que l'expression d'une 
protéine recombinante est associée avec des différences faibles, mais néanmoins significatives 
pour plusieurs voies métaboliques, particulièrement celles reliées à la formation d'ATP et de 
NADPH, tel que le cycle de Krebs, la voie des pentose phosphate ou la voie de l'enzyme malique. 
Les cellules induites présentaient un métabolisme plus efficace, puisqu'une plus grande 
proportion du glucose, le nutriment principal, était acheminée dans le cycle TCA. A l'inverse, 
aucun changement majeur n'a été détecté au niveau du métabolisme des acides aminés, dont la 
glutamine. Comme un changement de température a été opéré au moment de l'induction pour 
favoriser la productivité, cette étude se voulait également la première caractérisation détaillée du 
métabolisme des cellules CHO sous des conditions légèrement hypothermique.  
Par la suite, l'impact du moment d'induction sur la productivité des cultures a été étudié, 
puisque ce paramètre influe à la fois sur la quantité de biomasse et sur la productivité spécifique 
des cellules. A cette fin, des cellules ont été prélevées à différents stades de croissance, puis ont 
été transférées pour être induites dans du milieu frais. Les cinétiques de croissance, de 
consommation et de production durant la phase de production ont été comparées pour l'ensemble 
des conditions d'induction. En comparaison avec les cultures induites à concentrations élevées, 
les cellules induites à faibles densités cellulaires ont atteint un pic de concentration plus faible, 
mais la longévité des cultures et la productivité spécifique des cellules étaient plus élevées, ce qui 
s'est traduit par une augmentation de la concentration finale en produit. Afin de mieux 
caractériser les effets observés sur le plan physiologique, une analyse des flux métaboliques par 
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traceurs isotopiques a été réalisée pour comparer les cultures induites respectivement à faible et à 
haute densité cellulaire. Pour cette étude, le nombre de mesures a été étendu en considérant 
également les distributions de masse de deux acides organiques. En accord avec les différences 
observées au niveau de la croissance et de la productivité cellulaire, il a été constaté que plusieurs 
flux intracellulaires sont affectés par le moment d'induction. Il en a été conclu que la disponibilité 
des nutriments avait un impact marqué durant la phase de production après induction. Plus 
particulièrement, il a été révélé que le glucose est consommé plus efficacement dans le cas des 
cultures à  haute densité, alors que la contribution des acides aminés s'en trouvait, elle, diminuée. 
Les résultats précédents ont été obtenus pour un changement de milieu complet au moment 
de l 'induction, une opération qui ne serait pas aisément transposable pour la production à grande 
échelle. Pour cette raison et parce que la disponibilité des nutriments semblent avoir un impact 
majeur sur la productivité et/ou la croissance, la possibilité d'augmenter les rendements par le 
biais d'une stratégie fed-batch a été explorée.  Il a été constaté que des ajouts de solutions 
concentrées effectués post-induction augmentaient de façon substantielle la productivité des 
cultures par rapport au mode batch. Plus encore, il a été observé que lorsque la glutamine est 
alimentée en excès, les cultures atteignent des concentration cellulaires maximales plus grandes. 
Cependant, les cultures limitées en glutamine présentaient elles une productivité spécifique plus 
grande, ce qui a conduit à des rendements en produit similaires. Afin de mettre en lumière 
l'impact physiologique du niveau de glutamine dans l'alimentation, une étude comparative des 
flux métaboliques avec traceurs isotopiques a été réalisée dans des cultures en mode semi-
continu. Les changements majeurs en terme de croissance et de productivité se traduisaient 
également par des différences observables au niveau de la distribution des flux métaboliques. 
Plus particulièrement, le métabolisme du lactate était grandement influencé par le niveau de 
glutamine alimenté aux cellules durant la phase d'induction.  
Globalement, l'ensemble des travaux réalisés semble suggérer une corrélation inverse entre le 
taux de croissance et la productivité spécifique des cellules. Les caractérisations métaboliques 
effectuées pourraient néanmoins procurer une bonne base pour l'identification de marqueurs 
physiologiques de la productivité, permettant ainsi de poursuivre le développement et 
l'optimisation des procédés avec induction. Ces travaux démontrent également la valeur de la 
technique de 
13
C-MFA comme outil de caractérisation du métabolisme. 
ix 
 
ABSTRACT 
Mammalian cell cultures have become the predominant production platform in today’s multi-
billion dollar biopharmaceutical industry. Mammalian cells have the unique capacity to 
synthesize recombinant proteins with proper folding and post-translational modifications. Due to 
the increasing demand for biotherapeutics, the pressure to reduce the costs associated with 
process development and the need to shorten the time to market, continuous efforts have been 
made in mammalian cell technologies to maximize both the product yields and quality. This has 
been mostly achieved through the design of enhanced expression vectors, improved medium 
formulations and the application of fed-batch strategies supporting high cell densities. In recent 
years, there has been also a growing interest in the development of inducible mammalian 
expression systems, which allow decoupling of the growth and production phases and open up 
the possibility to define specific operating conditions that are favorable for each phase. Moreover, 
cells can presumably be grown more rapidly before induction, as they do not have the extra 
metabolic burden associated with recombinant protein expression. In such biphasic systems, a 
suitable timing for induction and an efficient feeding protocol pre/post-induction are among the 
most crucial factors to ensure a high volumetric productivity. Due to the complex metabolism of 
mammalian cells, the targeted optimization of cell culture processes remains challenging, but can 
be greatly facilitated with the aid of new metabolic engineering approaches. In particular, the use 
of isotopic tracers and 
13
C-metabolic flux analysis (
13
C-MFA) was shown to provide a more 
detailed and accurate description of cellular physiology than the classical metabolite balancing 
technique, although its application to mammalian cells is still in its infancy. 
The main objective of this work was thus to apply 
13
C-metabolic flux analysis to 
quantitatively characterize the primary metabolism of recombinant CHO cells harboring an 
efficient inducible expression system, as a systematic approach to guide the determination of key 
process conditions and allow the rational development of a feeding protocol to increase culture 
productivity. To this end, analytical methods for conducting informative labeling experiments 
and mass spectrometry measurements, as well as computational tools allowing reliable metabolic 
flux quantification had to be developed or adapted from the literature.  
First, this method was used to analyze the central carbon metabolism of a recombinant CHO 
cell line in relation with cellular productivity. The goal was to quantitatively evaluate the burden 
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imposed by recombinant protein expression on the primary metabolism of cells in culture. This 
was achieved by conducting a comparative study of the intracellular flux map distribution with 
and without the induction of recombinant protein expression. We performed cultures with 
multiple 
13
C-labeled substrates and measured the resulting mass distribution of extracellular 
metabolites (lactate and three amino acids) by mass spectrometry. This additional data was used 
in conjunction with extracellular rate measurements to obtain reliable metabolic flux estimates. 
Through this analysis, we have notably demonstrated that heterologous protein expression is 
correlated with small, but significant differences in a number of important intracellular pathways, 
most of them related to ATP and NADPH formation, including the pentose phosphate pathway, 
the malic enzyme reaction and the TCA cycle. Induced cells were found to exhibit an increased 
flux of pyruvate into the TCA cycle, indicative of a more efficient glucose utilization. However, 
no significant difference could be inferred with respect to amino acid metabolism, including 
glutamine. Since a temperature shift was performed at the time of induction, this study was also 
the first comprehensive characterization of CHO cell metabolism under mild-hypothermia 
conditions. 
We have then investigated the impact of the timing of induction on culture productivity, 
since this parameter can affect both the cumulative biomass concentration and the cell specific 
productivity. Cells taken at different stages of growth were transferred and induced in fresh 
medium and the kinetics of growth, nutrient consumption and product formation were compared 
during the production phase. Compared to cultures induced at a high cell concentration, low cell 
density inductions achieved lower maximum cell concentrations, but exhibited higher cell 
specific productivity and greater culture longevity, which gave a greater final product titers. To 
gain more physiological insights into the observed differences, 
13
C-metabolic flux analysis was 
performed to characterize and compare the metabolism of cells induced at respectively low and 
high cell densities. The range of measurements was extended by including the mass distributions 
of two organic acids. In line with differences observed in terms of growth and productivity, 
several calculated intracellular fluxes were found to be affected by the timing of induction. It was 
inferred that the corresponding availability of nutrients had a determinant impact on the induction 
phase. Most notably, glucose utilization efficiency was increased in high cell density induction, 
whereas the contribution of amino acids became marginal.  
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The previous results were however obtained by doing a complete medium exchange at the 
time of induction, an operation which cannot be easily implemented at large-scale. For this 
reason and since the results implied a strong correlation between nutrient availability and cellular 
growth/productivity, we then explored the possibility to increase the product yield by using a fed-
batch process. We found that performing concentrated feed additions post-induction greatly 
increase the productivity of cultures compared to induction in batch mode. More interestingly, we 
observed that when glutamine was fed in excess to the cells, the cultures reached greater 
maximum cell concentrations. While cell growth was comparatively lower in glutamine-limited 
fed-batch, the final product titers were found to be similar, indicative of an increased cell specific 
productivity. To further assess the physiological impact of glutamine levels on the cells, a 
comparative 
13
C-metabolic flux analysis was conducted in semi-continuous cultures to analyze 
both culture regimes. The marked changes in cellular growth and productivity were clearly 
reflected in the metabolism of the cells. In particular, lactate metabolism was found to be greatly 
influenced  by the amount of glutamine present in the feed during the production phase.  
Overall, the results from all our studies tend to suggest that there may be some negative 
correlation between cell growth and cellular productivity. Nonetheless, the metabolic 
characterizations performed in this work may provide useful clues for the identification of 
physiological markers of cell growth and/or productivity that could further guide the optimization 
of inducible expression systems. Our work also demonstrates that 
13
C-metabolic flux analysis is a 
valuable tool for characterizing cell metabolism and supporting cell culture process optimization. 
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CHAPTER 1 INTRODUCTION 
 
1.1 Background 
Nowadays, two thirds of top selling biopharmaceutical products are being produced by 
mammalian cell culture. The fact that these cells have the ability to produce proteins with human-
like posttranslational modifications often makes them the most suitable host system. Due to the 
high and growing demand for biotherapeutics, in particular antibodies, efforts have been made to 
improve the efficiency of cell culture processes in order to speed up the time-to-market and 
reduce the development/production costs. Significant advances have been made in the field of 
cell culture technology over the last decades, with product concentrations now routinely reported 
in the 5-10 g/L range. These yields have been achieved owing to the development of improved 
expression vectors, the selection of high producing cell lines, the design of enhanced medium 
formulations, and through the development of fed-batch and perfusion processes supporting high 
cell density. Moreover, progresses in cellular engineering have also led to the development of 
new inducible promoter systems, such as the widely used tetracycline- or ecdysone-based 
systems (Kaufmann, Mazur, Marone, Bailey, & Fussenegger, 2001; No, Yao, & Evans, 1996), or 
the recent cumate gene-switch (Mullick et al., 2006). In such expression system, the growth and 
production phases can be effectively decoupled, in that way allowing to optimize each phase 
independently. Despite these advances, significant challenges still remain for further improving 
the efficiency of cell culture processes; the complex behavior of mammalian cells in culture is 
currently only partially understood because of the multitude of parameters governing cell growth, 
metabolism and productivity. This lack of knowledge restricts the capacity to identify robust 
biomarkers of productivity, to rationally develop medium formulation and feeding strategy and to 
efficiently engineer cells with desired characteristics (Selvarasu et al., 2012). In this context, 
metabolic engineering approaches are now increasingly being applied to mammalian cell 
systems. They involve the investigation and modification of biochemical reactions, metabolic 
networks and metabolic flux control (Boghigian, Seth, Kiss, & Pfeifer, 2010; T. Omasa et al., 
2010). Among the various approaches, metabolic flux analysis has become a rational tool to 
characterize cell physiology by detailed quantification of major intracellular fluxes in the central 
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carbon metabolism of cells (Wiechert, 2001). However, due to the complexity of mammalian 
cells, conventional metabolic flux analysis has to rely typically on hardly verified assumptions to 
estimate intracellular flux distributions. It is now recognized that a more accurate determination 
of metabolic fluxes in complex biological systems can be performed with the aid of stable isotope 
labeling experiments and mass spectrometry measurements, a technique called “13C-metabolic 
flux analysis”.  
1.2 Thesis hypothesis and objectives 
This work tested the main hypothesis that there are some links between the cell metabolism and 
specific productivity, and that a comprehensive metabolic characterization in relation with 
environmental variables will allow investigation of these links and offer a huge potential for 
rational process design. The work was focused on investigating an inducible mammalian 
expression system, motivated by the facts that (1) inducible systems offer a unique opportunity 
for controlling the recombinant protein expression level of a single cell line (thereby allowing to 
highlight metabolic changes related specifically to cellular growth or productivity, and not due to 
clonal effects) and (2) while inducible mammalian systems are increasingly available, studies 
assessing the impact of key process conditions on the productivity of induced cell cultures are 
sparse. Hence, the main goal of the thesis was to quantitatively characterize the primary 
metabolism of a recombinant CHO cell line harboring an efficient inducible expression system 
with the aid of isotopic tracers. 
The specific objectives were: 
1. To develop an experimental and computational framework for acquiring isotopic 
stationary 
13
C-labeling data and estimating the main intracellular fluxes in cultivated 
mammalian cells 
2. To assess quantitatively the metabolic load imposed by recombinant protein production in 
an inducible mammalian expression system by isotopomer analysis 
3. To investigate the main factors and process conditions affecting cell growth and 
productivity during the induction phase with the aid of isotopic tracers 
4. To study the impact of various feeding protocols on the growth and productivity of 
induced cells 
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1.3 Thesis organization 
Chapter 1 provides a general context and background, as well as the main hypothesis and 
research objectives of the thesis. Chapter 2 presents a literature review of the main strategies used 
for the enhancement of cell culture productivity, as well as the current challenges hindering 
process development and the need for improved metabolic characterization to address them. This 
is followed by a review of the main mathematical approaches to quantify intracellular flux 
distributions in mammalian cells and a discussion on their main advantages and limitations. The 
set of experimental and computational methods used during this research project is described in 
Chapter 3. Chapter 4 was published as a research article entitled “Probing the metabolism of an 
inducible expression system” in the Journal of Biotechnology. In this paper, we quantitatively 
assess the metabolic load of recombinant protein production on the primary metabolism of CHO 
cells using an efficient inducible expression system and 
13
C-metabolic flux analysis. This 
approach allowed us to obtain reliable estimates for the main intracellular fluxes, including 
pathways that cannot be observed from external rate measurements (e.g. the pentose phosphate 
pathway). Chapter 5 presents the second article of this thesis entitled “The impact of the timing 
of induction on the metabolism and productivity of CHO cells” and published in Biochemical 
Engineering Journal. In this contribution, we have investigated how the induction conductions 
affect the cells’ physiological state and the ensuing process productivity. In Chapter 6, entitled 
“Elucidating the effects of post-induction glutamine feeding on the growth and productivity 
of CHO cells”, we have demonstrated that cell growth and productivity can be greatly enhanced 
during the induction phase through the application of a fed-batch strategy. The metabolic impact 
of different feeding regime was also explored with the aid of isotopic tracers. This work was 
submitted for publication in Biotechnology Progress. Chapter 7 consists in a general discussion 
of all the work performed in this thesis and, finally, the conclusion and recommendations for 
future works are presented in Chapter 8.  
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CHAPTER 2 LITERATURE REVIEW 
 
2.1 Industrial mammalian cell culture 
In recent years, mammalian cell culture has become the most important method for the 
production of secreted products such as recombinant proteins and monoclonal antibodies 
(Langdom, 2008). The first use of large-scale mammalian cell culture was for vaccine 
development in the 1950s, while the first modern biotechnology product manufactured using 
mammalian cells, recombinant insulin, was approved in 1982. Since then, around 100 
biopharmaceutical products (including recombinant hormones, growth factors, blood factors, 
monoclonal antibody based products, interferons, therapeutic enzymes, and recombinant 
vaccines) have gained approval in US and 60% - 70% of them are produced using mammalian 
cell culture (Langdom, 2008; Walsh, 2010). The most widely used mammalian cell lines to 
express recombinant based products are Chinese Hamster Ovary (CHO) cells, mouse myeloma 
NSO cells, Baby Hamster Kidney (BHK) cells, Human Embryo Kidney (HEK-293) cells, and 
C127 cells (Langdom, 2008). Even though mammalian cell culture is more complicated, more 
expensive and time consuming compared to other expression platforms (e.g. microbial, insect or 
plant cell culture), it is an essential requirement for a wide range of biopharmaceuticals because 
mammalian cells have the unique ability to perform proper post-translational modifications and 
secrete bioactive glycoproteins (Langdom, 2008; Li, Vijayasankaran, Shen, Kiss, & Amanullah, 
2010). 
 
2.2 Recombinant protein expression by mammalian cells 
Although varieties of mammalian cells are available, only some of them are commonly used as 
host systems for recombinant protein production. The selection of a host system is typically 
determined by its ability to grow in suspension (preferably in serum-free medium), its genetic 
stability, its low risk of accidental infection by potentially pathogenic viruses and its capability to 
deliver a bioactive product at a high production rate. Over the past two decades, Chinese Hamster 
Ovary (CHO) cells have been extensively used for the industrial production of biopharmaceutical 
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products, in particular glycoproteins. This expression platform has been enhanced using different 
strategies including genetic engineering, cellular engineering and metabolic engineering (Datta, 
Linhardt, & Sharfstein, 2013). CHO cells have become the predominant host used to produce 
recombinant proteins and are currently involved in the production of 70% of all therapeutic 
proteins (Jayapal, Wlaschin, Hu, & Yap, 2007).  
The establishment of a cell line for manufacturing recombinant protein requires an expression 
vector construction and an efficient transfection method for either the transient or stable gene 
expression. Transient gene expression has been increasingly used over the past decade. 
Technological developments in transient transfection of CHO cells and its current status have 
been recently reviewed (Geisse & Voedisch, 2012). The main advantage of transient expression 
systems is the short development time; usually significant amounts of product can be produced 
within several days. Thus, they have lower development costs compared to stable expression 
systems and are well suited to fulfill the needs of basic research and preclinical studies (Matasci, 
Hacker, Baldi, & Wurm, 2008).  But due to difficulty in scaling up transient expression into 
bioreactor systems, stable expression is preferred for the industrial production of larger quantities 
of protein.  
A lot of efforts have also been made to improve the host cells characteristics using various 
cellular engineering approaches, for instance to achieve better control over product glycosylation 
(Go et al., 2013; Seth, Hossler, Yee, & Hu, 2006), decreasing programmed cell death by 
overexpression of anti-apoptotic genes (Elmore, 2007; Mohan, Kim, Koo, & Lee, 2008) or 
reducing waste accumulation (Jeong et al., 2001; S. H. Kim & Lee, 2007; Lim et al., 2010), just 
to name a few of the most significant ones. Another interesting avenue of research that is gaining 
increased interest is focused on the development of inducible mammalian expression systems. 
2.2.1 Inducible expression system 
The primary advantage of inducible expression systems is the ability to effectively decouple cell 
growth and product formation, since the recombinant product expression can be biochemically 
controlled (S.S. Ozturk & Hu, 2005; Rita Costa, Elisa Rodrigues, Henriques, Azeredo, & 
Oliveira, 2010). This is particularly advantageous in the case where the recombinant product 
exhibits  a certain cytotoxicity for host cells. Initially, expression systems involved inducers 
having pleiotropic effects on host cells, such as heat shock induction (Brown & Rush, 1990; 
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Burdon, 1986), heavy-metal induction (Heuchel et al., 1994; Schützendübel & Polle, 2002) or 
glucocorticoid induction (Aoyama & Chua, 1997; Heuchel et al., 1994). However, owing to the 
broad range of effects that they produced on the host cells and the typically high levels of basal 
expression that they exhibit, more efficient inducible promoter expression systems have been 
developed. The most widely used are based on the tetracycline (tet) (Forster et al., 1999; Gossen 
& Bujard, 1992), the streptogramin (Fussenegger et al., 2000), the ecdysone (Hoppe, Marban, & 
Johns, 2000; No et al., 1996) and, more recently, the cumate (Gaillet et al., 2010; Mullick et al., 
2006) systems. All these systems consist of a regulatory plasmid and an expression plasmid. The 
former is used for repressor or trans-activator expression, while the latter includes the regulated 
promoter linked to the gene product of interest. Its expression is then controlled by the addition 
(or removal) of an inducer compound to the culture medium, which regulates the activity of the 
repressor (or activator) (Rita Costa et al., 2010).  
From a process development point of view, the use of an inducible expression system is attractive 
in that it provides the unique flexibility for defining operating conditions that are specific to the 
growth and production phases respectively (Panda, 2003). Several studies have been conducted 
dealing with inducible expression in yeasts (Holmes, Darby, Wilks, Smith, & Bill, 2009) and 
mostly bacterial systems (Choi, Keum, & Lee, 2006; Weuster-Botz, Altenbach-Rehm, & Arnold, 
2001). In particular, it has been demonstrated that the process productivity can be dramatically 
increased by the selection of an appropriate induction time (Huber & Buchs, 2011) and by the 
implementation of a post-induction feeding strategy (Choi et al., 2006). But unlike for yeast and 
microbial systems, the literature devoted specifically to the optimization of processes involving 
mammalian inducible expression systems is still very sparse. Induction protocols are essentially 
defined by trial-and-error experiments for determining favorable operating conditions in terms of 
time of induction, concentration of inducer, culture medium, etc. Towards the goal of applying a 
more rational approach, the following section will review the most common methods/strategies 
for improving the productivity of mammalian cell cultures. 
2.3 Culture strategies for the enhancement of productivity 
In a cell culture process, the final product concentration is determined by the cell specific 
production rate, the biomass concentration and the culture longevity. Changes in any of these 
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variables will thus affect the required culture volume and production scale for a desired amount 
of antibody (P. W. Sauer, Burky, Wesson, Sternard, & Qu, 2000). Most of the culture strategies 
developed to date have been successful at increasing peak cell concentration and/or extending 
culture longevity, but some have also been found to improve cell-specific productivity. At the 
process level, significant enhancements were achieved by the development of culture modes 
allowing to reach high cell densities (i.e. fed-batch and perfusion cultures). Other common 
process strategies involve environmental perturbations to stimulate cell productivity. These 
aspects are reviewed in the following sections. Significant enhancements in cell culture 
performance were also due to improved expression vectors and host cell engineering, but these 
topics will not be covered here and have been recently reviewed in details by Dietmair et al. 
(Dietmair, Nielsen, & Timmins, 2011). 
 
2.3.1 Cell culture modes 
When mammalian cells are grown in batch mode, the maximum cell density and productivity are 
typically limited by the accumulation of metabolic by-products, mainly lactate and ammonia, or 
by the depletion of essential nutrients in the culture medium (Xie & Wang, 2006). Such 
limitation/inhibition can be alleviated, at least in part, using other modes of operation. Fed-batch 
is by far the most commonly employed culture mode for the industrial production of cell culture-
based recombinant proteins. In typical fed-batch cultures, cells are supplied with a concentrated 
nutrient feed (either intermittently or continuously) without medium removal, thereby avoiding 
the early depletion of key medium components and allowing to maintain cell growth/viability 
over prolonged time. The development of an efficient feeding strategy involves a balance 
between different parameters such as the nature and concentrations of nutrients in the feed 
solution, the timing of nutrient additions and the rate of feeding (Jain & Kumar, 2008). This is 
not a trivial task due to the complexity of mammalian cell metabolism and the still limited 
knowledge about the intracellular regulating factors of product synthesis. The most frequent fed-
batch protocols are designed to minimize the accumulation of lactate and ammonia (T. A. Bibila 
& D. K. Robinson, 1995). Many experimental studies on antibody production by mammalian 
cells have shown that maintaining low levels of glucose/glutamine can effectively reduce the so-
called “overflow metabolism” and the ensuing production of waste metabolites (Helder J. Cruz, 
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Moreira, & Carrondo, 2000; Kurokawa, Park, Iijima, & Kobayashi, 1994; Jan Ljunggren & 
Häggström, 1994). However, the successful implementation of such strategy requires an efficient 
monitoring and control scheme to ensure that the main nutrients are not completely depleted from 
the culture environment. Moreover, maintaining low substrate concentrations can cause 
significant and undesired changes on the gene expression for glycosylation and impact the quality 
of secreted antibodies (Kochanowski et al., 2008; Wong, Wong, Goh, May, & Yap, 2010). 
Minimizing waste metabolite formation was also accomplished through substitutions of the main 
carbon sources in culture medium. For example, the simultaneous substitution of glucose by 
galactose and glutamine by glutamate in fed-batch cultures of CHO cells was shown to reduce 
significantly the generation of metabolic by-products, although the cell specific growth rate was 
slightly impaired by those substitutions (Altamirano, Paredes, Cairo, & Godia, 2000; Altamirano, 
Paredes, Illanes, Cairo, & Godia, 2004). Another rational approach that proved successful for 
fed-batch cultures involves feeding the cells with stoichiometric amount of concentrated 
nutrients. Cell requirements were derived from simple mass balance equations and, in the case of 
hybridoma cells, this led to substantial improvements in terms of cell growth and product yield 
compared to batch cultures (Liangzhi Xie & Daniel I. C. Wang, 1996).  
 
While the majority of current industrial bioreactors are operated in fed-batch mode, a perfusion 
process can be more advantageous in some cases, for instance when the product of interest is 
unstable in the culture environment. In this mode of operation, a constant supply of nutrients and 
a concomitant removal of culture medium are performed at the same rate, while cells are retained 
inside the bioreactor through some filtering device placed inside the vessel (e.g. spin filter) or on 
the outflow (e.g. acoustic separator). The main advantage of the perfusion mode is that the cells 
are retained in a favorable biochemical environment (high nutrient and low waste 
concentrations), which allows to reach high cell densities while minimizing the residence time of 
the product (Dalm et al., 2007; O. Henry, Kamen, & Perrier, 2007). However, in this mode of 
operation, large volumes of fresh and spent media must be fed/harvested to/from the bioreactor 
and the product can be significantly diluted. Consequently, the main disadvantages of perfusion 
systems are the inherent complexity and costs of the production/purification steps (Chon & 
Zarbis-Papastoitsis, 2011; Mercille, Johnson, Lanthier, Kamen, & Massie, 2000). Nonetheless, 
viable cell concentrations of 1-5×10
7
 cells/ml at 10 volumes/day dilution rate and product titres in 
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the range of several g/L are typically achieved with current perfusion technology, which is on 
average an order of magnitude greater than conventional batch processes (Woodside, Bowen, & 
Piret, 1998), but comparable to the performance of optimized fed-batch cultures. 
 
The chemostat is another type of continuous mode, but without cell retention (Martens, de 
Gooijer, van der Velden-de Groot, Beuvery, & Tramper, 1993). Its operation is in general 
difficult and the cell concentrations achieved are very low due to the constant culture dilution. 
This mode is thus mostly employed in research to conduct metabolic studies of cells under 
defined steady-state culture conditions (H. P. Bonarius et al., 2001; Miller, Blanch, & Wilke, 
1988). The semi-continuous (or repeated-batch) mode is an alternative form of operation, 
whereby a fraction of the culture volume is removed and replaced by fresh medium on a daily 
basis. This mode allows to approximate steady-state conditions, while preserving the relative 
simplicity of batch mode (Olivier Henry, Kwok, & Piret, 2008) and is thus relatively easy to 
perform at lab scale.  
2.3.2 Environmental perturbations affecting cell productivity 
Numerous strategies have been found to increase the cell specific productivity, typically by 
changing the culture environment through the addition of a specific compound (e.g. sodium 
butyrate, dimethyl sulphate, valproic acid) or by altering the physico-chemical conditions (e.g. 
mild hypothermia or hyper osmolality). It's interesting to note that most of these environmental 
perturbations have been associated with changes in metabolic and signalling pathways 
(O'Callaghan & James, 2008). For example, sodium butyrate addition has been shown in many 
instances to stimulate the production of recombinant proteins (Hendrick et al., 2001; McMurray-
Beaulieu, Hisiger, Durand, Perrier, & Jolicoeur, 2009; Sunley & Butler, 2010). Up to 6 fold 
increase in antibody specific productivity was reported through the addition of sodium butyrate 
(Chun, Park, Chung, & Bang, 2003). However, in some cases this compound was also shown to 
induce cell growth or programmed cell death (F. Chen et al., 2011; Wang et al., 2004) and its use 
as a productivity enhancer must thus be assessed for each host cell system. It is also largely 
documented that operating cultures at lower temperature (usually between 30-33⁰C) during the 
production phase can have a positive impact on culture productivity, and this effect was observed 
with several cultivated mammalian cell systems (Fox, Patel, Yap, & Wang, 2004; Kou et al., 
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2011; Sunley & Butler, 2010). For example, Yoon et al. reported that their CHO cell line 
exhibited lower specific growth rates (reduction of 30-63%) under mild hypothermic conditions, 
however,  the cell specific productivity was enhanced greatly (4-25 fold) (Yoon, Hwang, & Lee, 
2004). Although the mechanisms of the mild hypothermic response are not completely 
understood, it is believed that cell growth usually arrest in G0/1 phase of the cell cycle, resulting 
in an extension of viable cell lifetime (O'Callaghan & James, 2008). Hyperosmotic stress also  
induces cell cycle arrest in G0/1 phase and often lead to increased cell-specific productivity (N. 
S. Kim & Lee, 2002; M. S. Lee, Kim, Kim, & Lee, 2003; Sun, Zhou, Liang, McNeeley, & 
Sharfstein, 2004). Some strategies can be used in combination, such as the report on combining 
osmotic and temperature shifts to achieve increase of interferon production (Han, Koo, & Lee, 
2009). It is interesting to point out that reported increases in productivity are often correlated with 
decreases in the proliferation rate (Dinnis & James, 2005). 
 
2.3.3 Challenges in cell culture process enhancement 
Over the last two decades, together with improvements of expression vectors and host cell 
engineering, optimization of culture media and cultivation processes have led to about a five-fold 
increase in cell densities, a three-fold enhancement in culture longevity and a 100-fold increase in 
product concentration (Dietmair et al., 2011). While many of the approaches described previously 
have shown to be practically effective for increasing product yields, most of these studies also 
underscore that more comprehensive analysis and mechanistic understanding of cell metabolism 
is necessary to assess and eventually control rationally how mammalian cells respond to 
environmental perturbations and process conditions. To this day, bioprocess optimization is often 
largely based on trial-and-error experiments. This is notably the case when developing fed-batch 
protocols, since cellular growth and protein expression are two complex metabolic functions, and 
it is not yet well understood how these two functions and nutritional requirements are related. 
Further characterization of the underlying limiting metabolic factors is thus needed to allow for 
the rational development of adapted feeding strategies in fed-batch processes. To maximize final 
product concentration, it appears that a suitable trade-off must sometimes be found between the 
levels of gene expression and cell growth (Dinnis & James, 2005). Therefore, elucidating the 
alterations in central carbon metabolism caused by recombinant protein production is 
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instrumental for the establishment and optimization of a productive mammalian cell expression 
platform. This has led to extensive studies on cell metabolism and the development of 
comprehensive metabolic models, as reviewed in the next section. 
2.4 Metabolic characterization of mammalian cells 
2.4.1 Theoretical aspects of mathematical approaches  
Mathematical approaches have a crucial importance for quantitatively characterizing cell 
physiology under relevant process conditions. Cell metabolism consists of highly interconnected 
metabolic pathways that involve thousands of intracellular reactions catalyzed by enzymes. The 
rates of the intracellular biochemical reactions are defined as the metabolic fluxes. Together with 
intracellular metabolite pools, metabolic fluxes are considered to represent the minimal 
information needed for describing cell physiology and metabolism under a set of environmental 
conditions (G. Stephanopoulos, 1999). Different mathematical modeling methods have been 
developed for describing cellular functions, either individual function (Single Cell Method, 
SCM) or the function of overall (Population Balance Model, PBM) cellular processes (Sidoli, 
Mantlaris, & Asprey, 2004). In traditional metabolic studies, models were formulated based only 
on extracellular metabolites (such as nutrients and products) and biomass concentration 
(Sanderson, Phillips, & Barford, 1996). Often, these unstructured models have a narrow range of 
applicability and fail to predict cellular behaviour under many relevant process conditions 
(Gombert & Nielsen, 2000). Advances in analytical methods have allowed the development of 
more structured models. Moreover, the vast increase in computing power and speed made 
possible to solve large and highly non-linear models.  
A mathematical model able to describe the cellular metabolism is a fundamental tool in metabolic 
engineering. These models can be stoichiometric, whereby a set of algebraic equations is used to 
describe the intracellular reactions and can be used to simulate metabolic fluxes at steady-state. 
Kinetic models on the other hand are usually based on rate laws for biochemical reactions and 
can provide a dynamic description of cell metabolism. Up to now, stoichiometric models have 
had more widespread applications when dealing with large metabolic networks. While kinetic 
models can be powerful tools for studying the dynamics of metabolic and biosynthetic pathways 
(Baughman, Huang, Sharfstein, & Martin, 2010; Ghorbaniaghdam, Henry, & Jolicoeur, 2013), 
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the typical lack of relevant enzymatic kinetic and intracellular concentration data often 
constitutes a severe limitation for their development, validation and use. With the stochiometric 
approach, which is usually simply based on steady-state mass balances, there is no need to 
consider intracellular metabolite concentrations and kinetic parameters. Various intracellular 
processes can be specified within stoichiometric models, thereby allowing for example to account 
for the metabolic requirements and energetic cost for recombinant protein production (Sheikh, 
Förster, & Nielsen, 2005). 
2.4.2 Stoichiometric models and metabolic flux analysis 
Because of their relative ease of application, stoichiometric models of metabolic networks are 
now widely used tools in metabolic engineering (Boghigian et al., 2010). They are at the heart of  
"metabolic flux analysis", a technique which aims at quantifying the actual rates of intracellular 
reactions occurring inside a cell. The stoichiometry of a network is defined in a "m" by "n" 
dimensional matrix, which is called the stoichiometric matrix ("S"). Here, "m" is the number of 
internal metabolites and "n" is the number of intracellular reactions (fluxes). Each entry in the 
matrix corresponds to the stoichiometric coefficient of the m
th
 metabolite participating in the n
th
 
reaction. Since most metabolites participate in only a small number of reactions, the 
stoichiometric matrix is typically sparse, meaning that most of the entries are zero (Boghigian et 
al., 2010).  
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Figure 2-1 illustrates this concept for a very simple example network. Studies are mainly carried 
out under the assumption of metabolic steady-state, which is a prerequisite for stationary 
metabolic flux analysis and implies that there is no significant accumulation of internal 
metabolites in the system (G. Stephanopoulos, 1999). Thus, a system of linear equations is 
obtained in the form: 
S m x n .V=0 
It should be emphasized that, in practice, true steady state conditions do not need to be reached. 
In most cases, fluxes are calculated during the exponential growth phase of the cells. During this 
phase, if a dramatic transient does not occur, the so-called pseudo-steady state assumption has 
been found to hold reasonably well (Niklas & Heinzle, 2012; Sidorenko, Wahl, Dauner, Genzel, 
& Reichl, 2008). 
Depending on the number of linearly independent metabolite balances (r), given by the rank of 
matrix S, and the number of reactions (n), three scenarios are possible (K. Lee, Berthiaume, 
Stephanopoulos, & Yamush, 1999): 
1- If r = n, the system is determined. These systems usually have a unique solution and are 
algebraically and computationally the simplest.  
2- If r > n, the system is over-determined. Fluxes can be calculated by a least squares 
regression. Redundant equations can also be used to validate data and model consistency. 
Figure  2-1: Principle of stoichiometric models 
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3- If r < n, the system in under-determined with "n-r" degrees of freedom. An infinite 
number of solutions exist for these systems. Only a subset of fluxes can be directly 
calculated. 
 
In most biochemical networks, the number of unknown fluxes exceeds the number of 
independent equations (underdetermined system) (Boghigian et al., 2010). This happens due to 
the lack of measurements and the presence of parallel metabolic pathways (e.g. the pentose 
phosphate pathway or the malate shunt), cyclic pathways and bidirectional reaction steps (H.P. 
Bonarius, Schmid, & Tramper, 1997; Wiechert, 2001). A unique flux distribution cannot be 
computed in this case, unless additional constraints or model assumptions are considered. Several 
approaches have been proposed to address this issue. Although some of the fluxes may be 
calculable, it will result in a limited and incomplete picture of cell metabolism (Klamt & 
Schuster, 2002). Bonarius et al. (H.P. Bonarius et al., 1997) reviewed several strategies involving 
theoretical assumptions or constraints that can be used to solve underdetermined network: mass 
balances of cofactors and co-metabolites (e.g. ATP and NADH), objective functions solved by 
linear optimization (e.g. minimizing the consumption of ATP) and irreversibility of reactions. 
However, validation of these assumptions has been repeatedly called into question (Fischer & 
Sauer, 2005; F. Llaneras & Pico, 2008; Wiechert, 2001).  
A better approach is to fully resolve metabolic networks using additional independent data 
derived from labeling experiments with tracers, as described in the following section. 
2.4.3 Metabolic flux analysis with isotopic tracers 
The traditional use of isotopic tracer experiments in metabolic studies goes back to 1940-1960s, 
when such experiments were used for the structural identification of biochemical reactions (U. 
Sauer, 2006). For decades, this approach involved the use of radioactive tracers (e.g. 
14
C) and 
they was intensively used for the evaluation of metabolic fluxes during the 1980s (Blum & Stein, 
1982). Since then, radioactive tracers have been replaced for the most part by stable isotopes (e.g. 
13
C-labeling). Isotopic tracer experiments have become a powerful technique to analyse 
metabolic networks, owing to advances in nuclear magnetic resonance (NMR) and mass 
spectrometry (MS) technologies, along with the development of efficient computational 
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algorithms (Crown & Antoniewicz, 2013). The main differences between radioisotopes and 
stable isotopes are related to the output of the measurement methods for evaluating the 
enrichment. For radioisotopes, the results of isotopic enrichment measurement are reported in 
terms of specific activity (or dpm/mol). Only the total labeling data is available and there is no 
information regarding the relative amount of labeled or unlabeled molecules in a sample. Thus, 
only one balance equation may be written for the total radioactivity. In contrast, more 
experimental data can be derived from stable isotopic experiments (Kelleher, 2001). For example, 
mass spectrometry measurements can provide the relative amount of each mass isotopomer and a 
balance equation can thus be written for the fractional abundance of each of them. Accordingly, 
metabolic flux analysis based on stable isotopic experiments, so called "
13
C-metabolic flux 
analysis, can allow to investigate the metabolism on a more global level than radioisotope 
experiments (Zupke & Stephanopoulos, 1995).  
 
 
Figure  2-2: Typical procedure for isotopic tracer experiments and flux analysis 
 
With 
13
C-metabolic flux analysis, additional constraints for intracellular flux estimation can be 
provided through the use of 
13
C-labeled substrates and subsequent measurement of isotope 
integration into intracellular or extracellular metabolite pools. An overview of how labeling 
experiments are typically performed is depicted in Figure 2-2. In such experiment, cells in culture 
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are fed with medium containing one or several specifically labeled substrates. Upon being 
consumed by the cells, the labeled carbon is then distributed throughout the metabolic network. 
Techniques based on Mass spectrometry (MS) or nuclear magnetic resonance (NMR) 
spectrometry can then be used to measure the level of isotope enrichment in different metabolites. 
The resulting enrichment data, in combination with extracellular flux measurements, can be used 
together with stoichiometric balancing to compute the intracellular fluxes for the system. In 
principle, this technique enables the quantification of certain metabolic fluxes which cannot be 
estimated solely from extracellular rate measurements and mass balancing. This is notably the 
case for parallel pathways, cyclic and reversible pathways. However, these pathways can be 
observed with isotopic tracers since they will give rise to distinct isotopomer distribution patterns 
(an isotopomer is a metabolite with a specific 
13
C-labeling pattern) (Christensen & Nielsen, 
2000b). Since the method is based on carbon balancing, flux estimation does not rely on energy 
and/or redox balance assumptions. The energy and redox balances can however be assessed from 
the resulting flux distribution obtained via 13C-MFA (Quek, Wittmann, Nielsen, & Kromer, 
2009; Wittmann, 2002).    
 
17 
 
 
Figure  2-3: Major technical and computational advances in the development of 
13
C-MFA. Figure 
taken from (Boghigian et al., 2010). 
 
Until recently, 
13
C-metabolic flux analysis has been predominantly used to estimate intracellular 
fluxes in the central carbon metabolism of microorganisms such as bacteria (Al Zaid Siddiquee, 
Arauzo-Bravo, & Shimizu, 2004; Schaub, Mauch, & Reuss, 2007; Schmidt, Nielsen, & 
Villadsen, 1999) and yeasts (Costenoble et al., 2007; Kleijn et al., 2007; W. A. van Winden et al., 
2005). Labeling experiments are facilitated from the fact that these organisms can grow in 
defined medium containing a single carbon source. These studies were conducted during both 
steady-state and pseudo-steady-state conditions by simultaneous metabolite and isotopomer 
balancing. 
Because 
13
C-MFA offers a huge potential for rational process design, it has recently found 
increasing applications in metabolic studies of mammalian cells. However, one of the major 
challenge for the application of this method to mammalian cells lies in the relative complexity of 
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the culture media, which contain multiple carbon sources (e.g. glucose, amino acids, lipids). As a 
result, the 13C-labeled tracer can be significantly diluted due to the presence of unlabeled carbon 
sources, making the determination of reliable enrichment data difficult. Nonetheless, in the last 
decade, several isotopic tracer studies were conducted to obtain flux distributions in many 
relevant mammalian cell lines, such as Hybridoma cells (H. P. Bonarius et al., 1996; H. P. 
Bonarius et al., 2001; H. P. Bonarius, Timmerarends, de Gooijer, & Tramper, 1998; Paredes, 
Sanfeliu, Cardenas, Cairó, & Gòdia, 1998; Zupke & Stephanopoulos, 1995), Chinese Hamster 
Ovary cells (CHO) (Woo Suk Ahn & Antoniewicz, 2011; Deshpande, Yang, & Heinzle, 2009; C. 
Goudar et al., 2010; Mohan et al., 2008; Sengupta, Rose, & Morgan, 2011; Zamorano, Vande 
Wouwer, & Bastin, 2009; Zamorano, Wouwer, & Bastin, 2010), hepatic cells (Hofmann et al., 
2008; Maier, Hofmann, Reuss, & Mauch, 2008) and Human Embryonic Kidney 293 cells (HEK 
293) (Olivier Henry & Durocher, 2011; Olivier Henry, Jolicoeur, & Kamen, 2010). The 
experimental and computational aspects associated with 
13
C-metabolic flux analysis when 
applied in the context of mammalian cell cultures are reviewed in the following sections. 
 
2.5 Technical aspects of 13C-metabolic flux analysis 
2.5.1 Labeling experiments 
Several studies were focused on improving isotope labeling strategies/protocols to allow for a 
reliable estimation of intracellular fluxes. Typically, 
13
C-labeled substrates are fed to the cells 
until the labeled carbon is distributed throughout the metabolic network. Then, the 
13
C labeling 
patterns of certain metabolites are measured using modern analytical techniques such as high-
resolution NMR spectroscopy (C. Goudar et al., 2010; P. G. Henry et al., 2006; Mancuso, 
Sharfstein, Tucker, Clark, & Blanch, 1994; Shen et al., 1999; Simpson & Constantinidis, 2007; 
W. van Winden, Schipper, Verheijen, & Heijnen, 2001; Zupke & Stephanopoulos, 1995) or mass 
spectrometry (MS) (Maciek R Antoniewicz, Joanne K Kelleher, & Gregory Stephanopoulos, 
2007; H. P. Bonarius et al., 2001; Olivier Henry et al., 2010; Rühl et al., 2012; Wittmann, 2007). 
The design of labeling experiments is a crucial step in 
13
C-MFA in order to estimate the fluxes of 
interest with good confidence. Flux identifiability and accuracy depend on 1) the metabolic 
network structure 2) the specific labeled substrate(s) used and 3) the nature and number of 
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available labeling measurements. The first step is usually to select an appropriate labeled 
substrate (e.g. 100 % U-
13
C-glucose) or a mixture of specifically labeled substrates (e.g. 50 % 1-
13
C and 50 % U-
13
C glucose). Studies have proposed different approaches to guide the selection 
of an optimal tracer or combination of tracers (Crown, Ahn, & Antoniewicz, 2012; Libourel, 
Gehan, & Shachar-Hill, 2007; Metallo, Walther, & Stephanopoulos, 2009). Depending on 
whether a whole metabolic profile or specific fluxes are targeted, some tracers will be more 
suited than others. 
13
C-labeled glucose and glutamine are the most common tracers used for 
13
C-
MFA of mammalian cells, as they are usually the two main carbon sources in culture medium. 
Through simulations of a representative mammalian cell network, it was for example 
demonstrated that the TCA cycle fluxes can be well estimated using uniformly labeled glutamine, 
whereas 1,2-
13
C glucose can provide precise estimates for the pentose phosphate pathway 
(Metallo et al., 2009). However, these results were obtained for a given flux distribution, which is 
a priori unknown when conducting an isotopic tracer study, and for a given set of available 
measurements. Without prior knowledge, proper tracer selection has to be done through an 
iterative process based on the quality and quantity of measurements available. 
Typically, not all the fluxes in a network can be reliably estimated with a single experiment (P.F. 
Suthers et al., 2007). Thus, depending on the metabolic pathway structure, different labeling 
experiments will be best appropriate (Niklas & Heinzle, 2012). An isotopic labeling experiment 
can be performed in a single culture (using a single tracer or a mixture of tracers), but can also be 
performed in multiple parallel cultures, each having specifically labeled substrates. Provided that 
each culture can be maintained in a similar physiological state, the data extracted from all the 
parallel cultures can then be combined to infer a single representative  metabolic flux distribution. 
Henry et al. used four parallel experiments using three glucose tracers (1-, 6- and U-
13
C glucose) 
and one glutamine tracer (U-
13
C glutamine) and by analyzing only the resulting mass isotopomer 
distributions of extracellular lactate, they managed to elucidate and quantify all the main 
intracellular fluxes of HEK-293 cells (Olivier Henry et al., 2010). Recently, the technical and 
theoretical advantages of parallel labeling experiments have been reviewed by Crown and 
Antoniewicz (Crown & Antoniewicz, 2013). 
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2.5.2 Metabolic model construction 
The mammalian cell metabolism consists of thousands of known enzyme-catalyzed reactions. 
However, setting up of fully mechanistic models to describe cellular metabolism is usually not 
practical and most models employed in metabolic investigations are based on several 
simplifications (e.g. lumping of reactions). In a first step, a metabolic network should be 
constructed by adding piece by piece relevant biochemical reactions based on information 
derived from the literature. Many metabolic models have been proposed for the primary 
metabolism of several mammalian cells. As an example, a metabolic network of the central 
carbon metabolism of CHO cells is presented in Figure 2-4. This model has been constructed 
from both classical biochemistry text books and previously published stochiometric models 
(Altamirano et al., 2001; C. Goudar et al., 2010; Quek, Dietmair, Krömer, & Nielsen, 2010; 
Zamorano et al., 2010). In general, metabolic models of mammalian cells consider the following 
pathways:  
Glycolysis and lactate production (reactions 1-6) 
Glycolysis involves several enzyme-catalyzed reactions that convert glucose to pyruvate and 
usually constitutes a major source of energy for cultivated mammalian cells due to the high 
glucose uptake rate. Because of the large decline of net free energy, this is essentially an 
irreversible pathway. The overall reaction of glycolysis is: 
                                          
       
So the aerobic glycolysis generates 2 mol of ATP and 2 mol of NADH per mol of glucose 
consumed. Then, in the respiratory chain, NADH will release energy in the form of ATP. 
 
Pentose-phosphate pathway (reactions 7-10) 
This pathway contains an oxidative branch (reaction 7) and a non-oxidative branch (reaction 8-
10). The oxidative branch of pentose phosphate pathway (ox-PPP) is mainly responsible for 
producing the building blocks for nucleotides synthesis. This pathway also generates cytosolic 
NADPH in mammalian cells, through converting glucose-6-phosphate to ribulose-5-phosphate. 
Besides, the non-oxidative pentose phosphate pathway (non-ox-PPP) links the pentose phosphate 
pathway to glycolysis through the reactions from xylulose-5-phosphate (X5P) to 
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glyceraldehydes-3-phosphate (GAP) and fructose-6-phosphate (F6P). In fact, non-ox-PPP 
consists of a series of many reversible reactions (transaldolase and transketolase reactions) which 
operate near equilibrium. The split between ox-PPP and non-ox-PPP part cannot be determined 
from extracellular rate measurements alone. In conventional metabolic flux analysis studies, it is 
usually assumed that the PPP flux will exactly meet the requirements for nucleotides synthesis 
(Niklas & Heinzle, 2012), that is, the transaldolase and transketolase activity is ignored and only 
ox-PPP is considered (Martens, 2007). However,  it is possible to quantify fluxes through the PPP 
with 
13
C-tracers and such questionable assumption is therefore not required.  
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Figure  2-4: a schematic metabolic network model for the central carbon metabolism of CHO cells 
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Tricarboxylic acid (TCA) cycle (reactions 11-16) 
Pyruvate produced during glycolysis is transported into mitochondria and is then converted into 
acetyl-CoA. The pyruvate dehydrogenase complex (PDC) catalyzes the irreversible conversion of 
pyruvate to acetyl-CoA and CO2 (reaction 11). PDC is actually a complex of three distinct 
enzymes: pyruvate dehydrogenase, dihydrolipoly transacetylase, and dihydrolipoly 
dehydrogenase. Acetyl-CoA then enters the TCA cycle, which is a major source of energy for 
cells. The net reaction of TCA cycle is: 
                                  
                         
       
In fact, only one ATP is produced per cycle, but the large formation of ATP happens in the 
respiratory chain where the NADH and FADH2 are oxidized in the electron-transport chain 
Besides ATP generation, TCA cycle also supplies intermediates required for the synthesis of 
biomass (e.g. citrate for lipid synthesis). 
 
Amino acid metabolism (reactions 26-45) 
Essential amino acids cannot be synthesized in mammalian cells and they must be supplied in the 
culture medium. Therefore, their catabolism is important to consider in metabolic studies. 
Mammalian cells can synthesize  non-essential amino acids that can be involved in both anabolic 
and catabolic pathways. Among all amino acids, glutamine is usually the most consumed. 
 
2.5.3 Flux estimation from labeling measurements 
Metabolic fluxes are calculated from measured labelling data according to the general procedure 
outlined in Figure 2-5. Whereas conventional MFA involves mass balance equations for each 
metabolite in a system, 
13
C-MFA relies on simultaneous metabolite and isotopomer balances  and 
involve consequently a large number of equations. Moreover, labeling data are nonlinear 
functions of the fluxes making the approach even more complex. As a result, there have been 
several studies devoted to the development of systematic procedures and computational 
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algorithms to efficiently estimate flux distribution from labeling data obtained via NMR or mass 
spectrometry. 
One of the first such modeling contributions was proposed by Zupke and Stephanopoulos (Zupke 
& Stephanopoulos, 1994) who introduced the elegant concept of “Atom Mapping Matrices” 
(AMMs), which can be used to compute 
13
C enrichments of metabolites from a known flux 
distribution and a given input labeled substrate. In their method, for each enzymatic reaction, an 
AMM is constructed to track the transfer of carbon atoms from reactants to products. The first 
application of this general approach was carried out to characterize the metabolism of Hybridoma 
cells with in vivo 
13
C NMR data (Zupke & Stephanopoulos, 1995). The first extensive labeling 
data set comprising more than 25 
1
H NMR measurements was generated and analyzed  by Marx 
et al. (Marx, de Graaf, Wiechert, Eggeling, & Sahm, 1996). subsequent studies performed by 
Wiechert et al. (Wiechert & de Graaf, 1997; Wiechert, Siefke, de Graaf, & Marx, 1997) 
presented detailed treatment of flux estimation with improved measurements obtained from 
1
H 
NMR experiments and they also discussed the statistical analysis of the resulting estimates. 
Follstad and Stephanopoulos (Follstad & Stephanopoulos, 1998) were able to analyze the effects 
of reversible reactions on the distribution of  
13
C carbons using the AMM technique. 
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Around the same time, the concept of isotopomer balancing was gaining increasing recognition in 
the field. A metabolite with "n" carbon atoms will have "2
n"
 isotopomers. While the formerly 
1
H 
NMR-based experiments only allowed the measurement of "n" enrichments per metabolite 
molecule, the measurement of isotopomers, through wisely planned 
13
C NMR experiments, could 
provide up to 2
n
 measurements per molecule, therefore enormously increasing the amount of raw 
data to estimate intracellular fluxes. Schmidt et al. (Schmidt, Carlsen, Nielsen, & Villadsen, 
1997) extended the concept of AMMs to “Isotopomer Mapping Matrices” (IMMs) and developed 
a SIMULINK module that could automatically generate isotopomer balances. With the use of 
IMMs, it is possible to formulate efficiently all isotopomer mass balances for each metabolite by 
means of "Isotopomer Distribution Vectors" (IDVs) and to calculate the fraction of each 
metabolite present in a specific isotope form. Isotopomer analysis is inherently much more 
complicated. As an illustrative example, considering two metabolites A and B with "n" and "m" 
number of carbons respectively (A is a substrate and B is a product), the size of IMM (AB) is 
2
m2n while the size of the AMM(AB) is mn. Klapa et al. (Klapa, Park, Sinskey, & 
Stephanopoulos, 1999) illustrated the technique of isotopomer enumeration and balancing, 
Figure  2-5: General procedure for 
13
C-based metabolic flux analysis  
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wherein only physically detectable isotopomers were balanced. This technique is advantageous in 
experiments using specifically labelled substrates (e.g. 1-
13
C glucose or 2-
13
C pyruvate) present 
in large percentages (90% and above), so that the natural abundance of 
13
C becomes negligible in 
the analysis. They applied this technique to analyze the TCA cycle in mammalian cells and 
developed the analytical formulas that can be used to evaluate fluxes from NMR data. With this 
approach, they were able to detect the presence or absence of glyoxylate shunt activity. A 
subsequent study discussed practical application of this work when applied to E. coli and labeling 
data gathered from mammals (S. M. Park, Klapa, Sinskey, & Stephanopoulos, 1999). The IMM 
approach was also used in conjunction with GC-MS data for studying the central carbon 
metabolism of Penicillium by Christensen and Nielsen (Christensen & Nielsen, 2000a).  
Although it could provide useful results, the IMM approach is cumbersome and isotopomer 
balances must be solved with an iterative scheme. To cope with these limitations, the cumomer 
(cumulative isotopomer) concept was soon after introduced by Wiechert et al. (Wiechert, 
Mollney, Isermann, Wurzel, & de Graaf, 1999). Compared to the isotopomer balancing approach, 
the main advantage of this method  is that intracellular fluxes are calculated by solving in cascade 
a set of linear equations. Thus, the concept of cumomer provides a much more efficient way to 
estimate fluxes, compared to the earlier iterative method which was computationally expensive, 
particularly for systems involving near-equilibrium reversible reactions. In a sequel paper, 
Mollney et al. (Mollney, Wiechert, Kownatzki, & de Graaf, 1999) analyzed the identifiability of 
the fluxes and detailed the procedures for the optimal design of carbon labeling experiments, 
taking into account various errors that arise in the raw labeling data. These procedures were 
incorporated into a carbon labeling evaluation software released in 2001 (Wiechert, 2001). 
Petersen et al. (Petersen et al., 2000) used this software and were able to successfully 
demonstrate a significant futile cycle in Corynebacterium glutamicum. 
The "Elementary Metabolite Unit" (EMU) is a recent model framework that was also developed 
to improve the efficiency of flux estimation (M.R. Antoniewicz, J.K. Kelleher, & G. 
Stephanopoulos, 2007). This approach consists in a powerful decomposition algorithm that only 
retains the relevant carbon transitions for the available measured mass distribution data. The 
functional units  (or  EMUs) resulting from the decomposition form the basis for describing the 
links between metabolic fluxes and labeling data. Since it is not required to simulate all possible 
isotopomers with the EMU framework, it yields a significant reduction in computational time for 
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flux determination and also for the evaluation of the associated confidence intervals (P. F. 
Suthers, Chang, & Maranas, 2010).  
2.5.4 Stationary and instationary 13C-MFA 
13
C-MFA can also be categorized into stationary and non-stationary approaches. In the stationary 
case, experiments must be designed in such a way that both isotopic and metabolic steady-states 
are achieved prior to sampling for mass spectrometry analysis. With cultivated mammalians cells 
under balanced-growth, it was shown that such conditions are attained within several hours 
(usually 4 to 6h) after tracer addition in the culture medium, but the dynamics of labeling can 
vary among different metabolites.  
Wiechert and his co-workers proposed an instationary (or transient) metabolic flux analysis, 
whereby the labeling time-courses of metabolites are considered for flux estimation (Noh et al., 
2007; Noh, Wahl, & Wiechert, 2006; Noh & Wiechert, 2006; Wiechert & Noh, 2005). The non-
stationary method requires to perform repeated sampling over time, whereas the stationary 
method only requires a single measurement performed under metabolic and isotopic steady-states 
(Morgan & Rhodes, 2002). Since the intracellular pools are typically very small, it is expected 
that equilibration is reached relatively fast and consequently the experiments can be very short. 
Moreover, the amount of costly labelled substrate can be reduced with this approach and, if 
enough experimental labeling data are available, instationary analysis also allows the estimation 
of intracellular pool sizes. But, as expected, the experimental, computational and mathematical 
difficulties for the transient case are much greater than for the steady-state case (Noh et al., 
2007). Recently, Noh et al. successfully applied instationary 
13
C-MFA for the analysis of E. coli 
cultures and discussed various aspects related to the experimental design (sampling intervals, 
feed label composition), the sensitivity analysis and the computational methods for the transient 
case (Noh et al., 2007; Noh et al., 2006; Noh & Wiechert, 2006). Hofmann and Maier 
demonstrated the application of this approach to study the metabolism of hepatic cells (Hofmann 
et al., 2008; Maier et al., 2008). They described an experimental set up to quantify the extra- and 
intracellular metabolite concentrations and also detailed methods allowing the measurements of 
mass isotopomer fractions by GC-MS and LC-MS. However, they did not consider the 
metabolism of all amino acids in their analysis. More recently, Ahn and Antonirewicz have 
reviewed the novel techniques available for dynamic metabolic flux analysis and outlined the 
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challenges that still need to be solved in the case of mammalian cells (W. S. Ahn & Antoniewicz, 
2012), which are essentially the slow labeling dynamics and the compartmentalization of cell 
metabolism.  
 
2.6 Application of metabolic flux analysis in CHO cell cultures 
As mentioned previously, among all mammalian cells, Chinese Hamster Ovary (CHO) cells are 
the most popular host system for the industrial production of recombinant proteins. It is thus not 
surprising that they have received a lot of attention and have been the subject of many 
comprehensive metabolic studies. This section provides a review of the main studies in which 
classical MFA and 
13
C-MFA were employed for CHO cell characterization and process 
improvements. 
2.6.1 Metabolic flux analysis of CHO cells 
In the past two decades, metabolic flux analysis has become an established tool and the primary 
approach to study in details mammalian cell metabolism. One of the first effort to perform such 
comprehensive characterization of CHO cells metabolism was carried out by Nyberg et al. 
(Nyberg, Balcarcel, Follstad, Stephanopoulos, & Wang, 1999). They employed metabolic flux 
analysis to validate the consistency of extracellular measurements and found that, with complex 
hydrolysate-containing media, the contribution of amino acids originating from the peptides is 
significant and must be taken into account when analysing the cell needs. They also investigated 
the relationship between cell metabolism and glycosylation site occupancy heterogeneity in 
different glucose and glutamine limited steady-state cultures (Nyberg, Balcarcel, Follstad, 
Stephanopoulos, & Wang, 2000). They found that glycosylation correlated with TCA cycle 
activity, but not with glycolysis. A similar study was performed recently and also revealed 
possible links between protein glycosylation and the primary metabolism of CHO cells (Burleigh 
et al., 2011). 
 
MFA studies were also conducted with the goal of helping the rational design of enhanced 
medium formulations. In particular, the identification of suitable substrates that can generate less 
29 
 
lactate and ammonia was investigated by several groups. Altamirano et al. have characterized by 
MFA the effects of substituting glutamine by glutamate and found that glutamate-based medium 
promoted a more efficient utilization of glucose and nitrogen sources (Altamirano et al., 2001). 
Several experimental observations confirmed that lactate can be re-metabolized by CHO cells 
(Luo et al., 2012; Tsao et al., 2005; Zagari, Jordan, Stettler, Broly, & Wurm, 2013). To better 
understand the factors which can cause the metabolic shift to lactate consumption, comparative 
metabolic flux analysis were performed in culture media containing different combinations of 
glucose and galactose (Altamirano, Illanes, Becerra, Cairo, & Godia, 2006; Wilkens, Altamirano, 
& Gerdtzen, 2011). These studies suggested that the metabolic shift happens when an insufficient 
amount of pyruvate is produced to support energy requirements properly. Comparative flux 
balance analysis performed before and after the metabolic switch revealed that lactate consuming 
cells exhibit an energy efficiency that is much greater than lactate producing cells (Martinez et 
al., 2013). Along the same line, results derived from MFA also revealed that AKT1 signaling, 
which is a major mechanism in regulation of cellular metabolism according to cells growth needs, 
plays a key role in facilitating the metabolic shift to lactate consumption (Mulukutla, Gramer, & 
Hu, 2012). In a recent study, Xing et al. (Xing et al., 2011) also demonstrated the application of 
MFA to support the optimization of medium and feed solution compositions. They first identified 
the limiting amino acids and those that were in excess by flux balance analysis, and this allowed 
them to define balanced amino acid compositions to be used for the fed-batch cultivation of CHO 
cells. The quasi real time application of metabolic flux analysis was also discussed (C. Goudar et 
al., 2006), opening up the possibility to use this technique as a powerful monitoring tool for 
industrial cell cultures. 
 
Other studies were concerned with computational aspects of classical metabolic flux analysis. 
Llaneras and Picó (Francisco Llaneras, Pic, amp, & Jes, 2007) and Zamorano et al. (Zamorano et 
al., 2009) introduced a detailed extension of MFA to determine intervals for non-calculable 
fluxes in an underdetermined network of CHO cells. Using a detailed metabolic network of more 
than 100 reactions, Zamorano et al. (Zamorano et al., 2010) demonstrated that for a well-posed 
system, the size of flux intervals can be significantly reduced by the addition of more 
extracellular measurements, except in the case of parallel pathways. Besides, Goudar et al. 
proposed a method to determine error propagation from extracellular measurements into the 
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estimated fluxes for high cell density CHO cell perfusion culture (Chetan T. Goudar, Biener, 
Konstantinov, & Piret, 2009). 
2.6.2 13C-Metabolic flux analysis of CHO cells 
Due to the inherent limitations of classical MFA, in particular the inability of this approach for 
estimating certain key intracellular fluxes, recent and emerging studies are now increasingly 
focused on the application of 
13
C metabolic flux analysis for refining CHO cell characterization. 
Using a mixture of isotopic tracers (10% U-
13
C glucose, 40% 1-
13
C glucose and the remaining 
50% unlabeled glucose) and 2D (
13
C,
1
H) COSY NMR analysis allowed to characterize the 
physiological state of CHO cells in high cell density perfusion cultures (C. Goudar et al., 2010). 
This study demonstrated a relatively good agreement between glycolytic and TCA flux estimates 
derived using respectively MFA and 
13
C-MFA. However, the pentose phosphate pathway and 
anaplerotic fluxes could only be estimated with the aid of isotopic tracers. Ahn and Antoniewicz 
performed comparative studies of CHO cell metabolism during the exponential and stationary 
phases (Woo Suk Ahn & Antoniewicz, 2011, 2013). These studies highlighted a significant flux 
rewiring in the transition from exponential growth to the stationary phase. The latter was 
characterized by a reduced glycolytic activity, a switch to lactate consumption and an increase in 
the oxidative pentose phosphate pathway flux. More importantly, they demonstrated the 
invalidity of some assumptions frequently employed in classical MFA, that is the non-negligible 
activity of oxidative PPP and pyruvate carboxylase fluxes in CHO cells. Another group also 
worked on characterizing the metabolism of CHO cell during non-growth phase, where most of 
antibody production usually takes place (Sengupta et al., 2011). They observed marked 
differences compared to flux distributions determined during the growth phase, mostly in terms 
of the portion of glucose oxidized through PPP and also in the fluxes around pyruvate node. By 
performing 
13
C-MFA at various stages of a fed-batch cultures, it was recently reported that cell 
growth is correlated with high glycolytic fluxes, whereas high antibody production seems 
associated with a high oxidative state (Templeton, Dean, Reddy, & Young, 2013). 
Although
 13
C-MFA has yielded valuable insights into the cellular metabolism, this technique can 
still be considered in its infancy when applied to mammalian cell cultures. But because it 
provides more reliable estimates of intracellular fluxes, it can be considered one of the most 
useful tool to support the analysis and rational optimization of cell culture processes.  
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CHAPTER 3 METHODOLOGY 
 
3.1 Cell line and culture conditions 
All experiments were performed using the recombinant CHO cell line, CHO-CUM2, which was 
kindly provided by Viropro International 120 Inc. (Montreal, Canada). This cell line stably 
expresses the reverse cumate transactivator described in (Mullick et al., 2006) and produces a 
human anti-CD20 monoclonal antibody. These cells were also adapted to serum-free suspension 
culture. Seed cultures were grown in a serum- and protein-free chemically defined medium 
HyClone SFM4CHO (Thermo Scientific, UT). The medium was supplemented with 30mM of 
glucose and 5mM of glutamine. T25 flasks (Corning, USA) were used to maintain cells at 37C in 
humid atmosphere of 5% CO2. The cultures were diluted 2 or 3 times per week to keep the cells 
in their exponential phase of growth. After two months of maintenance, new vials of frozen cells 
were thawed.  
 
For the experiments, the cultures were initially seeded at 0.2-0.5 × 10
6
 cells/ml into shake flasks 
of 125 ml. 1 μg/mL cumate was added to each flask to trigger the protein expression and, if 
required, the temperature was shifted to sub-physiological temperature (30-32C) for the duration 
of the production phase. Supernatants were collected by centrifugation at 300 g for 5 min and 
samples were stored at -80⁰C for subsequent analysis. 
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3.2 Analytical methods 
3.2.1 Determination of cell density and viability 
Cell numbers and viability were determined by mixing the cell suspension with Trypan blue 
(sigma) and counted on a hemacytometer. 25µl of Trypan blue 0.4% was added to 100µl of cell 
sample. A small volume of the prepared mixture was dispensed onto a hemacytometer. Total 
number of unstained and stained cells were counted under an inverted microscope (10× 
objective).  
The cell concentration in the sample was obtained by: 
                                            
 
And cell viability was given by: 
               
          
                      
     
 
3.2.2 Analysis glucose, lactate and glutamine concentrations 
The glucose, glutamine, and lactate concentrations in supernatants were measured using a dual-
channel immobilized oxidase enzyme biochemistry analyzer (2700 SELECT, YSI Inc. Life 
Sciences, Yellow Springs, OH, USA), using calibration buffers provided by the manufacturer. 
 
3.2.3 Analysis of amino acids using LC/MS 
Extracellular amino acid concentrations were determined on an Agilent 1290HPLC system 
(Agilent technologies, Quebec, Canada) coupled to an Agilent 6460 triple quadruple mass 
spectrometer (Agilent technologies, Quebec, Canada).  The underivatized amino acids were 
separated by a 2.1x150mm ZICTM-Hilic column (3.5um, 200A, PEEK) (Merck SeQuant) and 
2.1x20mm ZICTM-Hilic guard column (5um, 200A, PEEK) (Merck SeQuant) at a temperature 
of 35
o
C and at an injection volume of 5uL. The mobile phase buffer contained 20mM HCOONH4 
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at pH 4. The mobile phase A was 10% of the mobile phase buffer in water, and the mobile phase 
B was 10% of the mobile phase buffer in ACN. The mobile phase B linearly decreased from 90% 
to 35% in 19 min, then was increased to 90% in one min and hold at 90% for 15 min at a flow 
rate of 0.1ml/min. 
3.2.4 Analysis of 13C-labeling patterns  
The 
13
C fractional enrichment of lactate and amino acids in the samples was measured on an 
Agilent 1100 series LC-MSTOF (Agilent technologies, Quebec, Canada). First, 200µL of 
supernatant samples were deproteinized by adding 1mL cold acetone (-20⁰C) and then were 
vortexed strongly. After centrifugation at 20,000g for 5 min, the solutions were filtered and 
evaporated in vacuo. After that, 400 µL of water was added to the samples. The analysis was 
done in negative electrospray mode without derivatization using a Kinetex HILIC Phenomenex 
column, 100 x 4.6mm and 2.6um particle size. The eluants used were 5mM ammonium formate 
(in water) and acetonitrile containing 0.1% formic acid. The gradient was in HILIC mode and 
went from 90% to 50% ACN with a total run time of 20 minutes.  
Organic acids were analyzed on a UPLC-MS/MS (Agilent, Quebec, Canada) equipped with a 
1290 infinity binary pump, an autosampler, a column controller and a 6460A triple quad mass 
spectrometer.  20uL of supernatant sample were filtered through a 0.22 µm PTFE filter 
(Millipore, Ontario, Canada) before injection. Organic acids were separated on a Hypercarb 
column (100*2.1 mm, 5 µm) and a Hypercarb pre-column (2.1*10, 5 µm) (Thermo Fisher, 
Ontario, Canada) with mobile phase A: 20mM ammonium acetate at pH 7.5, and mobile phase B: 
10 % (v/v) methanol in water at a flow rate of 0.3 mL/min. The mobile phase gradient was: 10% 
A from 0 to 5 min, linear gradient from 10 to 20% A from 5 to 10 min, linear gradient from 20 to 
100% A from 10 to 20 min, 100% A from 20 to 30 min, linear gradient from 100 to 10% A from 
30 to 32 min and, finally, 10% A from 32 to 40 min. The negative electrospray ionization model 
was selected for the analysis with an Agilent Jet Stream source. The mass spectrometer operation 
conditions were set as follows: gas temperature 300
o
C, gas flow rate 7L/min, nebulizer pressure 
40 psi, sheath gas temperature 300
o
C, sheath gas flow 12L/min and capillary voltage -3.5kv. 
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3.2.5 Quantification of Monoclonal antibody 
Monoclonal antibody titer was measured by enzyme-linked immunosorbent assay (ELISA). First, 
a goat anti-human IgG1 (H+L) solution (Jackson ImmunoResearch) diluted to 2.5 µg/ml in 
50mM sodium carbonate (Fischer Scientific) was added to 96-well plates (Costar) and incubated 
at 4C overnight. Then, blocking non-specific sites was carried out by adding PBS solution 
containing 1% casein. After incubation for 1h at 37C, either samples or standards diluted in 
PBS-casein were added in triplicate and incubated for 1h at 37C. The wells were then incubated 
with 1/10,000 diluted peroxidase-conjugated affinipure fragment Goat anti-human IgG (Jackson 
ImmunoResearch) for 1h at 37C. After each of the previous steps, the wells were washed three 
times (PBS with 1% w/v Tween 20). Finally, the reaction was revealed by 3,3′,5,5′-
Tetramethylbenzidine (TMB) (Sigma) and stopped after 10-15 minutes by adding 1N 
hydrochloric acid. The absorbance at 450 nm was measured using a Victor
3
 V microplate reader 
(Perkin-Elmer). 
 
Cell specific productivities were determined from ELISA data by using the slopes when the 
integral viable cell concentration (IVCC) in 10
6
cells-day/mL was plotted against the antibody 
concentration (mg/L). The IVCC was calculated using the following equation (P. W. Sauer et al., 
2000): 
                        
       
 
          
 
   
  
  
 
Where, ti and Ci are time (day) and viable cell concentration (10
6
cells/mL) at point i, 
respectively.  
 
3.3 Calculation of specific nutrition uptake rates and specific 
metabolite production rates  
The following logistic equations were used to fit the viable cell density, nutrient and product 
concentration profiles in batch cultures (Olivier Henry et al., 2008). All parameters in the 
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equations are non-negative. The cell specific rates are then easily calculated as these equations 
are analytically differentiable (Chetan T Goudar, Joeris, Konstantinov, & Piret, 2005). 
For viable cell density: 
     
  
            
                    
For nutrient concentration profiles: 
     
  
       
                               
For lactate production: 
     
  
            
                          
 
For fed-batch cultures, cell specific rates were derived from the following balance equations: 
 
    
  
    
 
 
  
    
  
       
 
 
         
      
  
        
 
 
  
where F is the feed rate, V is the culture volume and qi denotes the specific uptake/production 
rates. 
Since glutamine spontaneously degrades to form ammonia, the glutamine decomposition rate 
constant ( ) has been evaluated under the experimental conditions used in this work, without 
cells. Then, the actual glutamine specific uptake rate was determined using: 
      
  
                
 
 
                
 
36 
 
3.4 Calculation of biosynthetic rates 
For the purpose of studying central carbon metabolism, the biomass composition of proteins, 
DNA, RNA, lipids and carbohydrates is needed for the flux analysis. For CHO cells, biomass 
compositions can be found in the literature. The drain of metabolites for biomass synthesis was 
collected from previous reports (Table 3-1) (Martens, 2007; Sheikh et al., 2005). The average 
biomass composition was assumed to be 74.2% protein, 1.6% DNA, 6.1% RNA, 10.1% lipids 
and 5.04% carbohydrates, based on published data (Quek et al., 2010; Sheikh et al., 2005). the 
average molecular weight of biomass was calculated to be 135 g/mol and a dry cell weight was 
assumed to be 350 pg/cell for CHO cells (Woo Suk Ahn & Antoniewicz, 2011; Altamirano et al., 
2001).  The average amino acid composition of biomass protein is shown in Table 3-2. In our 
metabolic model, individual fluxes of biomass were lumped into a general biomass reaction.  
 
Table  3-1: Average biomass composition 
Metabolite mmol/gDW Metabolite mmol/gDW 
dAMP 0.0148 Cholesterol 0.0182 
dCMP 0.0099 Phosphatidylcholine 0.0695 
dGMP 0.0099 Phosphatidylethanolamine 0.0263 
dTMP 0.0148 Phosphatidylinositol 0.0095 
AMP 0.033 Phosphatidylserine 0.0026 
CMP 0.0551 Phosphatidylglycerol 0.0013 
GMP 0.0624 Diphosphatidylglycerol 0.0028 
UMP 0.033 Sphingomyelin 0.0084 
glycogen 0.28 Amino acids in Table 2 
 
For different compounds of biomass, we have the following equation: 
      
  
            
where X is the mass fraction of a component on a dry basis. As it was shown that there is little 
heterogeneity in composition among different CHO cell lines (Selvarasu et al., 2012), we 
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assumed insignificant potential variations of cellular composition. So, the biosynthetic rates were 
obtained by the macromolecular composition of cells and from the growth rate. 
Amino acid requirements for MAb biosynthesis were predicted based on published average IgG1 
composition (Quek et al., 2010) (Table3-2). The molecular weight of IgG1 was calculated to be 
126 kg/mol. 
 
 
 
 
Table  3-2 : Amino acid (AA) composition of biomass and IgG1  
AA Biomass (mmol AA/g cell) MAb (mol AA/mol MAB) 
Gln 0.322 0.03999 
PRo 0.313 0.07173 
Val 0.416 0.08568 
Leu 0.564 0.06296 
Lys 0.570 0.06084 
Met 0.138 0.01277 
Thr 0.386 0.10560 
Ile 0.324 0.03293 
His 0.143 0.02293 
Arg 0.377 0.02261 
Phe 0.219 0.04153 
Tyr 0.182 0.02875 
Cys 0.145 0.02517 
Ser 0.430 0.01064 
Glu 0.386 0.05181 
Ala 0.600 0.05847 
Gly 0.538 0.06601 
ASP 0.359 0.03654 
TRP 0.044 0.02240 
ASN 0.288 0.04487 
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3.5 Calculation of intracellular fluxes  
We have developed Matlab-based algorithms to perform steady-state 
13
C-MFA using mass 
isotopomer distribution data. As illustrated in Figure 3-1, the program consists of three parts. The 
first part automatically generates the metabolite and isotopomer balance models from a text-file 
containing the list of biochemical reactions and the corresponding carbon transitions. The code is 
an implementation of the elementary metabolite unit network decomposition method (M.R. 
Antoniewicz et al., 2007). This method allows to retain the minimum information required to 
simulate the available labeling data within a metabolic network based on the atom transitions of 
all the biochemical reactions. Typically, the decomposition will reduced the number of equations 
by at least one order of magnitude. 
 
Figure  3-1 : Workflow of the algorithm 
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In the second part, a constrained nonlinear least-squares regression (Figure  3-2) is performed 
using the built-in Matlab function fmincon to minimize the sum of weighted squared residuals 
(WSR) between measured (  
    ) and simulated variables (  
   ): 
 
   
             
          
      
           
      
      
      
 
   
  
 
    
   is the inverse of covariance matrix, and "i" is the number of parallel experiments. The 
minimization is repeated a minimum of ten times with random (but feasible) initial estimates of 
the free fluxes (the dimension of the free flux vector equals the degrees of freedom in the system) 
to ensure the attainment of a global optimal solution.  
 
 
 
Figure  3-2: Algorithm for intracellular flux estimation based on weighted least-squares parameter 
estimation 
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Finally, nonlinear confidence intervals for the flux were determined based on the sensitivity of 
the WSR to flux variations using the method developed by Antoniewicz et al. (Antoniewicz, 
Kelleher, & Stephanopoulos, 2006). Although more computationally intensive, this approach was 
shown to yield a more accurate estimate of flux uncertainty compared to local estimates of the 
standard deviations. 
 
3.6 Statistical evaluation of the fit 
Since obtaining a set of fluxes that minimizes the difference between measured and simulated 
data does not guarantee that the model is adequate, validation of the fit was performed based on a 
chi-square goodness-of-fit test. The minimized variance-weighted sum of squared residuals 
(WSR) is assumed to follow a chi-square distribution with the number of degrees of freedom 
defined as the difference between the number of independent measurements and the number of 
unknown free fluxes. The resulting WSR must be between χ2α/2(df) and χ
2
1-α/2(df). Outside this 
range, there is either a lack of fit or over fitting. Individual residuals were also verified to be 
linearly distributed using a normal probability plot (using the function normplot in Matlab). 
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CHAPTER 4 PROBING THE METABOLISM OF AN INDUCIBLE 
MAMMALIAN EXPRESSION SYSTEM USING EXTRACELLULAR 
ISOTOPOMER ANALYSIS 
 
4.1 Presentation of the article 
This section contains an article entitled “Probing the metabolism of an inducible mammalian 
expression system using extracellular isotopomer analysis”. This work has been published in 
“Journal of Biotechnology” on April 2013 (Volume 164, Issue 4, Pages 469–478). In this 
manuscript, we quantitatively assess the metabolic load of recombinant protein production on the 
primary metabolism of CHO cells using an efficient inducible expression system. A comparative 
13
C-metabolic flux analysis was conducted, whereby cells were grown in parallel semi-
continuous cultures containing various labeled glucose and glutamine tracers. This approach 
allowed us to obtain reliable estimates for the main intracellular fluxes, including pathways that 
cannot be observed from external rate measurements (e.g. the pentose phosphate pathway). To 
the best of our knowledge, this is the first time that a comprehensive isotopic tracer study is 
conducted to evaluate the impact exerted by heterologous protein expression in mammalian cells. 
Our analysis also provides the first detailed metabolic flux map for CHO cells under mild 
hypothermic conditions. 
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4.2.1 Abstract 
In an effort to quantitatively assess the impact of recombinant protein expression on the primary 
metabolism of mammalian cells in culture, we have employed an efficient inducible expression 
system and conducted a comparative study of the intracellular flux map distribution with and 
without the induction of recombinant protein synthesis. Cells were grown in parallel semi-
continuous cultures with various singly and uniformly labelled substrates and the resulting mass 
isotopomer distributions of lactate and extracellular amino acids were measured by mass 
spectrometry. These distributions were used to quantify the main intracellular fluxes. The 
analysis revealed that, under mild hypothermic conditions, the onset of protein expression is 
correlated with small but significant changes in several key pathways related to ATP and 
NADPH formation. More specifically, we observed that induced cells exhibit a more efficient 
utilization of glucose, characterized by an increased flux of pyruvate into the TCA cycle. In 
contrast, the catabolic rates of most amino acids remained relatively unaffected. Such analysis is 
instrumental to guide the identification of robust biomarkers of productivity, as well as the 
development of medium formulations optimized for recombinant protein production. 
Keywords: CHO cells, inducible expression, 
13
C-metabolic flux analysis, recombinant protein 
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4.2.2 Introduction 
Mammalian cells continue to be the preferred expression system for the production of valuable 
therapeutic proteins and vaccines, which require specific post-translational modifications that 
cannot be performed in other microorganisms. Monoclonal antibodies (MAb) produced by 
mammalian cell culture form the most important group of new biopharmaceuticals approved or 
under development and their market is expected to grow significantly in the next few years 
(Walsh, 2010). In order to meet the growing demand for MAb, there is a continuing need to 
develop robust, cost-effective and efficient cell culture processes. Conventional process 
development for mammalian cell culture MAb platforms has been conducted mainly by 
experimental and especially trial-and-error methods (Baughman et al., 2010). Despite significant 
advances in the field of cell culture technology, the establishment of an optimal set of process 
conditions remains mostly cell line-specific. Typically, improvements in product titers have been 
essentially achieved through an increase of the cumulative integrated viable cell density, but 
factors limiting the cell specific productivity of mammalian cells are still poorly understood 
(Meleady et al., 2011). Efforts to further enhance processes have thus rapidly underscored the 
need for better characterization and control of the complex mammalian cell metabolism in 
culture. In particular, compared to parental cells, recombinant cells typically exhibit reduced 
specific growth rates and increased nutrient utilization (Yallop, Nørby, Jensen, Reinbach, & 
Svendsen, 2003). Assessing and analysing the impact of recombinant protein expression on the 
cells’ central metabolism is thus of utmost importance for the establishment and optimization of a 
productive mammalian cell expression platform. 
To this end, quantification of metabolic fluxes can provide critical insights into the fundamental 
processes of biological systems and allow the identification of possible metabolic bottlenecks 
(Boghigian et al., 2010; Metallo et al., 2009; J. H. Park, Lee, Kim, & Kim, 2008). In turn, such 
information has proven to be invaluable to enable the targeted optimization of cell culture 
processes. Many comprehensive metabolic models have now been developed for the most 
relevant industrial cell lines such as CHO, BHK, HEK-293 and hybridoma cells (Niklas & 
Heinzle, 2012). However, a complete and accurate determination of the flux distribution in 
mammalian cell networks is generally impossible to obtain from routine measurements and 
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simple metabolite balancing, due to the typically large number of biochemical reactions involved 
on the one hand, and the existence of reversible, cyclic and parallel pathways on the other hand. 
To cope with this problem and alleviate the need to resort to questionable assumptions or 
constraints, additional independent information can be derived with the use of isotopic tracers. 
13
C-metabolic flux analysis (
13
C-MFA) has recently been increasingly applied to mammalian 
systems in order to obtain a more detailed and accurate description of cellular physiology. The 
technique is based on culturing cells with specific 
13
C-labeled substrates and subsequently 
measuring the label distribution in the network’s metabolites using either mass spectroscopy 
(Woo Suk Ahn & Antoniewicz, 2011; H. P. Bonarius et al., 2001; Hofmann et al., 2008; Metallo 
et al., 2009; Niklas, Sandig, & Heinzle, 2011; Sengupta et al., 2011) or NMR analysis (H. P. 
Bonarius et al., 2001; C. Goudar et al., 2010; Mancuso, Sharfstein, Fernandez, Clark, & Blanch, 
1998). However, these approaches are experimentally challenging; they typically require the 
reliable and accurate determination of the mass distributions of several free intracellular 
metabolites, which necessitates careful and labor-intensive extraction/analysis procedures. 
Moreover, to ensure the achievement of proper metabolic and isotopic steady-states, such 
experiments are preferably carried out in a chemostat, which requires the setup of a complex 
culture system. Recent studies emphasized that adequate (pseudo-)steady conditions may be 
difficult to achieve in typical batch/fed-batch cultures (Deshpande et al., 2009). While transient 
isotopic studies can be performed (Woo Suk Ahn & Antoniewicz, 2011; Maier et al., 2008; J.D. 
Young, Walther, Antoniewicz, Yoo, & Stephanopoulos, 2007), they are even more 
experimentally/computationally demanding since, in addition to mass isotopomer distributions, 
the intracellular pool concentrations must either be accurately measured or estimated along with 
the unknown fluxes. 
In the current contribution, we demonstrate that reliable estimates can be obtained for several key 
intracellular fluxes using an approach that alleviates the need for a complex chemostat setup and 
the difficulties inherent in the extraction/analysis of intracellular metabolites. Cells were grown in 
parallel semi-continuous cultures containing various labeled glucose and glutamine tracers and 
only the resulting mass isotopomer distributions of extracellular metabolites (three excreted 
amino acids and lactate) were measured by LC-QTOF MS. The semi-continuous (or repeated 
batch) mode provides a simple and flexible operation with good approximation of 
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(pseudo)steady-state conditions (Olivier Henry et al., 2008). This method was used to analyze the 
central carbon metabolism of a mammalian cell line in relation with cellular productivity. To this 
end, we have employed a CHO cell line that has been engineered with an inducible expression 
system called the “cumate gene-switch” (Gaillet et al., 2007; Mullick et al., 2006). These cells are 
capable of robust growth in serum-free and protein-free suspension cultures and, upon addition of 
a non-toxic small molecule (cumate) in the culture medium, they start to express a recombinant 
antibody. Comparing the metabolism of the induced and non-induced cells using 
13
C-MFA 
allowed investigating the effect of the onset of protein expression on the primary metabolism of 
the cells. Confidence intervals for the evaluated fluxes were calculated to properly judge the 
significance of the observed similarities/differences. Such analysis is invaluable for the rational 
development of improved cell culture processes on both the metabolic and process scales 
(Boghigian et al., 2010). 
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4.2.3 Materials and methods 
4.2.3.1 Cell lines, medium and culture conditions 
The study was performed using an industrially relevant recombinant CHO cell line provided by 
Viropro International Inc. (Montreal, Canada) and producing a human anti-CD20 monoclonal 
antibody. The cell line was derived from CHO-Cum2 cells, which stably express the reverse 
cumate transactivator described in Mullick et al. (Mullick et al., 2006). Cells were grown in a 
costumed chemically-defined SFM4CHO medium (Hyclone). Prior to culturing the cells, the 
medium was supplemented with 4mM glutamine (Hyclone), 25mM glucose (Sigma), and 
0.05mg/ml dextran sulphate (Mw: 500000, Amersham Pharmacia Biotech). 
13
C labelling 
experiments were conducted by growing the cells in parallel shake-flask cultures containing 
respectively unlabeled, 1-
13
C, 6-
13
C, U-
13
C6 glucose (Cambridge Isotopes, all at 99 % purity) and 
U-
13
C5 glutamine  (Cambridge Isotopes, 97-99 % purity). This selection of tracers was motivated 
by their great impact on the identifiability and accuracy of  intracellular flux estimates (Metallo et 
al., 2009). To ensure that all cells were in a similar physiological state, they were initially seeded 
at 0.5×10
6
 cells/ml into a single Erlenmeyer flask at 37C in humid atmosphere of 5% CO2. 
Following an incubation period of 48 hours, this culture was distributed into 10 shake-flasks with 
a working volume of 10 mL. 1 µg/mL cumate was added to half of the flasks to trigger protein 
expression, while the remaining flasks were kept as controls (non-induced cells). Induced and 
non-induced cells were thus each cultured with unlabeled and labeled substrates. It should also be 
emphasized that cumate was shown to have no noticeable effect on mammalian cells growth and 
morphology at concentrations up to 200 µg/mL (Mullick et al., 2006). Since mildly hypothermic 
conditions were previously shown to improve protein production (Gaillet et al., 2010), the 
temperature was shifted to 32C at the time of induction. The cultures were run in semi-
continuous mode, whereby a fixed culture volume (approximately 25% to 35%) was replaced by 
fresh medium on a daily basis so as to maintain pseudo-constant cell and nutrient concentrations. 
Upon reaching pseudo-steady conditions and prior to tracer addition, cells were centrifuged so as 
to minimize the dilution effect caused by the accumulation of unlabeled extracellular metabolites. 
Cells were resuspended using the specific label-containing media and feeding was resumed for a 
minimum of three days to ensure the achievement of an isotopic pseudo-steady state. The control 
48 
 
 
cultures containing naturally labeled substrates were handled similarly, that is the cell 
centrifugation step and the temperature shift were also performed. 
 
4.2.3.2 Analytical methods 
Cell numbers and viability were determined by mixing the cell suspension with trypan blue 
(sigma) and counting on a hemocytometer. The culture samples were centrifuged at 300 x g for 
5min to separate cells and the supernatant. The supernatant was frozen at -20C for subsequent 
analysis. The glucose, glutamine, and lactate concentrations in supernatants were measured with 
a YSI 2700 biochemistry analyzer (Yellow Springs, OH). Monoclonal antibody concentration 
was quantified using an enzyme-linked immunosorbent assay. First, a goat anti-human IgG1 
(H+L) solution (Jackson ImmunoResearch) diluted to 2.5 µg/ml in 50mM sodium carbonate 
(Fischer Scientific) was added to 96-well plates (Costar) and incubated at 4C overnight. Then, 
blocking non-specific sites was carried out by adding PBS solution containing 1% casein. After 
incubation for 1h at 37C, either samples or standards diluted in PBS-casein were added in 
triplicate and incubated for 1h at 37C. The wells were then incubated with 1/10,000 diluted 
peroxidise-conjugated affinipure fragment Goat anti-human IgG (Jackson ImmunoResearch) for  
1h at 37C. After each of the previous steps, the wells were washed three times (PBS with 1% 
w/v Tween 20). Finally, the reaction was revealed by 3,3′,5,5′-Tetramethylbenzidine (TMB) 
(Sigma) and stopped after 15-20 minutes by adding 1N hydrochloric acid. The absorbance at 450 
nm was measured using a Victor
3
 V microplate reader (Perkin-Elmer). 
13
C fractional enrichment of lactate, alanine, glutamate and aspartate in the samples was 
measured on an Agilent 1100 series LC-MSTOF (Agilent technologies, Quebec, Canada). The 
analysis was done in negative electrospray mode without derivatization using a Kinetex HILIC 
Phenomenex column, 100 x 4.6mm and 2.6um particle size. The eluants used were 5mM 
ammonium formate (in water) and acetonitrile containing 0.1% formic acid. The gradient was in 
HILIC mode and went from 90% to 50% ACN with a total run time of 20 minutes. The analysis 
of amino acid concentrations was performed on an Agilent 1290HPLC system (Agilent 
technologies, Quebec, Canada) coupled to an Agilent 6460 triple quadruple mass spectrometer 
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(Agilent technologies, Quebec, Canada).  The underivatized amino acids were separated by a 
2.1x150mm ZICTM-Hilic column (3.5um, 200A, PEEK) (Merck SeQuant) and 2.1x20mm 
ZICTM-Hilic guard column (5um, 200A, PEEK) (Merck SeQuant) at column temperature of 
35
o
C and injection volume of 5uL. The mobile phase buffer contained 20mM HCOONH4 at pH 
4. The mobile phase A was 10% of the mobile phase buffer in water, and the mobile phase B was 
10% of the mobile phase buffer in ACN. The mobile phase B linearly decreased from 90% to 
35% in 19min, then was increased to 90% in one min and hold at 90% for 15min at a flow rate of 
0.1ml/min. 
4.2.3.3 Metabolic Network and intracellular flux calculation 
The metabolic model employed in this study was developed through an iterative process based on 
previous reports on mammalian cells (Woo Suk Ahn & Antoniewicz, 2011; C. Goudar et al., 
2010; Olivier Henry et al., 2010; Martens, 2007) and the information derived from the labelling 
experiments. The metabolic network consists of 68 biochemical reactions, including glycolysis, 
the pentose phosphate pathway, the Krebs Cycle, the catabolism of 20 amino acids and 
anaplerotic reactions (Table A). The model is also taking into account compartmentation between 
mitochondria and the cytosol. To account for biosynthetic requirements, the model includes 
simplified reactions for the biomass and antibody synthesis, which were established from 
published average biomass/product composition data (R. P. Nolan & Lee, 2012; Quek et al., 
2010) and assuming a dry cell weight of 350 pg/cell for CHO cells (Woo Suk Ahn & 
Antoniewicz, 2011; Altamirano et al., 2001). As it was shown that there is little heterogeneity in 
composition among different CHO cell lines (Selvarasu et al., 2012), any potential variations of 
cellular composition are not expected to be significant. Biosynthetic rates were thus determined 
based on this average composition and the average molecular weights of its constituents, as well 
as the measured cell specific growth rates (George Stephanopoulos, Aristidou, & Nielsen, 1998). 
A constant cell size was assumed in all experiments, since the semi-continuous mode of 
operation allowed to maintain the cells under balanced exponential growth conditions (Sadettin S 
Ozturk & Palsson, 1991; Quek et al., 2010). Crude estimates using a hemacytometer yielded 
average cell diameters of 13.81.8 and 14.41.9 µm for non-induced and induced cells, 
respectively.  Ribose-5-phosphate, Ribulose 5-phosphate, and Xylulose 5-phosphate were 
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combined into one single pool (P5P) and, assuming near equilibrium conditions, fructose-6-
phosphate and fructose-1,6-biphosphate were also lumped together. All reversible reactions 
considered in the network were separated into forward and backward fluxes and were constrained 
to be non-negative. For the transport of metabolites between compartments, it is assumed that 
citrate is co-transported with malate via the citrate/malate shuttle, pyruvate transport occurs via 
the pyruvate carrier, malate is transported via the dicarboxylate carrier and aspartate is transferred 
via the glutamate/aspartate shuttle. Cofactor balances were not included in the model. 
Furthermore, it was assumed that all carbon dioxide reincorporated into the system was 
unlabeled, since cultures were grown under humid air containing 5% unlabeled CO2 and since the 
medium also contained unlabeled bicarbonate as a buffer. Succinate and fumarate were combined 
into a single pool and the scrambling of 
13
C-labels was taken into account. The incorporation of 
unlabeled carbon into the TCA resulting from the oxidation of fatty acids was considered 
negligible. 
Cell specific nutrient uptake and metabolite production rates were calculated from concentration 
measurements by taking into account the daily medium exchange rate, as described in Henry et 
al.(Olivier Henry et al., 2008). The glutamine uptake rate was corrected to account for the 
spontaneous degradation of this substrate, assuming first order hydrolysis kinetics (k=0.048 d
-1
). 
To calculate the intracellular fluxes from measured consumption/production rates and the mass 
distribution data, we employed the elementary metabolite unit network decomposition method 
(Maciek R Antoniewicz et al., 2007; Quek et al., 2009; P. F. Suthers et al., 2010), based on the 
carbon transitions listed in Table A (Appendix). For each of the two conditions under 
investigation (induced and non-induced cells), we determined the set of intracellular fluxes 
minimizing the weighted sum of squared residuals (WSSR) between the vectors of simulated and 
experimental values:  
    11min covfree fluxes
Tn sim meas sim meas
i i i i iWSSR x x x x
   
    
where covi
-1
 is the inverse of the covariance matrix and n is the number of cultures performed 
with distinct isotopic tracers. Algorithms for generating metabolite/isotopomer balances, flux 
estimation and statistical evaluations of the fit were implemented in the Matlab environment. The 
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nonlinear least-squares regression was performed using the fmincon() function for constrained 
optimization. The minimization was repeated ten times with random initial estimates of free 
fluxes to ensure the attainment of a global optimal. Validation of the fit was performed based on 
a standard chi-square goodness-of-fit test and 95 % confidence intervals for the intracellular 
fluxes were evaluated using the method outlined in Antoniewicz et al. (Antoniewicz et al., 2006). 
For statistical comparison between corresponding fluxes of two groups (induced and non-induced 
cultures), unpaired two-tailed Student's t-tests were performed. 
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4.2.4 Results 
4.2.4.1 Kinetics of growth and substrate utilization 
Cells were grown in semi-continuous mode to meet the requirements for metabolic and isotopic 
pseudo-steady states. The time profiles of viable cell concentrations for the cultures performed 
with and without cumate addition are shown in Figure 4-1A. For each case, the data presented are 
the average and standard deviation from five parallel cultures. The apparent growth rates for the 
non-induced and the induced cultures were determined to be 0.36 (d
-1
) and 0.33 (d
-1
), 
respectively. To allow reliable intracellular flux estimation, all the parallel cultures performed 
with distinct labelled substrates had to be maintained in a similar physiological state. In order to 
check the similarity between the five cultures of each series and to assess whether metabolic 
pseudo-steady state conditions were attained, the main specific consumption and production rates 
were compared at 48h and 72h following tracer addition. These cell specific rates were evaluated 
from the measured concentrations, the medium exchange rate and the known fresh medium 
composition as described in Henry et al. (2008). As evident from the standard deviations shown 
in Figure 4-1B, good consistency among the parallel cultures within each set was observed. 
Moreover, the specific rates evaluated respectively at 48 and 72h showed no significant time-
dependent variation in cellular growth and only marginal reductions (< 5 %) in glucose uptake 
and lactate production, indicating that reasonable metabolic (pseudo) steady-state conditions were 
achieved. 
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Figure  4-1:Time profile of the average viable cell density for induced and non-induced cells in 
semi-continuous cultures. Labeled substrates were introduced at day 6 and the cultures were 
maintained for three subsequent days (A); comparison of glucose and glutamine consumption and 
lactate production rates for induced and non-induced cells at 48 and 72h post tracer addition (B). 
Standard deviations were computed from five parallel cultures in each set 
 
The measured cell specific consumption/production rates of amino acids 72h following tracer 
addition are reported in Table 4-1.  A net production of alanine, glutamate, aspartate, and glycine 
was observed, while all other amino acids were consumed by the cells. When comparing the 
cultures with and without cumate addition, we observed that the glutamine uptake rate was 
slightly enhanced (~14%) for the induced cells, while there was a concomitant decrease in 
glucose uptake rate (~8%). The molar ratio of lactate production on glucose consumption was 
also slightly reduced (0.86 vs 0.8). Interestingly, these yields of lactate on glucose are both 
noticeably lower than the typical values reported for mammalian cells in cultures under non-
limiting glucose concentrations (YLac/Glc1-2), suggesting that this cell line exhibits an efficient 
carbon metabolism, irrespective of the induction of recombinant protein expression. The 
measured cell specific antibody productivity for the cultures supplemented with cumate was 13.7 
pg/cell.d, whereas it was ~1 pg/cell.d in the case of non-induced cells, as a result of minor leaky 
expression. As shown in Table 4-1, the burden imposed by the synthesis of an extra protein was 
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not accompanied by a clear trend in the consumption patterns of essential and non-essential 
amino acids. 
4.2.4.2 13C-label incorporation into extracellular metabolites 
Labeled-carbon incorporation into extracellular lactate and amino acids was measured by LC-MS 
TOF analysis. The isotopomer mass distribution of each labeled substrate was also determined 
experimentally to confirm their level of purity. Clear signs of 
13
C-enrichment were detected in the 
isotopomer mass distributions of lactate, aspartate, alanine and glutamate (Figure 4-2 and 4-3), 
while all other extracellular amino acids exhibited patterns corresponding to their natural 
labelling. This result was consistent with the observed net specific rates of amino acids utilization 
(Table 4-1). The fresh medium did not contain any lactate, alanine or glutamate, thus their 
measured mass distributions were directly indicative of their enrichment. However, the medium 
contained low initial levels of aspartate, effectively diluting the labelling of this amino acid. 
Although produced, glycine was omitted from the analysis due to excessive tracer dilution, as this 
amino acids was present in the fresh medium and is mainly synthesized from unlabeled serine. 
Mass isotopomer distributions measured after 48h and 72h following the switch to label 
containing medium were compared to ensure the achievement of an adequate isotopic steady 
state. The results obtained for the non-induced and the induced cells are shown in Figure 4-2 and 
Figure 4-3, respectively. Considering the measurement errors involved (about 1-2 %), there were 
no significant time-dependent differences, indicating that these metabolites had achieved constant 
13
C-labeling within three days. Although some studies reported that stable labelling pattern in 
mammalian cells can be obtained after an incubation of only 4 to 6h with an isotopic tracer 
(Metallo et al., 2009), others have shown that some metabolites, particularly TCA intermediates, 
may require longer periods of time (Woo Suk Ahn & Antoniewicz, 2011; Maier et al., 2008; 
Sengupta et al., 2011).  
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Table  4-1: Measured cell specific uptake/production rates (in pmol/cell.d) at 72h after tracer 
addition 
Compound Non-induced cells Induced cells 
Glucose -2.38 ±0.12 -2.19 ±0.11 
Lactate 2.11 ±0.11 1.82 ±0.09 
Glutamine -0.82 ±0.04 -0.94 ±0.09 
Phenylalanine -0.05 ± 0.01 -0.06 ± 0.01 
Threonine -0.07 ± 0.01 -0.07 ± 0.01 
Isoleucine -0.06 ± 0.01 -0.07 ± 0.01 
Leucine -0.11 ± 0.01 -0.11 ± 0.01 
Methionine -0.04 ± 0.01 -0.04 ± 0.01 
Tyrosine -0.04 ± 0.01 -0.04 ± 0.01 
Valine -0.10 ± 0.01 -0.10 ± 0.01 
Proline -0.16 ± 0.02 -0.10 ± 0.01 
Serine -0.22 ± 0.02 -0.28 ± 0.03 
Asparagine -0.22 ± 0.02 -0.38 ± 0.04 
Cysteine -0.05 ± 0.01 -0.04 ± 0.01 
Arginine -0.12 ± 0.01 -0.12 ± 0.01 
Lysine -0.11 ± 0.01 -0.13 ± 0.01 
Histidine -0.04 ± 0.01 -0.04 ± 0.01 
Glutamate 0.07 ± 0.01 0.06 ± 0.02 
Alanine 0.26 ± 0.03 0.23 ± 0.02 
Aspartate 0.03 ± 0.01 0.04 ± 0.01 
Glycine 0.28 ± 0.03 0.18 ± 0.02 
 
Direct inspection of the mass distribution data provided early useful insights for the development 
and validation of the metabolic model. For example, the mass isotopomer distribution of 
glutamate in cultures grown with uniformly labeled glutamine clearly suggested that a significant 
portion of this metabolite originated from other carbon source(s) than glutamine. Indeed, 
glutamate 
13
C-enrichment was detected in all the cultures grown with labeled glucose. The 
reverse glutamate dehydrogenase and transaminase reactions were thus important to consider in 
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the metabolic analysis. It could also be observed that alanine and lactate, which are both mainly 
produced from pyruvate, exhibited similar but nonetheless distinct labelling patterns. This 
observation reinforced the importance of considering the effect of compartmentation, i.e. the 
presence of distinct pyruvate pools in the cytosol and the mitochondria (Peuhkurinen, Hiltunen, 
& Hassinen, 1983). In our work, the best agreement between simulated and experimental 
labelling data was obtained by considering that some alanine is derived from mitochondrial 
pyruvate, while lactate is generated from cytosolic pyruvate. While cytosolic pyruvate is mainly 
derived from glucose, mitochondrial pyruvate contains more label originating from glutamine. A 
similar assumption was employed by Walther et al. (Walther, Metallo, Zhang, & Stephanopoulos, 
2012) for describing the distinct labelling pattern of lactate and alanine in their analysis of a 
mammalian cell line. 
4.2.4.3 13C metabolic flux analysis 
The mass isotopomer distribution data from the samples collected 72h after tracer addition were 
used to conduct a 
13
C-Metabolic flux analysis. The isotope model contains 15 free fluxes and, 
combining the labelling data from all parallel cultures, 60 independent mass spectrometry 
measurements were available. Thus, the minimum and maximum allowed values for the WSSR 
were 30.6 and 61.7, respectively (chi-square threshold at 95% level of confidence with 45 
degrees of freedom) (Antoniewicz et al., 2006). We found an acceptable agreement between 
predicted and measured mass distribution data with WSSR values of 47.1 and 58.5 for non-
induced and induced cells, respectively. Comparisons of the fit between simulated and measured 
isotopomer data are shown in Figure 4-2 and Figure 4-3. Standard-deviation weighted residuals 
were also verified to be reasonably normally distributed as shown in the normal probability plots 
(Figure 4-2 and 4-3). The calculated intracellular flux distributions under both induced and non-
induced conditions are shown in Figure 4-4. The associated 95 % confidence intervals, from 
which the median and standard error values were evaluated (Jamey D Young, Shastri, 
Stephanopoulos, & Morgan, 2011), are included as Supplementary Material (Table 4-3). For 
some exchange fluxes, the associated confidence intervals equal or exceed the feasible range of 
values and these fluxes can thus be considered not observable with the tracers employed and the 
available MS data. However, relatively narrow confidence intervals could be obtained for most of 
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the corresponding net fluxes, thereby allowing to reveal some differences in the metabolism of 
induced and non-induced cells. The onset of protein expression was notably correlated with a 
reduction in glycolytic fluxes, a concomitant decrease in pentose phosphate pathway fluxes, 
while TCA fluxes from citrate to malate were found to be slightly enhanced. However, most 
anaplerotic reactions involving amino acids remained largely unaffected. These metabolic 
observations are further elaborated in the next section. 
58 
 
 
 
Figure  4-2: Measured (at 48 and 72h) and fitted (at 72h) mass distributions of lactate, alanine, 
aspartate, and glutamate in non-induced cells grown in 1-
13
C glucose (A), 6-
13
C glucose (B), U-
13
C6  glucose (C) and  U-
13
C5 glutamine (D); normal probability plot indicating an approximately 
normal distribution of the residuals (E);  Standard-deviation weighted residuals (F) 
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Figure  4-3: Measured (at 48 and 72h) and fitted (at 72h) mass distributions of lactate, alanine, 
aspartate, and glutamate in induced cells grown in 1-
13
C glucose (A), 6-
13
C glucose (B), U-
13
C6  
glucose (C) and  U-
13
C5 glutamine (D); normal probability plot indicating an approximately 
normal distribution of the residuals (E);  Standard-deviation weighted residuals (F)  
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4.2.5 Discussion  
Compared to parental cell lines, recombinant mammalian cell lines generally exhibit reduced 
growth rates and increased substrate utilization (Yallop et al., 2003), most likely to meet the 
specific energy and biosynthetic demands related to protein synthesis and related 
posttranslational modifications. Recent studies performed on yeasts and bacteria have 
characterized the metabolic response to the overproduction of recombinant protein and revealed 
significant redirections of intracellular carbon fluxes towards energy formation (Heyland, Blank, 
& Schmid, 2011; Heyland, Fu, Blank, & Schmid, 2011). The identification of potential metabolic 
burdens is critical to further enhance protein production in any expression system. Towards this 
goal and in an effort to analyse the impact of protein expression on the primary metabolism of 
mammalian cells in culture, we have employed an efficient inducible expression system and 
conducted a comparative study of the intracellular flux map distribution with or without the 
induction of recombinant protein synthesis. 
Under non-limiting glucose concentrations, cultivated mammalian cells typically display high 
glycolytic rates relative to TCA fluxes, thereby converting the majority of glucose consumed into 
lactate. In our study, the onset of protein expression was not accompanied by statistically 
significant changes in the reactions catalyzed by hexokinase and phosphoglucose isomerase, but 
we observed a significant decrease in the G6P dehydrogenase reaction, which generates ribose-5-
phosphate and NADPH (Figure 4-4). The former is an important building block for nucleotides, 
while the latter is essential for reductive processes, most notably the biosynthesis of fatty acids. 
Without cumate addition, we observed that the cells channelled 20 % of the glucose consumed 
toward the pentose phosphate pathway, while this value was reduced to 13 % when the cells were 
induced. Both values were within the range commonly reported for mammalian cells in culture 
(Altamirano et al., 2006; H. P. Bonarius et al., 2001), although some studies have measured up to 
40% (C. Goudar et al., 2010; Sengupta et al., 2011). The decrease in the pentose phosphate 
pathway flux observed in cultures grown with cumate was concomitant with the slight reduction 
in specific growth rate, therefore related, at least in part, to reduced biosynthetic needs. 
Whether the cells were induced or not, the flux distribution around the pyruvate branch point 
showed that a high proportion of pyruvate originated from glycolysis (75 to 78 %), while 21 to 
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24% came from the conversion of malate via malic enzyme, and a minor fraction was derived 
from the degradation of amino acids such as cysteine or serine. Furthermore, 49 to 58 % of the 
pyruvate pool was channelled into the TCA cycle, while only 35-40 % was converted into lactate. 
Therefore, irrespective of the recombinant protein expression, the cell line under study exhibited 
a highly efficient nutrient utilization, even under high residual glucose concentrations (glucose 
was maintained in the range of 12 to 16 mM in the semi-continuous cultures). The fraction of 
pyruvate entering the TCA in our study was noticeably higher than values previously reported for 
other CHO cell lines (Altamirano et al., 2001; C. Goudar et al., 2010), presumably related in part 
to the fact that our experiments were performed under mild hypothermic conditions. However, 
recent characterization during the stationary phase revealed that CHO cells can produce very little 
lactate (Sengupta et al., 2011) or even exhibit a net consumption rate of this metabolite (Woo Suk 
Ahn & Antoniewicz, 2011). We observed similar trends for lactate kinetics when cells were 
grown in batch mode (data not shown). 
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Figure  4-4: Metabolic flux map for non-induced (top values) and induced (bottom values) cells.  
The values are the median of the 95% flux confidence interval and standard errors were 
calculated from the upper and lower bounds of the 95 % confidence intervals. In the case of 
reversible reactions, the values correspond to the estimated net fluxes. * and ** indicate 
significance at p<0.1 and p<0.05, respectively. Abbreviations:  AA2= Leu, Lys, Ile, Tyr, Trp, and 
Thr; AA4= Val, Met, and Ile; AA5= His, Arg, and Pro. 
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Induced cells also exhibited a small but statistically significant increase (16 %) in the flux 
through pyruvate dehydrogenase (Figure 4-4). However, both induced and non-induced cells did 
not exhibit a significant flux via the pyruvate carboxylase, a common observation for cultivated 
mammalian cells (Quek et al., 2010). As a result of the increased entry of pyruvate via pyruvate 
dehydrogenase, an increase in the average TCA cycle fluxes was observed (Figure 4-4), 
presumably to support the additional production of energy required for protein synthesis and 
related cellular processes. From the resulting flux distributions and assuming a P/O ratio of 2.5 
for NADHm and 1.5 for FADH2m, it is evaluated that cells derived 90 % of the total ATP 
production from the TCA cycle.  Assuming a stoichiometry of 3.78 mol of ATP per mol of 
biomass and 4 mol of ATP per mol of antibody (Ryan P Nolan & Lee, 2011; L. Xie & D. I. 
Wang, 1996), the energy requirements for biomass and recombinant protein synthesis account 
respectively for only 10 % and a mere 1 % of the estimated ATP production rate. It is therefore 
unlikely that energy is the main factor limiting recombinant protein expression in cultivated cells.  
While we estimated a greater pyruvate recycling (i.e. pyruvate derived from TCA intermediates) 
via malic enzyme in the case of the induced cells, the observed differences are within the 
confidence intervals and cannot be considered significantly different with the data in hand. 
Together with the pentose phosphate pathway, malic enzyme constitutes a major route for the 
generation of NADPH. In the metabolic network considered herein, the main NADPH 
requirements are associated with the synthesis of fatty acids, nucleic acids and alanine. From the 
obtained flux distributions, the NADPH produced by the pentose phosphate pathway accounted 
for 0.9 and 0.6 pmol/cell-d for non-induced and induced cells, respectively. On the other hand, 
malic enzyme provided approximately 1.1 and 1.3 pmol/cell-d, respectively. Interestingly, the 
slightly greater contribution of malic enzyme observed in the case of the induced cells seemed to 
compensate for the reduction in NADPH synthesis via the pentose phosphate pathway. While our 
data suggested that NAPDH synthesis was relatively evenly distributed between the two 
pathways, contribution of the pentose phosphate pathway in the range of 18 to 90% of the total 
NADPH production have been reported in the literature for cultivated CHO cells  (Altamirano et 
al., 2006; Altamirano et al., 2001; C. Goudar et al., 2010), hybridoma cells (H. P. Bonarius et al., 
2001; Dalm et al., 2007), and HEK cells  (Olivier Henry & Durocher, 2011). 
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Glutamine was the main amino acid consumed by the cells, albeit at a rate significantly lower 
than glucose. The latter was the main carbon source for the TCA cycle (51-53 %), but glutamine 
also contributed a significant amount (38-40 %). The combined catabolism of all other amino 
acids thus represented a small, but non-negligible fraction (7-11%) of the total carbon entering 
the TCA cycle as either acetyl-CoA, malate, -ketoglutarate or oxaloacetate.  Interestingly, 
induced and non-induced cells exhibited very similar catabolic rates for the amino acids. It 
appears thus that the varying anabolic needs for cell growth and recombinant protein synthesis 
did not significantly impact the contribution of amino acids towards energy production. Indeed, 
while the growth rate reduction exhibited by induced cells decreases the amino acid requirements 
for biomass synthesis by approximately 8 %, the onset of recombinant protein formation 
increases the biosynthetic demand for amino acids, on average by 9 to 15 %, as can been inferred 
from Table 4-4 in Supplementary Materials. As a result, the total anabolic demand for protein 
synthesis, in terms of amino acids and energy, is not expected to differ significantly between 
induced and non-induced cells. Consequently, the increased TCA cycle fluxes noted in the former 
cannot be attributed solely to the biosynthesis of the recombinant product, but can presumably be 
linked in part to the energetic costs associated with other protein processing events (e.g. folding, 
modification, secretion), may serve to compensate the reduced energy produced through 
glycolysis or support different maintenance energy requirements altogether. 
The induction of recombinant protein expression by the addition of cumate is thus associated 
with small, yet detectable changes in the primary metabolism of the cells. However, although 
recombinant protein production causes an increase load on the cells, it should be emphasized that 
the augmentation of total cellular protein resulting from MAb production is estimated to be at 
most approximately 15%, considering the measured specific productivity and assuming a protein 
dry cell weight of 240 pg/cell. Moreover, the production capacity is thought to be not limited at 
the anabolic level, but rather at the folding and assembly stages (Dinnis et al., 2006). Taken 
together, this may explain the relatively modest changes observed in the intracellular flux 
distribution. Despite the small magnitude of these changes, our results nonetheless provide a 
quantitative indication that recombinant protein expression is positively correlated with an 
increased flux through pyruvate dehydrogenase and a corresponding increase in TCA cycle 
fluxes. 
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Our study also demonstrated that the use of multiple isotopic tracers in parallel semi-continuous 
cultures, combined with isotopomer analysis of extracellular metabolites, allows to obtain 
reliable estimates of the main intracellular fluxes.  Semi-continuous cultures retain the technical 
simplicity of batch mode, while maintaining the cells under balanced growth conditions over a 
sufficiently long time to ensure the achievement of pseudo-steady isotopic and metabolic states. 
Additionally, by varying the daily exchange rate, this mode of operation could allow in principle 
to run experiments under different apparent growth rates, similar to classical kinetic studies 
performed in continuous cultures. While repeated feeding with expensive label-containing media 
may appear prohibitive, this is balanced by the fact that cultures can easily be performed at fairly 
small scale (even well plates), in contrast to chemostat. The main drawbacks of this approach are 
related to the uncontrolled culture conditions (with respect to pH and pO2), as well as the 
necessity to conduct several cultures in parallel and ensure that they remain in a comparable 
physiological state.  
4.2.6 Conclusion  
The use of an efficient inducible mammalian expression system combined to a relatively 
straightforward experimental approach allowed us to characterize the primary metabolism of 
CHO cells in relation with their specific productivity. The main intracellular fluxes were 
quantified with relatively narrow confidence intervals, thereby allowing to decipher metabolic 
changes related to the onset of recombinant protein expression. Our study notably revealed small 
but significant variations in a number of key pathways related to ATP and NADPH formation, 
including the pentose phosphate pathway, the malic enzyme and the TCA cycle. When 
expressing the recombinant antibody, cells exhibited a more efficient utilization of glucose with 
comparatively more carbon incorporated into the TCA cycle. Characterizing the primary 
metabolism of other cells exhibiting different productivities may confirm the observed trends in 
our study and further guide the identification of reliable physiological markers and desirable 
metabolic states for production. In turn, this can provide a rational basis for maximizing the 
productivity through the selection of an appropriate induction time and the design of an efficient 
feeding strategy pre- and post-induction.  
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Table  4-2: Biochemical network and atom transition 
Reaction Carbon Transition 
Glycolysis   
 
GLC  G6P abcdef = abcdef 
 
G6P ↔ F6P abcdef = abcdef 
 
F6P  2 GAP abcdef = cba + def 
 
GAP  PYR abc = abc 
 
PYR  LAC abc = abc 
 
PYR ↔ PYRm abc = abc 
 PPP   
 
G6P  P5P + CO2 abcdef = bcdef + a 
 
2P5P ↔ S7P + GAP abcde + fghij = abfghij + cde 
 
P5P + E4P ↔ F6P + GAP abcde + fghi = abfghi + cde 
 
S7P + GAP ↔ F6P + E4P abcdefg + hij = abchij + defg 
 TCA   
 
PYRm  AcCOAm + CO2 abc = bc + a 
 
AcCOAm + OAAm  CITm ab + cdef = fedbac 
 
CITm ↔ aKGm + CO2 abcdef = abcde + f 
 
aKGm  SUCm + CO2 abcde = bcde + a 
 
SUCm  0.5 MALm + 0.5 MALm abcd = 0.5 abcd + 0.5 dcba 
 
MALm ↔ OAAm abcd = abcd 
 
MALm ↔ MAL abcd = abcd 
 
OAA ↔ MAL abcd = abcd 
  MALm  PYRm + CO2 abcd = abc + d 
 
PYRm + CO2  OAAm abc + d = abcd 
 
CITm + MAL  CIT + MALm abcdef + ghij = abcdef + ghij 
 
CIT  AcCOAc + OAA abcdef = ed + fcba 
 Amino acid reactions   
 
GLN  GLU abcde = abcde 
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GLU ↔ aKGm abcde = abcde 
 
PYRm  ALA  abc = abc  
 
PYR   ALA  abc = abc  
 
ASP + aKGm ↔ OAAm + GLU abcd + efghi = abcd + efghi 
 
SER  GLY + C abc = ab + c 
 
PYR  SER abc = abc 
 
CYS  PYR abc = abc 
 
MET + SER  SUCm + CYS + C   
 
MET  MET1 + C abcde = abcd + e 
 
MET1 + SER  MET2 + CYS abcd + efg = abcd + efg 
 
MET2 + CO2in  CO2 + SUCm abcd  +  e = a  +  bcde 
 
VAL  SUCm + CO2   
 
VAL + CO2in  SUCm + VAL2 abcde + f = decf + ab 
 
VAL2  CO2 + CO2 ab = a + b 
 
ILE  AcCOAm + SUCm   
 
ILE + CO2in  CO2 + ILE1 abcdef + g = a + debfcg 
 
ILE1  AcCOAm + SUCm abcdef = ab + cdef 
 
LEU  3AcCOAm   
 
LEU + CO2in  LEU1 + LEU2 abcdef + g = age + bcdf 
 
LEU1  CO2 + AcCOAm abc = a + bc 
 
LEU2  AcCOAm + AcCOAm abcd = ab + cd 
 
THR  AcCOAm + GLY abcd = ab + cd 
 
LYS  2AcCOAm + 2 CO2   
 
LYS  LYS1 + LYS2 abcdef = af + bcde 
 
LYS1   CO2 + CO2 ab = a + b 
 
LYS2   AcCOAm + AcCOAm abcd = ab + cd 
 
TRP  ALA + 2AcCOAm + 4 CO2   
 
TRP  TRP1 + TRP2A abcdefghijk = abcd + efghijk 
 
TRP1  ALA + CO2 abcd = abc + d 
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TRP2A  TRP2 + TRP3 abcdefg = abcd + efg 
 
TRP2  AcCOAm + AcCOAm abcd = ab + cd 
 
TRP3  CO2 + CO2 + CO2 abc = a + b + c 
 
TYR  2AcCOAm + MALm + CO2   
 
TYR  TYR1 + TYR2 abcdefghi = abcde + fghi 
 
TYR1   MALm + CO2 abcde = bcde + a 
 
TYR2  AcCOAm + AcCOAm abcd = ab + cd 
 
PHE  TYR abcdefghi = abcdefghi 
 
HIS  GLU abcde = abcde 
 
PRO  GLU abcde = abcde 
 
ARG  GLU abcde = abcde 
 
ASN  ASP abcd = abcd 
Transport 
 
GLC ex  GLC abcdef = abcdef 
 
GLN ex  GLN abcde = abcde 
 
PRO ex  PRO abcde = abcde 
 
VAL ex  VAL abcde = abcde 
 
LEU ex  LEU abcdef = abcdef 
 
LYS ex  LYS abcdef = abcdef 
 
MET ex  MET abcde = abcde 
 
THR ex  THR abcd = abcd 
 
ILE ex  ILE abcdef = abcdef 
 
HIS ex  HIS abcde = abcde 
 
ARG ex  ARG abcde = abcde 
 
PHE ex  PHE abcdefghi = abcdefghi 
 
TYR ex  TYR abcdefghi = abcdefghi 
 
CYS ex  CYS abc = abc 
 
SER ex  SER abc = abc 
 
TRP ex  TRP abcdefghijk = abcdefghijk 
70 
 
 
 
ASN ex  ASN abcd = abcd 
 
LAC  LAC ex abc = abc 
 
GLU  GLUex abcde = abcde 
 
ALA  ALA ex abc = abc 
 
GLY  GLY ex ab = ab 
 
ASP  ASP ex abcd = abcd 
Biomass Reaction   
 
0.912 Protein + 0.0315 P5P + 0.0379 G6P + 0.317 AcCOAc  BIOMASS 
Recombinant Product Synthesis  
 
0.059 ALA + 0.023 ARG + 0.045 ASN + 0.037 ASP + 0.025 CYS + 0.040 
GLN + 0.052 GLU + 0.066 GLY + 0.023 HIS + 0.033 ILE + 0.063 LEU + 
0.061 LYS + 0.013 MET + 0.042 PHE + 0.072 PRO + 0.011 SER + 0.106 THR 
+ 0.022 TRP + 0.029 TYR + 0.086 VAL  ANTIBODY 
 
Cellular Protein Synthesis 
 
0.081 ALA + 0.051 ARG + 0.039 ASN + 0.049 ASP + 0.020 CYS + 0.044 GLN + 0.052 
GLU + 0.073 GLY + 0.019 HIS + 0.044 ILE + 0.076 LEU + 0.077 LYS + 0.019 MET + 
0.030 PHE + 0.042 PRO + 0.058 SER + 0.052 THR + 0.006 TRP + 0.025 TYR + 0.056 
VAL  PROTEIN 
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4.3 Supplementary data 
Table  4-3: Estimated intracellular fluxes (pmol/cell.d) in non-induced and induced cells 
   
 
  
 
 
Reaction 
Non-induced cells Induced cells 
Optimal 
Flux 95 % C.I. 
Media
n 
Value 
Optimal 
Flux 95 % C.I. 
Median 
Value 
GLC   G6P 2.26 [2.26 , 2.34] 2.30 2.08 [2.08  , 2.20] 2.14 
G6P ↔ F6P net 1.76 [1.61 , 1.86] 1.74 1.76 [1.62 , 1.87] 1.75 
 
exch 12.00 [0.00 , inf] - 12.00 [0.00 , inf] - 
F6P  2 GAP 2.03 [1.99 , 2.11] 2.05 1.92 [1.88 , 1.99] 1.94 
GAP   PYR 4.20 [4.15, 4.39] 4.27 3.91 [3.86 , 4.13] 3.99 
PYR   LAC 2.20 [1.90 , 2.31] 2.13 1.88 [1.64 , 2.00] 1.83 
PYR ↔ PYRm net 1.80 [1.63 , 1.99] 1.81 1.88 [1.74 , 2.13] 1.93 
 
exch 3.55 [1.81 , 7.01] - 3.84 [2.12 , 9.12] - 
G6P   P5P + CO2 0.44 [0.31 , 0.59] 0.45 0.27 [0.16 , 0.41] 0.28 
2P5P ↔ S7P + GAP net 0.14 [0.10 , 0.19] 0.15 0.08 [0.04 , 0.11] 0.08 
 
exch 0.55 [0.00 , inf] - 0.34 [0.00 , inf] - 
P5P + E4P ↔ F6P + 
GAP net 0.14 [0.10 , 0.18] 0.14 0.08 [0.04 , 0.11] 0.08 
 
exch 0.00 [0.00 , inf] - 0.00 [0.00 , inf] - 
S7P + GAP ↔ F6P + 
E4P net 0.14 [0.09 , 0.19] 0.14 0.08 [0.04 , 0.12] 0.08 
 
exch 2.69 [0.00 , inf] - 12.00 [0.00 , inf] - 
PYRm   AcCOAm + CO2 2.49 [2.36 , 2.73] 2.54 2.88 [2.68 , 3.22] 2.95 
PYRm + CO2  OAAm 0.05 [0.00 , 0.27] 0.13 0.08 [0.00 , 0.22] 0.11 
AcCOAm + OAAm  CITm 2.79 [2.64 , 3.03] 2.83 3.21 [3.00 , 3.54] 3.27 
CITm ↔ aKGm + 
CO2 net 1.98 [1.81 , 2.22] 2.02 2.48 [2.24 , 2.83] 2.54 
 
exch 0.00 [0.00 , 1.54] - 0.00 [0.00 , 5.00] - 
aKGm  SUCm + CO2 2.80 [2.58 , 3.08] 2.83 3.34 [3.01 , 3.79] 3.40 
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SUCm  0.5MALm + 
0.5MALm net 2.85 [2.64 , 3.13] 2.89 3.40 [3.07 , 3.83] 3.45 
 
exch 0.00 [0.00 , inf] - 12.00 [0.00 , inf] - 
MALm↔ OAAm net 2.66 [2.33 , 2.93] 2.63 2.90 [2.59 , 3.23] 2.91 
 
exch 0.00 [0.00 , inf] - 0.00 [0.00 , inf] - 
MAL ↔ MALm net 0.81 [0.68 , 0.84] 0.76 0.73 [0.63 , 0.77] 0.70 
 
exch 0.95 [0.68 , inf] - 7.40 [0.63 , inf] - 
OAA ↔ MAL net 0.81 [0.68 , 0.84] 0.76 0.73 [0.63 , 0.77] 0.70 
 
exch 0.41 [0.00 , inf] - 2.09 [0.00 , inf] - 
CITm  CIT 0.81 [0.68 , 0.84] 0.76 0.73 [0.63 , 0.77] 0.70 
CIT  ACCOA + OAA 0.81 [0.68 , 0.84] 0.76 0.73 [0.63 , 0.77] 0.70 
MALm  PYRm + CO2 1.03 [0.91 , 1.36] 1.13 1.25 [1.09 , 1.45] 1.27 
GLN  GLU 0.78 [0.73 , 0.81] 0.77 0.88 [0.82 , 0.97] 0.89 
GLU ↔ αKG net 0.82 [0.75 , 0.88] 0.82 0.86 [0.80 , 0.97] 0.89 
 
exch 8.10 [5.10 , 13.42] - 4.80 [3.36 , 5.77] - 
PYR  ALA  0.00 [0.00 , 0.12] 0.06 0.08 [0.00 , 0.17] 0.09 
PYRm  ALA  0.28 [0.15 , 0.32] 0.23 0.16 [0.06 , 0.28] 0.17 
ASP +  αKG ↔ OAA + 
GLU net 0.08 [0.06 , 0.11] 0.08 0.23 [0.19 , 0.27] 0.23 
 
exch 0.10 [0.08 , 0.12] - 0.26 [0.20 , 0.31] - 
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Table  4-4: Amino acids requirements for biomass and product synthesis (in pmol/cell.d).  
Rates were calculated from average biomass/antibody compositions and the measured cell 
specific growth/production rates. Due to the very low basal expression of non-induced cells, the 
requirements for antibody synthesis were neglected. 
 
Non-induced cells Induced cells 
Biomass Product Biomass Product 
Ala 0.076 --- 0.069 0.006 
Arg 0.048 --- 0.044 0.002 
Asn 0.036 --- 0.033 0.005 
Asp 0.045 --- 0.041 0.004 
Cys 0.018 --- 0.017 0.003 
Gln 0.041 --- 0.037 0.004 
Glu 0.049 --- 0.045 0.006 
Gly 0.068 --- 0.062 0.007 
His 0.018 --- 0.017 0.002 
Ile 0.041 --- 0.037 0.004 
Leu 0.071 --- 0.065 0.007 
Lys 0.072 --- 0.066 0.007 
Met 0.017 --- 0.016 0.001 
Phe 0.028 --- 0.025 0.005 
Pro 0.039 --- 0.036 0.008 
Ser 0.054 --- 0.050 0.001 
Thr 0.049 --- 0.045 0.011 
Trp 0.006 --- 0.005 0.002 
Tyr 0.023 --- 0.021 0.003 
Val 0.052 --- 0.048 0.009 
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Figure  4-5: Measured cell specific uptake/production rates (in pmol/cell.d) during                 
semi-continuous cultures of induced and non-induced CHO cells. 
From day 3, a fixed culture volume was replaced by fresh medium on a daily basis so as to 
maintain pseudo-constant cell and nutrient concentrations. The switch to label containing 
medium was performed on Day 6. Thus, days 8 and 9 correspond to 48 and 72h post tracer 
addition, respectively. 
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CHAPTER 5 THE IMPACT OF THE TIMING OF INDUCTION ON 
THE METABOLISM AND PRODUCTIVITY OF CHO CELLS IN 
CULTURE 
5.1 Presentation of the article 
This section contains the article entitled “The impact of the timing of induction on the 
metabolism and productivity of CHO cells in culture” which was published in "Biochemical 
Engineering Journal" (Volume 79, 2013, Pages 162–171). In this study, we demonstrate that, in 
a biphasic process, cell growth and recombinant protein expression during the production phase 
are largely determined by the time, and the prevailing cell concentration, at which the induction is 
performed. It is shown that the potential benefit of inducing a culture with a high cell 
concentration is negated by a significant drop in cell specific productivity, most likely related to a 
reduced availability of nutrients or waste metabolite accumulation. An isotopic tracer experiment 
was conducted to assess the metabolic differences between culture induced at respectively low 
and high cell densities. The resulting intracellular flux maps were compared in an effort to 
identify metabolic fluxes that are correlated to cell specific growth or productivity.  
 
Compared with the previous chapter, the labeling experiments carried out in this study were 
performed with fewer labeled substrates, based on simulation work indicating that using 1-
13
C 
glucose and U-
13
C glutamine would be the most efficient combination to provide reliable flux 
estimates. 
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5.2.1 Abstract  
Efficient inducible mammalian expression systems are becoming increasingly available and are 
particularly attractive from a process optimization point of view in that they allow decoupling the 
growth and production phases. In biphasic processes, the timing of induction is one of the most 
critical factors to consider for maximizing the productivity, since it will affect both the 
cumulative biomass concentration and the cell specific productivity. In an effort to assess how 
these two factors must be balanced for optimal productivity, we have performed a metabolic 
characterization of CHO cells expressing a recombinant antibody and harboring an efficient 
inducible expression system. Cells taken at different stages of growth were transferred and 
induced in fresh medium at their corresponding cell densities, and the kinetics of growth, nutrient 
consumption and product formation were compared during the production phase. Low cell 
density inductions achieved lower maximum cell concentrations, but exhibited higher cell 
specific productivity and greater culture longevity, and ultimately led to increased final product 
titers. To gain more physiological insights into the observed differences, 
13
C metabolic flux 
analysis was performed to characterize and compare the metabolism of cells induced at 
respectively low and high cell concentrations. A number of key intracellular fluxes were found to 
be affected by the cell density and the corresponding availability of nutrients during the induction 
phase. While glucose utilization efficiency is increased in high cell density induction, thereby 
reducing the specific lactate production rate, it appears to be compensating for the decreased 
catabolic rates of amino acids. The comprehensive metabolic characterization performed in this 
work can help guide the development of an efficient feeding strategy pre- and post-induction. 
 Keywords: Inducible expression, 
13
C-metabolic flux analysis, CHO cell cultures 
78 
 
 
5.2.2 Introduction  
Nowadays, two thirds of the top selling biopharmaceutical products are manufactured using 
mammalian cell systems, and CHO cells in particular remain the dominant expression platform in 
industry (Walsh, 2010). The fact that these cells have the ability to synthesize proteins with 
human-like posttranslational modifications makes them the most suitable host system for many 
valuable biotherapeutics. Due to the increasing demand for biologics, the pressure to reduce the 
cost associated with process development and the need to shorten the time to market, continuous 
efforts have been made in mammalian cell technologies to maximize both the yields and product 
quality.  This has been mostly achieved through the design of enhanced expression vectors, 
improved medium formulations and the application of fed-batch strategies supporting high cell 
densities as well as extending culture time (Butler & Meneses-Acosta, 2012; Dietmair et al., 
2011; Lim et al., 2010; O'Callaghan & James, 2008).  
In recent years, there has been also a growing interest in the development of inducible 
mammalian expression systems, such as the widely used tetracycline- (Gossen & Bujard, 1992) 
and ecdysone-regulated expression platforms (No et al., 1996).  In these systems, expression of 
the transgene of interest is typically initiated upon the addition of a regulating compound to 
culture medium (Rita Costa et al., 2010). The use of inducible expression systems is particularly 
advantageous in the case of recombinant products which have known cytotoxic effects on the 
host cells, since the production can be triggered once cells have been grown to sufficiently high 
cell densities. More generally, the ability to decouple the growth and production phases allows 
one to perform biphasic cultivations, which are particularly attractive from a process optimization 
point of view in that they permit to define specific operating conditions that are optimal for each 
phase (Trummer et al., 2006b). Indeed, the cell specific productivity of mammalian cells is 
usually non-growth associated (Li et al., 2010) and is sometimes reported to be inversely 
correlated with their proliferation rate (Al-Rubeai, Emery, Chalder, & Jan, 1992; F. W. Lee, 
Elias, Todd, & Kompala, 1998). Moreover, cells can presumably be grown more rapidly before 
induction as they do not have the extra metabolic load associated with recombinant protein 
expression (Lipscomb, Mowry, & Kompala, 2004). Such metabolic burden was demonstrated in 
yeast and bacteria (Glick, 1995; Heyland, Blank, et al., 2011; Heyland, Fu, Blank, & Schmid, 
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2010). Although recombinant proteins account for a lower fraction of total cellular proteins in the 
case of mammalian cells (typically below 10 to 15 %), recombinant cell lines also exhibit signs 
of increased metabolic load, in the form of reduced cellular growth and altered rates of nutrient 
utilization (Kuystermans, Krampe, Swiderek, & Al-Rubeai, 2007; Yallop et al., 2003), 
presumably due to the energy being diverted towards product synthesis. Many studies have also 
reported notable increases in cell specific productivity and culture longevity when the production 
phase is performed at a lower culture temperature (typically 30 to 32 C), related to the ensuing 
reduction or arrest of cell growth (Fogolin, Wagner, Etcheverrigaray, & Kratje, 2004; Kaufmann, 
Mazur, Fussenegger, & Bailey, 1999; Kaufmann et al., 2001; Kumar, Gammell, Meleady, Henry, 
& Clynes, 2008; Trummer et al., 2006a). 
In the development of an efficient biphasic process, the timing of induction is one of the most 
crucial factors to optimize, as the final product yield will ultimately be determined by both the 
cumulative viable cell density and the cell specific productivity. These two factors must be 
carefully balanced, as they depend and impact on the culture environment, most notably substrate 
and toxic by-product concentrations. Indeed, the benefits of performing the induction at high cell 
concentrations can be partly or wholly negated by a reduction in cell specific productivity or a 
shorter duration of the production phase, as a result of decreased nutrient availability and/or 
waste metabolite accumulation. In particular, lactate and ammonia are well known inhibitors of 
both cellular growth and productivity, with adverse effects typically reported for lactate 
concentrations above 20 mM and ammonia levels as low as 2-3 mM (H. J. Cruz, Freitas, Alves, 
Moreira, & Carrondo, 2000; Glacken, 1986; S.S. Ozturk, Riley, & Palsson, 1992).  It is thus 
instrumental to characterize how the conditions at induction will affect the cell’s physiological 
state and the ensuing process productivity. While mammalian inducible expression platforms are 
becoming more and more available, comprehensive metabolic studies are still missing and 
needed to allow the rational optimization of biphasic cultures. 
Towards this goal, the main objective of this work was to quantitatively assess the impact of 
different cell densities at induction on the primary metabolism and specific productivity of CHO 
cells in culture. To this end, we have employed a recombinant cell line harboring a cumate-
inducible expression system (Mullick et al., 2006) that exhibits very low basal expression levels 
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in the repressed state and high expression upon induction with cumate, a small non-toxic 
molecule. Cells taken from the same batch culture at different stages of growth were re-
suspended and induced in fresh medium, and the kinetics of growth, nutrient consumption and 
product formation were compared during the production phase. To gain more insights into the 
observed changes, two culture conditions corresponding to low and high cell density induction 
were further characterized by 
13
C-metabolic flux analysis, whereby induced cells were grown in 
parallel cultures containing a mixture of 
13
C-labeled tracers and the resulting mass isotopomer 
distributions of extracellular metabolites secreted by the cells (amino and organic acids) were 
measured by LC-QTOF-MS. The main intracellular fluxes were calculated along with confidence 
intervals and this allowed to analyze the cell metabolism in relation with the prevailing culture 
conditions and the measured cellular productivities. Such analysis is needed to guide the rational 
development of biphasic processes, in particular to support the design of a balanced and efficient 
feeding protocol post-induction. 
5.2.3 Materials and Methods 
5.2.3.1 Cell lines, medium and culture conditions 
A recombinant CHO cell line, CHO-CUM2, was obtained from Viropro International Inc. 
(Montreal, Canada). The cell line stably expresses the reverse cumate transactivator described in 
Mullick et al. (Mullick et al., 2006) and produces a recombinant human anti-CD20 monoclonal 
antibody. In our study, we employed a custom serum- and protein-free, chemically defined 
SFM4CHO medium (Hyclone). This basal medium did not contain any glucose and glutamine, so 
as to facilitate the metabolic characterization and the isotopic tracer study described below. 
Before culturing the cells, the fresh medium was supplemented with 5mM  glutamine (Hyclone), 
30mM glucose (Sigma), and 0.05mg/ml dextran sulphate (Mw: 500000, Amersham Pharmacia 
Biotech). [1-
13
C] glucose (99%) and [U-
13
C5] glutamine (98%) were purchased from Cambridge 
Isotope Laboratories (Andover, MA). Glucose and glutamine tracers were dissolved in deionized 
water at 650mM and 200mM, respectively, as a stock solution.  
For the growth phase, recombinant cells were inoculated at 0.2×10
6
 cells/mL in a 250 mL 
Erlenmeyer flask and grown in suspension with unlabeled substrates at 37C in a 5% CO2 and 
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95% humid atmosphere. From this batch culture, cells were harvested for four consecutive days 
(at 24, 48, 72 and 96h), centrifuged and re-suspended in fresh medium. All culture conditions 
were performed in duplicate 125 mL flasks. Harvested cells were not diluted and the inductions 
were thus carried out at increasing cell densities from day 1 to day 4. The medium exchange was 
performed so as to avoid early nutrient limitations, especially for high cell density cultures, while 
also minimizing isotopic tracer dilution effects caused by the presence of residual unlabeled 
glucose/glutamine and by the previous accumulation of unlabeled extracellular metabolites. In 
cultures seeded with cells harvested on day 2 and day 3, the inductions were done in medium 
containing [1-
13
C] glucose and [U-
13
C] glutamine. 1 µg/mL cumate was added to each flask to 
trigger the protein expression and the temperature was shifted from 37C to 30C for the duration 
of the production phase. Supernatants were collected by centrifugation at 300 g for 5 min and 
samples were stored at -80⁰C for subsequent analysis.  
5.2.3.2 Quantification of cell density and metabolites 
Samples from cell cultures were taken daily and monitored for viable cell density. When the cell 
density was high, samples were diluted with phosphate-buffered saline (PBS). Culture samples 
were mixed with trypan blue and cell numbers were counted using a hemacytometer and a 
standard light microscope. Glucose, lactate, and glutamine concentrations were measured off-line 
using a YSI 2700 Biochemistry Analyser (Yellow Springs, OH). Extracellular amino acid 
concentrations were determined on an Agilent 1290HPLC system (Agilent technologies, Quebec, 
Canada) coupled to an Agilent 6460 triple quadruple mass spectrometer (Agilent technologies, 
Quebec, Canada).  The underivatized amino acids were separated by a 2.1x150mm ZICTM-Hilic 
column (3.5um, 200A, PEEK) (Merck SeQuant) and 2.1x20mm ZICTM-Hilic guard column 
(5um, 200A, PEEK) (Merck SeQuant) at a temperature of 35
o
C and at an injection volume of 
5uL. The mobile phase buffer contained 20mM HCOONH4 at pH 4. The mobile phase A was 
10% of the mobile phase buffer in water, and the mobile phase B was 10% of the mobile phase 
buffer in ACN. The mobile phase B linearly decreased from 90% to 35% in 19min, then was 
increased to 90% in one min and hold at 90% for 15min at a flow rate of 0.1ml/min. 
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5.2.3.3 Analysis of 13C-labeling patterns  
The 
13
C fractional enrichment of lactate, aspartate, alanine and glutamate in the samples was 
measured on an Agilent 1100 series LC-MSTOF (Agilent technologies, Quebec, Canada). First, 
200µL of supernatant samples were deproteinized by adding 1mL cold acetone (-20⁰ C) and then 
were vortexed strongly. After centrifugation at 20,000g for 5 min, the solutions were filtered and 
evaporated in vacuo. After that, 400 µL of water was added to the samples. The analysis was 
done in negative electrospray mode without derivatization using a Kinetex HILIC Phenomenex 
column, 100 x 4.6mm and 2.6um particle size. The eluants used were 5mM ammonium formate 
(in water) and acetonitrile containing 0.1% formic acid. The gradient was in HILIC mode and 
went from 90% to 50% ACN with a total run time of 20 minutes. The mass isotopomer 
distributions of α-ketoglutarate and succinate were analyzed on a UPLC-MS/MS (Agilent, 
Quebec, Canada) equipped with a 1290 infinity binary pump, an autosampler, a column 
controller and a 6460A triple quad mass spectrometer.  20uL of supernatant sample were filtered 
through a 0.22 µm PTFE filter (Millipore, Ontario, Canada) before injection. Organic acids were 
separated on a Hypercarb column (100*2.1 mm, 5 µm) and a Hypercarb pre-column (2.1*10, 5 
µm) (Thermo Fisher, Ontario, Canada) with mobile phase A: 20mM ammonium acetate at pH 
7.5, and mobile phase B: 10 % (v/v) methanol in water at a flow rate of 0.3 mL/min. The mobile 
phase gradient was: 10% A from 0 to 5 min, linear gradient from 10 to 20% A from 5 to 10 min, 
linear gradient from 20 to 100% A from 10 to 20 min, 100% A from 20 to 30 min, linear gradient 
from 100 to 10% A from 30 to 32 min and, finally, 10% A from 32 to 40 min. The negative 
electrospray ionization model was selected for the analysis with an Agilent Jet Stream source. 
The mass spectrometer operation conditions were set as follows: gas temperature 300
o
C, gas flow 
rate 7L/min, nebulizer pressure 40 psi, sheath gas temperature 300
o
C, sheath gas flow 12L/min 
and capillary voltage -3.5kv. 
 
5.2.3.4 Quantification of monoclonal antibody 
Monoclonal antibody titers were measured by an enzyme-linked immunosorbent assay (ELISA). 
First, a goat anti-human IgG1 (H+L) solution (Jackson ImmunoResearch) diluted to 2.5 µg/ml in 
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50mM sodium carbonate (Fischer Scientific) was added to 96-well plates (Costar) and incubated 
at 4C overnight. Then, blocking of non-specific sites was carried out by adding a PBS solution 
containing 1% casein. After incubation for 1h at 37C, either samples or standards diluted in 
PBS-casein were added in triplicate and incubated for 1h at 37C. The wells were then incubated 
with 1/10,000 diluted peroxidase-conjugated AffiniPure gragment goat anti-human IgG (Jackson 
ImmunoResearch) for 1h at 37C. After each of the previous steps, the wells were washed three 
times with PBS-Tween buffer (PBS, 1% Tween 20). Finally, the reaction was revealed by 
addition of 3,3′,5,5′-Tetramethylbenzidine (TMB) (Sigma) and stopped after 10-15 minutes by 
adding 1N hydrochloric acid. The absorbance at 450 nm was measured using a Victor
3
 V 
microplate reader (Perkin-Elmer). 
 
5.2.3.5 Determination of specific rates 
To obtain reliable specific rate estimates, logistic equations were used to model the viable cell 
density, as well as nutrient and product concentration profiles (Chetan T Goudar et al., 2005; 
Olivier Henry et al., 2008). Glutamine uptake rates were corrected to account for the spontaneous 
decomposition of this substrate in the culture medium, which was experimentally determined 
under the culture conditions used in this work, yielding a first-order kinetic constant of 0.03 d
-1
. 
Average antibody cell specific productivities were determined from the slopes when the integral 
of viable cell concentrations were plotted against the corresponding antibody concentrations (P. 
W. Sauer et al., 2000).  
 
5.2.3.6 Metabolic network and intracellular flux evaluation 
For intracellular flux analysis, a detailed metabolic network was constructed based on previous 
models for CHO cells (Woo Suk Ahn & Antoniewicz, 2011; Ghorbaniaghdam et al., 2013; C. 
Goudar et al., 2010; Zamorano et al., 2009). The metabolic network includes glycolysis, the 
oxidative and non-oxidative branches of the pentose phosphate pathway, the TCA cycle and 
anaplerotic reactions. Reversible reactions were separated into forward and backward fluxes 
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constrained to be non-negative. To account for biosynthetic requirements, the model includes 
simplified reactions for the biomass and antibody synthesis, which were established from 
published average biomass/production composition data (Quek et al., 2010) and by assuming a 
dry cell weight of  0.350 mg/10
6
 for CHO cells (Woo Suk Ahn & Antoniewicz, 2011; Altamirano 
et al., 2001). A detailed list of the biochemical reactions and their corresponding C atom 
transitions can be found in Table A1 (Appendix A). The inputs used for flux estimation were the 
measured extracellular rates, as well as the labeling patterns of three secreted extracellular amino 
acids (aspartate, alanine and glutamate) and three extracellular organic acids (lactate, succinate 
and α-ketoglutarate). Standard assumptions related to 13C analysis of mammalian cells were 
employed (Woo Suk Ahn & Antoniewicz, 2011; Metallo et al., 2009; Munger et al., 2008) and 
details are provided in the supplemental material. All calculations were performed in Matlab 
using the elementary metabolite unit network decomposition method (M.R. Antoniewicz et al., 
2007). The constrained nonlinear least-squares regression was performed using the built-in 
function “fmincon” to minimize the sum of weighted squared residuals (WSR) between measured 
and simulated variables. The minimization was repeated ten times with random initial estimates 
of free fluxes to ensure the attainment of a global optimal solution. Validation of the fits was 
performed based on a standard chi-square goodness-of-fit test and 95 % confidence intervals for 
the intracellular fluxes were evaluated using the method outlined in Antoniewicz et 
al.(Antoniewicz et al., 2006). For statistical comparison of the corresponding fluxes obtained 
under two conditions (i.e. induction at low and high cell densities), unpaired two-tailed Student's 
t-tests were performed in Excel. 
5.2.4 Results  
In order to investigate and quantify the effects of induction conditions on the metabolism and 
productivity of CHO cells, cultures were induced in fresh medium and under mild-hypothermia 
conditions after being seeded with cells taken from a single uninduced batch culture at various 
stages of growth. The resulting induced cultures were analyzed at two levels. First, extracellular 
measurements were used to evaluate and compare the main kinetic rates of cellular growth, 
nutrient consumption, metabolite production and antibody formation post-induction. Second, a 
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more refined metabolic characterization was performed by quantifying the main intracellular 
fluxes with the aid of isotopic tracers and mass spectrometry measurements. 
 
Table  5-1: Kinetics of growth and product formation for different induction times 
Time of induction relative to growth phase Day 1 Day 2 Day 3 Day 4 
Cell density at induction (106cells/mL) 0.600.05 1.20.1 3.40.3 4.70.5 
Cell specific growth rate post-induction (d-1) 0.350.05 0.250.04 0.170.02 0.180.03 
Max. cell density post-induction (106cell/mL) 4.30.2 5.00.3 7.10.7 8.10.4 
Final MAb concentration (mg/L) 13620 15724 8112 639 
Avg. cell specific productivity (pg/cell.d) 4.00.8 6.01.2 2.00.5 1.50.3 
 
5.2.4.1 Impact of increasing cell densities at induction on cellular kinetics 
The growth curve for the uninduced batch culture, which was run at 37°C, is shown in Figure 5-
1A along with the different harvest points. The first two harvest points corresponded to relatively 
low densities (<1.2x106 cells/mL) with cells taken in their early exponential phase, while for the 
subsequent harvests, the cells were in their mid-exponential and early-stationary phases, 
respectively. Cell viability was nonetheless greater than 95 % in all the cultures which were 
induced to initiate the production phase. The resulting cell concentration profiles post-induction 
are shown in Figure 5-1B and the corresponding glucose, glutamine, lactate and antibody profiles 
are depicted in Figures 5-1C to 5-1F. The main kinetics of growth and product formation are 
summarized in Table 5-1 for all four induction conditions. Cultures induced at low cell densities 
exhibited relatively similar growth profiles (Figure 5-1B), reaching maximum cell densities of 4 
to 5x106 cells/mL in 8 to 9 days, with average cell specific growth rates of 0.25 to 0.35 d-1 (see 
Supplementary Figure 5-5). The inductions performed at higher cell densities reached cell 
concentrations that were twice as high and the maxima were attained in 4 to 5 days, but exhibited 
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reduced specific growth rates (0.17 d-1 and 0.18 d-1, respectively) and cell viability started to 
decline rapidly after only 5 to 6 days post-induction. As shown in Figure 5-1F, the corresponding 
final MAb titers were significantly decreased in these cultures, reaching only 40 to 50 % of the 
maximum MAb concentrations achieved with lower cell densities at induction, albeit in a shorter 
time (6-7 days vs 11-13 days). The average cell specific antibody production rate was 
approximately 3-fold higher in low cell density cultures. 
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Figure  5-1: (A) Viable cell concentration profile during the growth phase at 37°C in a batch 
culture. Arrows indicate the times at which cells were harvested, re-suspended in fresh medium 
and induced at a temperature of 30°C. Viable cell density (B), glucose (C), glutamine (D), 
Lactate (E) and antibody concentration profiles post-induction.  
Error bars represent the standard error of duplicate experiments. Open symbols correspond to 
culture conditions that were performed with isotopic tracers for conducting a comparative 13C-
metabolic flux analysis. 
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Table 5-2 presents the cell specific uptake and metabolite secretion rates evaluated at 48h post-
induction for all four conditions. As shown in Figure 5-1C, low residual concentrations of 
glucose were only observed at the end of the cultures, whereas glutamine was depleted 4 days 
post-induction in the cultures induced at high cell density. The cell specific glucose uptake and 
lactate production rates at 48h post-induction were both found to decrease with increasing cell 
density (Table 5-2). In addition, while the yield of lactate produced on glucose consumed was 
about 2 for low cell concentrations, this ratio decreased to 0.9 in higher cell density cultures. This 
is indicative of a significant change in nutrient utilization efficiency by the cells, most likely 
linked with the different prevailing culture conditions (e.g. the reduced nutrient availability). 
Moreover, in the high cell density cultures, lactate reached a maximum on day 2 or 3 and was 
consumed thereafter. As evident from Figure 5-1E, this metabolic shift seemed to coincide with 
the (near) depletion of glutamine in the culture environment. Greater cell specific glutamine 
uptake rates were also observed in cultures induced at low cell density and these rates decreased 
by up to 50 % for inductions at elevated cell concentrations. The utilization rates of other amino 
acids were also examined (Table 5-2) and, in all the cultures, most of them were consumed by the 
cells except for alanine, glycine, glutamate and aspartate that were found to be accumulated in the 
culture medium. When comparing the different induction conditions, the overall trend is a 
reduction of the amino acids uptake/secretion rates with increasing cell density at induction.  
Even though all inductions were carried out in fresh medium (i.e. with similar initial nutrient 
levels), taken together, the measured kinetic rates clearly indicated that cells reached distinct 
metabolic states two days post-induction, depending on the prevailing cell density during 
production and presumably related to nutrient availability, toxic waste levels or cell age effects. 
In turn, these different physiological states impacted the overall productivity of the cultures, 
emphasizing the need to characterize the cell metabolism in relation with process conditions to 
further improve the yields. 
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Table  5-2: Cell specific uptake/secretion rates (in pmol/cell.d) measured 48h post-induction 
 
Low cell density inductions High cell density inductions 
Time of 
induction Day 1 Day 2 Day 3 Day 4 
Glucose -1.50 ±0.14 -1.36 ±0.14 -1.16 ±0.10 -1.00 ±0.10 
Lactate 3.02 ±0.25 2.79 ±0.28 1.07 ±0.11 0.90 ±0.10 
Glutamine* -0.40 ±0.03 -0.45 ±0.06 -0.28 ±0.07 -0.20 ±0.04 
Phenylalanine -0.01 ±0.01 -0.01 ±0.01 -0.01 ±0.01 0.00 ±0.01 
Threonine -0.05 ±0.01 -0.03 ±0.01 -0.01 ±0.01 0.00 ±0.01 
Leucine/Ileucine -0.21 ±0.04 -0.20 ±0.02 -0.08 ±0.01 -0.06 ±0.02 
Methionine -0.02 ±0.01 -0.02 ±0.01 -0.02 ±0.01 -0.01 ±0.01 
Tyrosine -0.02 ±0.01 -0.01 ±0.01 -0.02 ±0.01 -0.02 ±0.01 
Valine -0.04 ±0.01 -0.03 ±0.01 -0.03 ±0.01 -0.01 ±0.01 
Proline -0.06 ±0.01 -0.05 ±0.01 -0.02 ±0.01 -0.02 ±0.01 
Alanine 0.15 ±0.02 0.11 ±0.03 0.17 ±0.05 0.21 ±0.03 
Glycine 0.11 ±0.01 0.05 ±0.01 0.02 ±0.01 0.10 ±0.01 
Serine -0.11 ±0.01 -0.07 ±0.01 -0.08 ±0.01 -0.09 ±0.01 
Asparagine -0.47 ±0.05 -0.24 ±0.03 -0.13 ±0.03 -0.19 ±0.03 
Glutamate 0.22 ±0.04 0.15 ±0.03 0.15 ±0.05 0.10 ±0.03 
Aspartate 0.18 ±0.02 0.10 ±0.02 0.10 ±0.03 0.00 ±0.02 
Arginine -0.13 ±0.02 -0.09 ±0.01 -0.02 ±0.01 -0.02 ±0.01 
Lysine -0.03 ±0.01 -0.08 ±0.01 -0.02 ±0.01 -0.03 ±0.01 
Histidine -0.07 ±0.01 -0.03 ±0.01 -0.01 ±0.01 -0.03 ±0.01 
* After correction for spontaneous decomposition. 
 
  
90 
 
 
 
Figure  5-2: Fractional abundances of labeled mass isotopomers at 48h after inductions performed 
respectively at low and high cell densities, for the following metabolites: lactate, alanine, 
aspartate, glutamate, succinate and ketoglutarate. Cells were induced in fresh medium containing 
[1-
13
C]- glucose and [U-
13
C5]- glutamine.  
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5.2.4.2 13C-metabolic flux analysis post-induction  
As inferred from extracellular rate measurements, the metabolic activity of cells during the 
production phase is greatly affected by the cell density at induction. In order to shed more light 
into the underlying physiological changes, a comprehensive 
13
C-metabolic flux analysis was 
performed to compare cultures induced respectively at low and high cell concentrations, 
corresponding to harvest points performed on day 2 and day 3 of the growth phase (Culture2 and 
Culture3 in Figure 5-1). For these two conditions, exponentially growing cells were transferred 
and induced into 
13
C-tracer containing medium, and exponential growth was maintained for a 
minimum of 3 days post-induction, albeit at a lower rate due mainly to the temperature shift. At 
48h post-induction, cell-free supernatant samples were collected and analyzed by mass 
spectrometry to measure the relative mass isotopomer distributions of six secreted metabolites, 
including three amino acids (alanine, aspartate and glutamate) and three organic acids (lactate, 
succinate and a-ketoglutarate). This period of time was chosen to ensure the attainment of 
pseudo-steady isotopic and metabolic state conditions, as well as to minimize isotopic tracer 
dilution effects from unlabeled biomass. Indeed, previous isotopic tracer studies conducted with 
mammalian cells have shown that isotopic steady-state conditions are typically attained within 24 
hours (Olivier Henry & Durocher, 2011; Maier et al., 2008; Munger et al., 2008; Niklas et al., 
2011). As shown in Figure 5-2 and consistent with the differences observed at the level of the cell 
kinetic rates (Table 5-2), cultures induced at low and high cell densities exhibited distinct 
labeling patterns for all the measured metabolites. These measured mass isotopomer distributions 
are reflective of the activity of the intracellular pathways and hence can provide both qualitative 
and quantitative information about cell metabolism. For example, the measured mass isotopomer 
distributions of alanine and lactate differed to some extent (Figure 5-2), even though both 
metabolites have pyruvate as their main precursor. Such apparent discrepancies can be due to 
tracer dilution from an unlabeled carbon source (e.g. free metabolites derived from protein or 
lipid turnover) or may suggest the presence of two distinct intracellular pools of pyruvate in the 
cytosol and the mitochondria (Peuhkurinen et al., 1983). The detection of fully labeled lactate, 
originating from [U-
13
C5] glutamine partial oxidation, was indicative of some pyruvate recycling 
from the TCA, e.g. via malic enzyme. Such information was thus taken into account in the 
development of the metabolic model (Table 5-3). 
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Figure  5-3: Metabolic flux maps 48h post-induction at low (A) and high (B) cell densities. (C) 
Comparison of key intracellular fluxes. Standard errors were calculated from the upper and lower 
bounds of the 95 % confidence intervals.  
* indicates significance at p<0.05. Abbreviations:  AA2 = Leu, Lys, Ile, Tyr, Trp, and Thr; AA4 
= Val, Met, and Ile; AA5 = His, Arg, and Pro.   
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The measured mass isotopomer data and the specific uptake/production rates calculated at 48h 
post-induction were utilized to estimate the intracellular flux distributions. The model contained 
19 free fluxes to optimize and since 24 independent mass isotopomer distributions were available 
for each induction conditions, the minimum and maximum allowable values for the variance-
weighted sum of squared residuals (WSSR) were 1.1 and 11.1, respectively (chi-square test for 
95% level of confidence with 5 degrees of freedom). The data and assumed metabolic network 
yielded statistically acceptable fits with WSSR values of 3.7 and 8.3 for low and high cell density 
conditions, respectively. The obtained flux maps are shown in Figure 5-3, along with the 
statistical significance of the observed differences. The complete flux distributions and the 
associated 95% confidence intervals are included as Supplementary Material (Table 5-4). For a 
number of key intracellular reactions, inductions performed at low and high cell densities yielded 
significantly different flux values (Figure 5-3C). These metabolic observations are further 
elaborated in the next section. 
5.2.5 Discussion  
For biphasic cultivation, the common approach consists in initially growing the cells to 
sufficiently high concentrations, while ensuring that they maintain high viability before the onset 
of the production phase. Hence, the induction is typically made when cells are still in their mid-
exponential phase rather than at the maximum cell density (Bi, Shuttleworth, & Al-Rubeai, 2004; 
Kumar et al., 2008; Nam, Ermonval, & Sharfstein, 2009; Trummer et al., 2006b). Both the 
cumulative viable cell density and the cell specific productivity need to be balanced in order to 
maximize product titers and it is thus crucial to determine an optimal induction time. The goal of 
this study was to quantitatively assess the effects of the timing of induction on both MAb 
productivity and cell metabolism, so as to provide a sound basis for directing process 
improvement efforts. At the time of induction, the temperature was shifted to 30°C as mild-
hypothermia conditions are commonly associated with increased cellular productivity and 
extended culture longevity due to cell arrest in G0/G1 phase (Sunley & Butler, 2010). The 
temperature shift caused a significant reduction in the cell specific growth rate for all the 
inductions, but this decrease was more pronounced with increasing cell densities, even though the 
cell viability was initially high in all the cultures. This behavior is not specific to biphasic 
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cultures with temperature shift, as a similar cellular growth reduction was reported for hybridoma 
cells inoculated at increasing inoculum age (Martial, Dardenne, Engasser, & Marc, 1991). In our 
experiments, the lowest growth rate observed during the production phase corresponded to cells 
harvested from late exponential/early stationary phase. It is thus likely that growth kinetics post-
induction are determined by the levels of nutrients and waste metabolites present, but also by the 
physiological state of the cells prior to the harvest and the magnitude of the sudden change in 
environmental conditions resulting from the fresh medium exchange. In addition, high cell 
densities could not be maintained for more than 4 to 6 days post-induction, most likely due to a 
nutrient limitation as the decrease in cell viability coincided with glutamine depletion. Such early 
reduction in cell viability is obviously not desirable as proteolytic degradation may eventually 
hamper the stability and/or quality of the product (M. Yang & Butler, 2000).  The cultures 
induced at high cell concentrations also had significantly reduced specific antibody productivity 
and, despite greater cell numbers, yielded lower final antibody titers. The presence of an optimal 
shift time with respect to culture productivity was also demonstrated in the case of CHO cells 
expressing a recombinant glycoprotein (Fox et al., 2004). Taken together, these results 
emphasized the need to balance both factors (biomass concentration and cell specific 
productivity) in order to maximize the volumetric yield. Given that cell growth was slowed but 
not fully arrested upon induction at low temperature, the growth phase should not simply aim at 
maximizing the biomass content, but should maintain the cells in a favorable productive 
metabolic state. Decreased cellular specific productivity with increasing cell densities have been 
previously reported, notably in perfusion cultures, and this apparent “cell density effect” was 
speculated to be related to the reduced availability of key nutrients in the culture environment 
(Craig Seamans & Hu, 1990; Zeng, 1996). In our cultures, glutamine was likely one of the key 
limiting factors considering that this substrate is both an important energy source for mammalian 
cells and one of the major building blocks for cellular and recombinant protein synthesis 
(Neermann & Wagner, 1996).  
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The kinetics of nutrient uptake and metabolite formation were also significantly affected by the 
cell density at induction. Increasing the cell concentration led to an overall decrease in the uptake 
rates of glucose and most amino acids. This may be related in part with the reduction in cellular 
growth observed, but was also due to the lower concentrations of these nutrients at 48h post-
induction. Indeed, the metabolism of mammalian cells tends to become increasingly efficient as 
the residual substrate concentrations are small in the culture environment, and this is at the basis 
of common fed-batch strategies to minimize the formation of ammonia and lactate (T.A. Bibila & 
D.K. Robinson, 1995).  A clear metabolic shift towards lactate consumption was observed in all 
the cultures, and appeared to coincide, or slightly precede, the time of glutamine depletion and 
the cessation of net cell growth. This is a common behavior reported for CHO cells in culture 
(Altamirano et al., 2006; Zagari et al., 2013), although it has not always been correlated directly 
with amino acid depletion (Mulukutla et al., 2012). This metabolic change occurred nonetheless 
more rapidly when the cells were induced at high cell density and thus, in this case, an early shift 
towards lactate consumption seems to be an indicator of poor process productivity. Even prior to 
the exhaustion of glutamine and the onset of lactate consumption, the measured kinetic rates 48h 
post-induction indicated that the cultures were already in distinct metabolic states as a result of 
being harvested and induced at different stages of cell growth.  
The differences found in extracellular rate measurements for increasing cells densities at 
induction were further examined at the intracellular level by conducting a comparative 
13
C-
metabolic flux analysis. This approach is increasingly being used for the in-depth metabolic 
characterization of cultivated mammalian cells, as it allows the reliable quantification of central 
carbon metabolism (W. S. Ahn & Antoniewicz, 2012; Zamboni, 2011). In turn, this provides 
invaluable information to enable the targeted optimization of cell cultures, both at the cellular and 
process levels. When cells were induced at high density, the main glycolytic fluxes were 
significantly reduced (Figure 5-3), as could be inferred from the observed reduction in glucose 
uptake rate. However, extracellular rates alone do not allow determining the split between 
glycolysis and the pentose phosphate pathway (PPP), which is producing building blocks for 
nucleotides and is also the main source of cytosolic NADPH in mammalian cells. The latter is 
notably essential in the cell's anabolism, mainly in the synthesis of amino acids and fatty acids.  
In conventional metabolic balancing studies, it is usually assumed that PPP is only responsible 
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for nucleotides synthesis (Niklas & Heinzle, 2012), that is, the activity of transaldolase and 
transketolase is ignored and only the oxidative branch is considered (Martens, 2007). The use of 
labeled substrates alleviates the need of such questionable assumptions. Our analysis revealed 
that the oxidative branch of the pentose phosphate pathway was lower for the high cell density 
cultures (0.16 pmol/cell.d vs 0.26 pmol/cell.), although 95 % confidence intervals are 
overlapping. For both low and high cell density inductions, this flux corresponded approximately 
to 18 % of the total glucose uptake rate being channeled via PPP, which is in line with most 
previous isotopic investigations of mammalian cells in culture (H. P. Bonarius et al., 2001; C. 
Goudar et al., 2010), although it should be emphasized that these studies were all performed at 
37°C. Recent studies have also reported that the PPP can be significantly enhanced when the cells 
are in the stationary phase, thereby generating more NADPH presumably to counteract oxidative 
stress (Woo Suk Ahn & Antoniewicz, 2011; Sengupta et al., 2011; Tuttle, Stamato, Perez, & 
Biaglow, 2000). However, in the present study, even the high cell density cultures displayed 
exponential growth for the first few days post-induction and such enhancement in PPP activity 
was not observed. 
The main metabolic fluxes around the pyruvate branch point were markedly different for the two 
conditions under investigation. In cultures induced at low cell density, only about 17 % of the 
pyruvate intracellular pool entered the TCA, while 80 % was converted to lactate via lactate 
dehydrogenase, and the remaining fraction was converted into amino acids. This inefficient 
utilization of glucose, referred to as “overflow metabolism”, is commonly observed in animal cell 
systems under substrate excess conditions (Amribt, Niu, & Bogaerts, 2013; Doverskog, 
Ljunggren, Öhman, & Häggström, 1997; J. Ljunggren & Haggstrom, 1992), such as those 
prevailing at the beginning of batch cultures. In contrast, at high cell density, the fluxes were 
more evenly distributed between lactate and the TCA (59 % vs 41 %). Interestingly, this 
distribution of fluxes at the pyruvate branch point is very similar to the one previously reported 
for CHO cells grown in high cell density perfusion cultures (C. Goudar et al., 2010). For 
cultivated mammalian cells, the entry of pyruvate into the TCA cycle occurs mainly via pyruvate 
dehydrogenase (PDH), while the pyruvate carboxylase (PC) flux is often considered negligible 
(Quek et al., 2010). However, flux through this pathway can only be determined with the aid of 
labeled tracers. Previous recent isotopic studies on CHO cells have shown that this flux is indeed 
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active, albeit at a lower rate than PDH (Woo Suk Ahn & Antoniewicz, 2011; C. Goudar et al., 
2010; Sengupta et al., 2011). Our analysis revealed that the anaplerotic conversion of pyruvate to 
oxaloacetate via PC accounted between 5 % and 27 % of the total pyruvate entering the TCA, 
with the greater contribution corresponding to low cell density conditions. Together with PC, the 
conversion of glutamate to α-ketoglutarate and the aspartate transaminase reaction were the other 
two significant anaplerotic pathways observed. Those pathways serve to replenish intermediates 
leaving the TCA cycle, mostly citrate for lipid synthesis, and were significantly more active in 
cultures induced at low cell density (Figure 5-3).  This can be attributed, at least in part, to the 
varying anabolic needs, which were reduced at high cell density given that the cell specific 
growth rate was 30 % lower.  
 
On the whole, amino acids accounted for approximately 60 % of the total carbon input into the 
TCA for cells induced at low cell concentration, whereas this fraction was reduced down to only 
20 % at higher cell densities. In the latter case, this is compensated by a greater pyruvate influx 
into the TCA. While a high proportion of pyruvate originated directly from glycolysis, pyruvate 
recycling from the TCA was also significant, accounting for an estimated 17 to 22 % of the total 
pyruvate pool, through the conversion of malate via malic enzyme. Together with the oxidative 
branch of the PPP, this pathway is a major source of reducing agent for the cells. In fact, NADPH 
formation was distributed almost evenly between these two pathways. The estimated NAPDH 
production rates were 1.1 and 0.57 pmol/cell.d for the low and high cell density cultures, which is 
consistent with the reduction in growth rate and the resulting decrease in biosynthetic 
requirements of the latter. 
 
Overall, the comparative 
13
C-metabolic flux analysis performed in this worked allowed us to 
characterize the main physiological changes resulting from two distinct conditions at induction. 
While glucose utilization efficiency is increased in high cell density induction, thereby reducing 
the specific lactate production rate, it seems to be compensating for the decreased catabolic rates 
of amino acids. Moreover, this metabolic state is associated with a lower overall productivity and 
culture longevity. Further improvement in process productivity can thus only be expected if one 
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could maintain a desired flux distribution at higher cell concentrations by enriching the culture 
medium at induction or by feeding the cultures post-induction. The latter would most likely be 
preferable so as to avoid the build-up of toxic by-products and could be rationally defined based 
on the calculated fluxes (L. Xie & D.I.C. Wang, 1996). As mentioned previously, it is possible 
that in high cell density cultures, cells already reached distinct metabolic states even prior to their 
induction. Maximizing product yields may thus require to initiate fed-batch operation prior to the 
production phase so as to always maintain suitable nutrient and waste metabolite levels. Towards 
this goal, this study could aid in the development of dynamic models (Amribt et al., 2013; 
Ghorbaniaghdam et al., 2013; R. P. Nolan & Lee, 2012; Provost & Bastin, 2004), which are 
greatly needed tools for process optimization and control. In particular, such model could guide 
the establishment of an optimal feeding profile for a fed-batch process. 
It should also be emphasized that the metabolic analysis in this work was confined to the 
exponential growth period immediately following the induction. It is evident that a significant 
flux rewiring occurred at a later stage of the production phase, most notably when lactate was 
consumed and/or as some nutrients reached limiting levels. However, in practice, process 
operation strategies should be devised so as to delay the attainment of such physiological state 
and consequently be determined based on the conditions prevailing at the beginning of the 
induction phase, i.e. prior to any limitation.  
5.2.6 Conclusion  
In this work, we have analyzed the impact of the timing of induction on the performance of a 
biphasic cell culture process. The greatest product yields were achieved when cultures were 
induced at low densities with exponentially growing cells. In contrast, and even with a complete 
medium exchange at the time of induction, high cell density cultures exhibited reduced culture 
longevity and cell specific productivity, most likely attributable to reduced nutrient availability.   
The decreased production rates were correlated with differences in some intracellular fluxes of 
primary metabolism, which could help to identify reliable physiological indicators of cell 
productivity. It is likely that performing additional nutrient feeding prior to and during  the 
production phase would allow to overcome, at least in part, the early limitations encountered at 
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elevated cell concentrations. To this end, the comprehensive metabolic characterization 
performed in this work could also help guide the development of an efficient feeding strategy 
pre- and post-induction. 
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Table  5-3 : Biochemical reactions and their corresponding C atom transitions 
Biochemical Reaction Carbon Transition 
Glycolysis   
GLC  G6P abcdef = abcdef 
G6P ↔ F6P abcdef = abcdef 
F6P  2 GAP abcdef = cba + def 
GAP  PYR abc = abc 
PYR  LAC abc = abc 
PYR  PYRm abc = abc 
 Pentose Phosphate Pathway   
G6P  P5P + CO2 abcdef = bcdef + a 
2P5P ↔ S7P + GAP 
abcde + fghij = abfghij + 
cde 
P5P + E4P ↔ F6P + GAP 
abcde + fghi = abfghi + 
cde 
S7P + GAP ↔ F6P + E4P 
abcdefg + hij = abchij + 
defg 
 TCA Cycle   
PYRm  AcCOAm + CO2 abc = bc + a 
AcCOAm + OAAm  CITm ab + cdef = fedbac 
CITm ↔ aKGm + CO2 abcdef = abcde + f 
aKGm  SUCm + CO2 abcde = bcde + a 
SUCm ↔ 0.5 MALm + 0.5 MALm abcd = 0.5 abcd + 0.5 dcba 
MALm ↔ OAAm abcd = abcd 
CITm + MAL  CIT + MALm 
abcdef + ghij = abcdef + 
ghij 
CIT  AcCOAc + OAA abcdef = ed + fcba 
MALm ↔ MAL abcd = abcd 
OAA ↔ MAL abcd = abcd 
PYRm + CO2  OAAm abc + d = abcd 
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MALm  PYRm + CO2 abcd = abc + d 
MAL  PYR + CO2 abcd = abc + d 
 Amino acid reactions   
GLN  GLU abcde = abcde 
GLU ↔ aKGm abcde = abcde 
PYRm + GLU  ALA + aKGm abc = abc  
ASP + aKGm ↔ OAAm + GLU 
abcd + efghi = abcd + 
efghi 
ASN ASP abcd = abcd 
PYR  SER, GLY abc = abc 
CYS  PYR abc = abc 
VAL, MET, ILE  SUCm abcd = abcd 
LEU, LYS, ILE, TYR, TRP, THR  AcCOAm ab = ab 
HIS, ARG, PRO GLU abcde = abcde 
 Biomass and Product Biosynthesis  
0.912 PROTEIN + 0.0315 P5P + 0.0379 G6P + 
0.317 AcCOAc + 0.0151 GAP  BIOMASS 
 
- 
0.0585 ALA + 0.0226 ARG + 0.0449 ASN + 0.0365 
ASP + 0.0252 CYS + 0.0400 GLN + 0.0518 GLU + 
0.0660 GLY + 0.0229 HIS + 0.0329 ILE + 0.0630 
LEU + 0.0608 LYS + 0.0128 MET + 0.0415 PHE + 
0.0717 PRO + 0.0106 SER + 0.1056 THR + 0.0224 
TRP + 0.0288 TYR + 0.0857 VAL  ANTIBODY 
 
- 
0.0811 ALA + 0.0510 ARG + 0.0389 ASN + 0.0485 
ASP + 0.0196 CYS + 0.0435 GLN + 0.0522 GLU + 
0.0727 GLY + 0.0193 HIS + 0.0438 ILE + 0.0763 
LEU + 0.0771 LYS + 0.0187 MET + 0.0296 PHE + 
0.0423 PRO + 0.0581 SER + 0.0522 THR + 0.0059 
TRP + 0.0246 TYR + 0.0562 VAL  PROTEIN 
- 
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5.3 Supplementary Material 
5.3.1 Metabolic flux analysis: description and assumptions  
 Cells are at metabolic and isotopic steady states after 48h of exponential growth in 
presence of labeled substrates. This assumption is supported by additional mass 
distribution measurements for lactate and amino acids performed at 72h (see 
Supplementary Figures 5-5 and 5-6), showing no significant variation compared to 48h.  
Previous investigations with mammalian cells have demonstrated that constant labeling is 
attained after such time (Olivier Henry & Durocher, 2011; Maier et al., 2008; Munger et 
al., 2008; Niklas et al., 2011). 
 Two distinct pools of pyruvate are assumed to be present; alanine is considered to be 
derived from mitochondrial pyruvate, while lactate is generated from cytosolic pyruvate. 
A similar assumption was employed by Walther et al. (Walther et al., 2012) and Gaglio et 
al. (Gaglio et al., 2011) for describing the distinct labeling patterns of lactate and alanine 
in their analysis. 
 Carbon dioxide is not balanced in the model and treated as an unlabeled reactant in 
carboxylation reactions.  
 For the transport of metabolites between compartments, it is assumed that citrate is co-
transported with malate via the citrate/malate shuttle, pyruvate transport occurs via the 
pyruvate carrier, malate is transported via the dicarboxylate carrier and aspartate is 
transferred via the glutamate/aspartate shuttle.  
 Cofactor balances (e.g. ATP, NADH) were not included in the model. 
 Succinate and fumarate are symmetric species and the scrambling of 13C-label was taken 
into account.  
 The incorporation of unlabeled carbon into the TCA resulting from the oxidation of fatty 
acids was considered negligible. 
 Although the mass isotopomer distributions of extracellular ketoglutarate and succinate 
were measured and used for the flux estimation, their secretion rates were below 0.1 % 
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that of the glucose uptake rate and were thus assumed to be negligible relative to all other 
uptake/production rates.  
 Tracer dilution effects resulting from unmeasured sources (e.g. protein/lipid turnover, 
unlabeled pools in the culture medium, subcellular compartmentalization effects) were 
accounted for by introducing dilution fluxes in the model as additional free fluxes to be 
optimized (Gaglio et al., 2011; Noguchi et al., 2009).  
 
5.3.2 Supplementary tables 
Table  5-4 : Calculated fluxes (in pmol/cell.d) and associated confidence intervals for cells 
induced at low and high cell densities, respectively. Dilution fluxes represent the percentage of 
the total metabolite pool diluted by unlabeled sources. 
      Low cell density induction High cell density induction 
Biochemical Reaction  Flux  Conf. 95% Flux Conf. 95% 
GLC   G6P 1.44 [ 1.17 , 1.7 ] 0.92 [ 0.72 , 1.12 ] 
LAC  LACex 2.64 [ 2.1 , 3.19 ] 1.11 [ 0.9 , 1.32 ] 
G6P  Biomass 0.03 [ 0.02 , 0.04 ] 0.02 [ 0.01 , 0.03 ] 
P5P  Biomass 0.02 [ 0.01 , 0.03 ] 0.01 [ 0.01 , 0.02 ] 
AcCOAc  Biomass 0.24 [ 0.17 , 0.31 ] 0.15 [ 0.08 , 0.23 ] 
GAP  Biomass 0.01 [ 0.01 , 0.01 ] 0.01 [ 0.01 , 0.01 ] 
GLNex  GLN 0.39 [ 0.26 , 0.51 ] 0.31 [ 0.16 , 0.45 ] 
His/Arg
/Pro  GLU 0.08 [ 0.06 , 0.1 ] 0.01 [ 0.01 , 0.01 ] 
VAL/M
ET/ ILE  SUCm 0.08 [ 0.06 , 0.1 ] 0.03 [ 0.02 , 0.05 ] 
Leu/Lys
/Ile/Tyr/
Trp/Thr  AcCOAm 0.23 [ 0.16 , 0.3 ] 0.02 [ 0.01 , 0.03 ] 
ALA  ALAex 0.21 [ 0.15 , 0.27 ] 0.22 [ 0.12 , 0.32 ] 
ASP  ASPex 0.12 [ 0.08 , 0.15 ] 0.11 [ 0.05 , 0.17 ] 
GLUin  GLUex 0.19 [ 0.14 , 0.25 ] 0.18 [ 0.09 , 0.27 ] 
PYR  AA3 0.08 [ 0.06 , 0.1 ] 0 [ 0 , 0 ] 
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ASNex  ASP 0.26 [ 0.19 , 0.32 ] 0.12 [ 0.07 , 0.17 ] 
ASXex  ASPex 1.61 [ 1.22 , 2 ] 1.67 [ 1.28 , 2.06 ] 
G6P ↔ F6P net 1.14 [ 1.08 , 1.31 ] 0.74 [ 0.64 , 0.75 ] 
  

  exch 0 [ 0 , inf ] >600 [ 0 , inf ] 
F6P  GAP + GAP 1.3 [ 1.29 , 1.34 ] 0.84 [ 0.81 , 0.84 ] 
GAP  PYR 2.68 [ 2.66 , 2.7 ] 1.72 [ 1.69 , 1.75 ] 
PYR  LAC 2.64 [ 2.1 , 3.19 ] 1.11 [ 0.9 , 1.33 ] 
G6P  P5P+CO 0.27 [ 0.1 , 0.33 ] 0.16 [ 0.15 , 0.26 ] 
P5P +P5P ↔ S7P + GAP net 0.08 [ 0.05 , 0.1 ] 0.05 [ 0.05 , 0.08 ] 
  

 exch 0 [ 0 , inf ] 6.41 [ 0 , inf ] 
P5P + 
E4P ↔ F6P + GAP net 0.08 [ 0.03 , 0.1 ] 0.05 [ 0.05 , 0.08 ] 
  
  
  exch 0 [ 0 , 0.08 ] 0 [ 0 , 0.04 ] 
S7P + 
GAP ↔ F6P + E4P net 0.08 [ 0.03 , 0.1 ] 0.05 [ 0.05 , 0.08 ] 
  
  
  exch 6.29 [ 0 , 0.07 ] 0.3 [ 0 , 0.6 ] 
PYR  PYRm 0.51 [ 0.42 , 0.62 ] 0.84 [ 0.81 , 0.98 ] 
PYRm  AcCOAm + CO 0.42 [ 0.35 , 0.52 ] 0.72 [ 0.71 , 0.72 ] 
AcCOAm 
+ OAAm  CITm 0.65 [ 0.58 , 0.75 ] 0.74 [ 0.73 , 0.76 ] 
CITm ↔ aKGm + CO2  net 0.41 [ 0.34 , 0.51 ] 0.59 [ 0.57 , 0.59 ] 
  
  
  exch 15 [ 1.55 , 15 ] 0 [ 0 , 0.93 ] 
aKGm  SUCm + CO2 0.78 [ 0.67 , 0.98 ] 0.87 [ 0.76 , 0.91 ] 
SUCm ↔ 
0.5MALm 
+0.5MALm  net 0.86 [ 0.74 , 1.07 ] 0.9 [ 0.88 , 0.94 ] 
  

exch 27 [ 1.87 , inf ] >600 [ 0 , inf ] 
MALm ↔ OAAm net 0.35 [ 0.07 , 0.6 ] 0.69 [ 0.41 , 0.76 ] 
  

  exch 8.5 [ 0.1 , inf ] 0.69 [ 0 , inf ] 
MALm ↔ MAL net 0.56 [ 0.44 , 0.61 ] 0.24 [ 0.15 , 0.32 ] 
  

  exch 27 [ 0.57 , inf ] >600 [ 0 , inf ] 
CITm  CIT 0.24 [ 0.17 , 0.31 ] 0.15 [ 0.08 , 0.23 ] 
CIT  AcCOAc + OAA 0.24 [ 0.17 , 0.31 ] 0.15 [ 0.08 , 0.23 ] 
OAA ↔ MAL net 0.24 [ 0.17 , 0.31 ] 0.15 [ 0.08 , 0.23 ] 
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
  exch 2.23 [ 0 , inf ] 6.27 [ 0 , inf ] 
GLN  GLU 0.39 [ 0.39 , 0.39 ] 0.31 [ 0.31 , 0.31 ] 
GLU ↔ aKGm net 0.38 [ 0.32 , 0.49 ] 0.09 [ 0.08 , 0.12 ] 
  

  exch 5.44 [ 0 , inf ] 69.4 [ 0 , inf ] 
PYRm + 
GLU  ALA + aKGm 0.13 [ 0.12 , 0.14 ] 0.2 [ 0.2 , 0.2 ] 
OAAm + 
GLU ↔ ASP + aKGm net 0.14 [ 0.14 , 0.14 ] 0.01 [ 0.01 , 0.01 ] 
  

  exch 0.48 [ 0.04 , inf ] 0.25 [ 0.04 , inf ] 
PYRm + 
COin  OAAm 0.16 [ 0 , 0.35 ] 0.04 [ 0 , 0.13 ] 
MALm  PYRm + CO 0.19 [ 0.1 , 0.33 ] 0.12 [ 0.06 , 0.23 ] 
MAL  PYR + CO 0.56 [ 0.5 , 0.69 ] 0.24 [ 0.15 , 0.34 ] 
GLU ↔ GLUin net 0.09 [ 
-
0.02 , 0.14 ] 0.04 [ 0.01 , 0.07 ] 
      exch 0.24 [ 0 , 1.64 ] 9.31 [ 0.36 , inf ] 
Dilution fluxes  (%)           (%)           
SUCdil  SUCex 0.44 [ 0.43 , 0.51 ] 0.29 [ 0.19 
,
  0.32 ] 
aKGdil  aKGex 0.29 [ 0.26 , 0.36 ] 0 [ 0 , 0.03 ] 
ALAdil  ALAex 0.37 [ 0.32 , 0.39 ] 0.09 [ 0.07 , 0.09 ] 
GLUdil  GLUin 0.35 [ 0.27 , 0.54 ] 0.44 [ 0.33 , 0.48 ] 
ASPdil  ASPex 0.93 [ 0.89 , 0.96 ] 0.94 [ 0.87 , 0.97 ] 
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5.3.3 Supplementary Figures 
 
Figure  5-4 : Viable cell (A), glucose (B), glutamine (C) and lactate (D) concentration profiles 
during batch cultivation of CHO cells without induction 
 
  
107 
 
 
 
Figure  5-5 : Measured and fitted mass isotopomer distributions of lactate, alanine, aspartate, 
glutamate, succinate and ketoglutarate 48h post-induction at low cell density. Cells were induced 
in medium containing [1-
13
C]- glucose and [U-
13
C5] Glutamine. Additional measurements for 
lactate and amino acids performed at 72h are also shown. 
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Figure  5-6: Measured and fitted mass isotopomer distributions of lactate, alanine, aspartate, 
glutamate, succinate and ketoglutarate 48h post induction at high cell density. Cells were induced 
in medium containing [1-
13
C] glucose and [U-
13
C5] Glutamine. Additional measurements for 
lactate and amino acids performed at 72h are also shown. 
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CHAPTER 6 ELUCIDATING THE EFFECTS OF POST-INDUCTION 
GLUTAMINE FEEDING ON THE GROWTH AND PRODUCTIVITY 
OF CHO CELLS 
6.1 Presentation of the article 
This section contains the manuscript entitled “Elucidating the effects of post-induction 
glutamine feeding on the growth and productivity of CHO cells” which is being submitted for 
publication in "Biotechnology Progress". In this study, we first demonstrate that the application 
of a fed-batch strategy post-induction can successfully increase the product yield compared to 
simple batch mode. We also highlight a significant physiological impact of glutamine levels on 
cell metabolism and productivity. Depending on whether glutamine was present in excess or at 
limiting concentrations, despite achieving similar final product yields, the cultures reached two 
distinct metabolic states characterized by marked differences in terms of specific growth and 
productivity. While the cell specific productivity seems to be enhanced in glutamine-limited 
cultures, this benefit is offset by the lower cell concentrations attained. We thus conducted 
13
C 
labeling experiments in semi-continuous cultures operated at respectively high and low glutamine 
concentrations. The resulting distinct intracellular flux maps can be associated with metabolic 
states favoring either cell proliferation or recombinant protein expression. As such, they can 
provide a sound basis for further fed-batch process development. 
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6.3 Abstract  
Inducible mammalian expression systems are increasingly being used for the production of 
valuable therapeutics. In such system, maximizing the product yield is achieved by carefully 
balancing the biomass concentration during the production phase and the specific productivity of 
the cells. These two factors are largely determined by the availability of nutrients and/or the 
presence of toxic waste metabolites in the culture environment. Glutamine is one of the most 
important components of cell culture medium, since this substrate is an important building block 
and source of energy for biomass and recombinant protein production. Its metabolism, however, 
ultimately leads to the formation of ammonia, a well-known inhibitor of cellular growth and 
productivity. In this work, we show that nutrient feeding post-induction can greatly enhance the 
product yield by alleviating early limitations encountered in batch. Moreover, varying the amount 
of glutamine in the feed yielded two distinct culture behaviors post-induction; whereas excess 
glutamine allowed to reach higher cell concentrations, glutamine-limited fed-batch led to 
increased cell specific productivity. These two conditions also showed distinctive lactate 
metabolism. To further assess the physiological impact of glutamine levels on the cells, a 
comparative 
13
C-metabolic flux analysis was conducted and a number of key intracellular fluxes 
were found to be affected by the amount of glutamine present in the feed during the production 
phase. Such information may provide useful clues for the identification of physiological markers 
of cell growth and productivity that could further guide the optimization of inducible expression 
systems.  
Keywords: inducible mammalian expression system, fed-batch, 
13
C metabolic flux analysis, 
glutamine metabolism 
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6.3.1 Introduction  
In recent years, mammalian cell culture has become the most important platform for the 
production of secreted products such as recombinant proteins and monoclonal antibodies 
(Langdom, 2008). To reduce the process development costs and time, as well as to cope with the 
demand of the ever expanding biopharmaceuticals market, continuous efforts are made to 
improve the productivity of cell culture processes. Significant increases in product titers have 
been achieved mainly through the ooptimization of culture conditions, the development of 
suitable cell culture media and the implantation of efficient feeding strategies to support high cell 
density in either fed-batch or perfusion cultures (Zhu, 2012). Considerable work has also been 
done at the genetic engineering level to improve the robustness of host cell system, for example 
by decreasing programmed cell death (Elmore, 2007; Mohan et al., 2008) or reducing toxic by-
product  accumulation (Irani, Wirth, van den Heuvel, & Wagner, 1999; Lim et al., 2010).  
The use of inducible mammalian expression systems offers another interesting avenue for the 
production of recombinant proteins. Many efficient regulated gene expression systems have been 
developed such as the tetracycline- or ecdysone-based systems (Kaufmann et al., 2001; No et al., 
1996), or the recent cumate gene-switch (Mullick et al., 2006). In such system, the growth and 
production phases can be effectively decoupled, thereby allowing optimizing each phase 
independently. Although significant product yield enhancement relative to batch were reported 
with the use of fed-batch (Huang, Marquis, & Gray, 2004) and perfusion (Lipscomb et al., 2004) 
modes, to date, optimization studies specific to inducible mammalian expression systems remain 
relatively sparse. 
In batch or fed-batch cell culture processes, the final product titers is determined by both the cell 
specific productivity and the integral of viable cells (P. W. Sauer et al., 2000). The challenge lies 
in the definition of suitable process conditions that can either simultaneously enhance these 
factors, or provide an optimal trade-off between the two. For instance, a number of investigations 
have shown that temperature reduction during the production phase leads to cell growth reduction 
or cessation, but a concomitant increase in cell specific productivity and a prolongation of culture 
duration is typically observed (Becerra, Berrios, Osses, & Altamirano, 2012; Sunley & Butler, 
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2010). Given the complex, sometimes inverse, relation between cellular growth and productivity, 
it is instrumental to decipher how process variables affect these kinetic rates.  
Several feeding strategies have been developed in industrial fed-batch processes to provide the 
optimal necessary nutrients for cells to grow and to produce protein. In fact, growth and protein 
production are two complex metabolic functions, but it is not well understood how these two 
functions and nutritional requirements are related. Providing excessive amounts of glucose and 
glutamine in the extracellular environment can indeed inhibit the growth or protein production 
due to the formation and accumulation of toxic metabolic by-products (lactate and ammonia). 
Minimizing the accumulation of these by-products by limiting the levels of glucose and 
glutamine is at the basis of several fed-batch control strategies (Dowd, Kwok, & Piret, 2001; 
Maranga & Goochee, 2006; Takuma, Hirashima, & Piret, 2007). With CHO cells, lactate 
accumulation has been found to have a lesser negative impact on cell growth and productivity, as 
a metabolic shift from lactate production to net consumption is frequently observed (Mulukutla et 
al., 2012; Tsao et al., 2005; Zagari et al., 2013). Glutamine is a major source of energy, nitrogen 
and, to some extent, carbon for mammalian cells. High rates of glutamine utilization are typically 
observed in CHO cells and many other cultivated mammalian cells (Neermann & Wagner, 1996) 
and its partial oxidation will lead to the formation of ammonia. Due to the detrimental effects of 
ammonia on growth and productivity (H. J. Cruz et al., 2000; S.S. Ozturk et al., 1992; Schneider, 
Marison, & von Stockar, 1996), as well as on product quality (M Yang & Butler, 2002), there is a 
greater concern about controlling the level of glutamine in fed-batch cultures (J. Kim, Kim, & 
Lee, 2012). 
Although the effect of extracellular glutamine levels on cell growth and antibody production have 
been investigated for CHO cell lines in both batch (Rajendra, Kiseljak, Baldi, Hacker, & Wurm, 
2012; Taschwer et al., 2012) and fed-batch (Jardon et al., 2012) cultures, comprehensive 
physiological studies of the regulation of glutaminolysis are still missing and greater 
understanding of the cell metabolism is needed to allow further significant cell culture process 
improvements.  
The goal of this work was thus to examine the effects of glutamine feeding on the metabolism 
and recombinant protein productivity of induced CHO cells. To this end, two fed-batch strategies 
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employing respectively low and high amounts of glutamine were performed and compared to a 
control batch culture. The two conditions leading to marked differences in terms of cell growth 
and productivity, a 
13
C-metabolic flux analysis was then conducted to further assess the impact of 
glutamine feeding at the intracellular level. So as to perform the analysis under pseudo-steady 
state conditions, this characterization was performed in semi-continuous cultures with varying 
concentrations of glutamine in the feed. The resulting intracellular flux distributions were 
compared in relation with the observed growth and production kinetics.  
 
 
6.3.2 Materials and methods 
6.3.2.1 Cell line and culture conditions 
The CHO cell line employed in this study harbors the cumate gene-switch transcription system 
that allows the regulated-expression of a recombinant antibody (Sheikholeslami, Jolicoeur, & 
Henry, 2013). The basal medium used in our investigation was SFM4CHO (Hyclone), a 
chemically defined and serum-free formulation initially free of glucose and glutamine as this was 
a requirement for the isotopic tracer studies described below. Cell maintenance and inoculum 
preparation were performed in shake flasks maintained at 37⁰C in humidified air with 5% CO2 
and the culture medium was supplemented with 30mM glucose and 5mM glutamine. For fed-
batch cultures, exponentially growing cells were inoculated in 125mL shake flasks with a 
working volume of 25mL and at a viable cell density of approximately 2×10
5
 cells/mL.  All 
cultures were induced by the addition of 1 µg/mL of cumate on day 2 to trigger recombinant 
antibody expression. The feeding protocol was initiated at the same time and consisted in adding 
every two days a fixed volume (10% of the initial culture volume) of a commercial chemically 
defined concentrated feed, CHO CD EfficientFeed B (Invitrogen). The feed was supplemented 
with either 4mM or 20mM of glutamine, referred to as low and high glutamine feeding, 
respectively. All culture conditions were performed in duplicate flasks, including controlled batch 
cultures. Supernatants were collected by centrifugation at 300 g for 5 min and samples were 
stored at -20⁰C for subsequent analysis. 
115 
 
 
6.3.2.2 Isotope labeling experiments  
For conducting the isotopic tracer studies, cells were inoculated at 2×10
5
 cells/mL in basal 
medium supplemented with unlabeled glucose and glutamine at 37C in a 5% CO2 and 95% 
humid atmosphere. Following induction with 1 µg/mL of cumate at 48h, the cultures were 
operated in semi-continuous mode, whereby a fixed culture volume was replaced by fresh 
medium on a daily basis so as to maintain pseudo-constant cell and nutrient concentrations 
(Olivier Henry et al., 2008). Two sets of semi-continuous cultures were performed, one in which 
the medium was supplemented with 1mM of glutamine, while the second set was supplemented 
with 5mM. Due to its unknown exact composition that would have hindered the 
13
C -flux 
analysis, the concentrated commercial feed employed in the fed-batch cultures was not used for 
the semi-continuous cultures. Upon reaching pseudo-steady conditions, cells were fed using the 
specific label-containing media and feeding was resumed for a minimum of five days to ensure 
the achievement of an isotopic pseudo-steady state. This period of time has been previously 
shown to be sufficient in the case of CHO cell cultures (Deshpande et al., 2009; Sheikholeslami 
et al., 2013).  Multiple parallel isotope labeling experiments were performed, containing 
respectively unlabeled, [1-
13
C], [6-
13
C], [U- 
13
C6]- glucose (Cambridge isotopes, all at 99% 
purity) and [U– 13C5] glutamine (Cambridge isotopes, 97–99% purity). The culture samples were 
centrifuged at 300 g for 5 min to separate cells and the supernatant. The supernatant samples 
were stored at -20⁰C for subsequent analysis and cell samples were extracted for determination of 
mass isotopomers of intracellular metabolites. 
6.3.2.3 Analytical methods  
Cell density was determined using hemacytometer and cell viability as assessed using trypan blue 
by the dye exclusion method. The recombinant antibody titers were quantified using an enzyme-
linked immunosorbent assay (ELISA) as described previously (Sheikholeslami et al., 2013). The 
concentrations of glucose, lactate and glutamine in the culture supernatant were determined with 
a biochemistry analyser (YSI 2700). Ammonia concentration in the supernatants was quantified 
by an enzymatic assay kit (AA0100, Sigma-Aldrich). Amino acid concentration was determined 
by an Agilent 1290 UPLC system (Agilent technologies, Montreal, Canada) coupled to an 
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Agilent 6460 triple quadruple mass spectrometer (Agilent technologies, Montreal, Canada) using 
the same conditions described in (Sheikholeslami et al., 2013). 
6.3.2.4 Metabolite extraction and LC-MS analysis 
For intracellular metabolite analysis, cells harvested daily from semi-continuous cultures were 
washed with cold PBS and extracted with 400 μL of 80% cold methanol. After 10 min on dry ice, 
the mixture was vortexed and then sonicated in ice and water. Suspensions were then centrifuged 
at 4°C for 7 min at 21,000 g. The supernatants were then transferred to a clean tube as extracts. 
Pellets were re-extracted as mentioned above with 200 μL of 50% cold methanol and 200 μl of 
cold water. At each extraction, supernatants were combined with the first extract and stored in 
−80 °C prior to analysis. The 13C fractional enrichment of intracellular metabolites in the samples 
was measured on an Agilent 1100 series LC-MSTOF (Agilent technologies, Quebec, Canada). 
First, 200µL of cell extract samples were deproteinized by adding 1mL cold acetone (-20⁰C) and 
then were vortexed strongly. After centrifugation at 20,000g for 5 min, the solutions were filtered 
and evaporated in vacuo. Finally, 400 µL of water was added to the samples. The analysis was 
done in negative electrospray mode without derivatization using a Kinetex HILIC Phenomenex 
column, 100 x 4.6mm and 2.6um particle size. The eluents used were 5mM ammonium formate 
(in water) and acetonitrile containing 0.1% formic acid. The gradient was in HILIC mode and 
went from 90% to 50% ACN with a total run time of 20 minutes. 
6.3.2.5 Determination of specific rates 
For fed-batch cultures, the specific rate of nutrient consumption, metabolite formation and 
production formation were estimated as outlined in (P. W. Sauer et al., 2000). First, the integral 
of viable cells for each discrete time interval was calculated according to: 
      
  
  
   
              
 
              (1) 
where        and       are the total number of viable cells at times t1 and t2, respectively. The 
specific antibody production rate was calculated by: 
    
             
      
  
  
         (2) 
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Where Ab1 and Ab2 denote the antibody concentrations at times t1 and t2. The specific formation 
rates of lactate and ammonia were calculated in a similar manner. The specific consumption rates 
of nutrients were obtained by dividing the cumulative amount of substrate consumed by the 
integral of viable cells: 
   
                       
      
  
  
       (3) 
The uptake rate of glutamine was corrected for the spontaneous decomposition rate of this 
nutrient in the culture media, which was experimentally determined in the absence of cells under 
the same incubation conditions. The first order degradation constant k was found to be 0.03 day
-1
. 
For semi-continuous cultures, the cell specific rates were determined from pseudo-steady state 
measurements and the daily medium exchange rate, as described in (Olivier Henry et al., 2008):  
   
( )feed
v
S SF
V X

        (4) 
where F correspond to the number of volume exchanges per time unit. 
6.3.2.6 Metabolic network model and intracellular flux evaluation 
The metabolic network considered in this work contains the major reactions of central 
metabolism and is based on previously established models for cultivated CHO cells (C. Goudar et 
al., 2010; Sheikholeslami et al., 2013; Zamorano et al., 2009). These include reactions for 
glycolysis, TCA cycle and the main amino acid degradation pathways. To account for 
biosynthetic requirements, the model includes simplified reactions for the synthesis of biomass 
and antibody, which were established from published average biomass/production composition 
data (Quek et al., 2010) and by assuming a dry cell weight of  0.350 mg/10
6
 for CHO cells (Woo 
Suk Ahn & Antoniewicz, 2011; Altamirano et al., 2001). The metabolic network is 
compartmentalized into mitochondria and cytosol and reversible reactions were separated into 
forward and backward fluxes constrained to be non-negative. The list of all reactions considered 
in the reaction network is presented in the Supplementary Table 1. The 
13
C-metabolic flux 
analysis was performed in Matlab R2009a using the elementary metabolite unit network 
decomposition method (M.R. Antoniewicz et al., 2007). The nonlinear least-squares regression 
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was performed using the built-in Matlab “fmincon” function to minimize the sum of weighted 
squared residuals (WSR) between measured and simulated variables. The labeling data from all 
parallel experiments of each set were simultaneously fitted to the same isotopomer model, 
thereby providing 60 independent measurements. The minimization was repeated ten times with 
random feasible initial estimates of free fluxes to ensure the attainment of a global 
optimal solution. Validation of the fit was performed based on a standard chi-square goodness-of-
fit test and 95 % confidence intervals for the intracellular fluxes were evaluated as outlined in 
(Antoniewicz et al., 2006; Sheikholeslami et al., 2013). For statistical comparison between 
corresponding fluxes of two conditions under investigation, unpaired two-tailed Student's t-test 
was performed in Excel.  
6.3.3 Results 
6.3.3.1 Batch and Fed-batch Cultures 
CHO cells cultures that had been started from the same inoculum were grown for two days and 
then induced at a cell density of about 1.5x10
6
 cells/mL. Following induction, cultures were fed 
every two days with a fixed volume of a concentrated feed containing either low or high 
glutamine concentrations. Induced but unfed cultures were also performed to serve as control. 
The resulting growth curves, glucose, glutamine and lactate concentration profiles are shown in 
Figure 6-1. Although exponential cell growth was observed in all the cultures post-induction, the 
fed-batch strategies, which only differed by the amount of glutamine present in the concentrated 
feed, yielded significantly different cell density profiles. High glutamine fed-batch reached a 
maximum viable cell density of around 11×10
6
 cells/ml, which was 1.8 times more than the low 
glutamine fed-batch cultures (6.2×10
6
 cells/ml) and 2.5 times more than the control batch 
cultures (4.4×10
6
 cells/ml). Similar to the control batch, the low glutamine fed-batch was most 
likely limited by glutamine between day 3 and day 4 (Figure 6-1C), as the onset of the stationary 
phase in these cultures coincided with the times when this substrate reached concentrations that 
were below the detection limit. The low glutamine feed nonetheless allowed to prolong the 
culture compared to the batch, which translated into a 30 % increase in the integral of viable cells 
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(IVC) (Table 6-1). In contrast, the high-glutamine feed led to a nearly 3-fold improvement in 
terms of IVC. 
Table  6-1: Effect of glutamine levels on maximum viable cell density, final antibody titer and 
specific productivity (average of two runs in each condition) 
 
Batch culture 
(control) 
Low glutamine fed-
batch culture 
High glutamine 
fed-batch culture 
Maximum cell density (×106 cells/mL) 4.8 ± 0.7 6.2 ± 0.4 11.2 ± 0.9 
Integral of viable cells (×106 cells-d) 673.9 ± 31 880.8 ± 42 1971.9 ± 51 
Maximum antibody titer (mg/L) 110 ± 14 292 ± 31 327 ± 22 
Cell specific productivity (pg/cell/d) 3.6 ± 0.2 10.2 ± 0.3 4.7 ± 0.7 
 
Another striking difference between the two fed-batch regimes is noted on their respective lactate 
concentration profiles. A significant metabolic shift to lactate consumption was observed in high-
glutamine fed-batch cultures at around day 4. This shift occurred while the cells were still 
exponentially growing and with residual glucose concentrations still well above 30 mM. In 
contrast, the low glutamine cultures exhibited much less lactate consumption and the metabolic 
shift was observed later during the culture (between day 6 and day 7).  
Glucose uptake rates tended to decrease over the course of all the cultures, even though glucose 
concentrations were always maintained above 15 mM in our experiments (Figure 6-1B).  The 
reduction in glucose consumption rate coincided with the onset of lactate consumption, 
suggesting some correlation between the uptake rates of these two carbon sources and a salient 
change in nutrient utilization efficiency by the cells. Compared to the control batch, fed-batch 
cultures achieved higher final levels of ammonia. However, these concentrations remained below 
5mM in all culture conditions (Table 6-1), that is, much less than commonly reported toxic levels 
of 10mM for CHO cells (P. Chen & Harcum, 2005).  
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Figure  6-1: Viable cell (A), glucose (B), glutamine (C) and lactate (D) concentration profiles in 
induced fed-batch cultures supplemented with respectively low and high levels of glutamine. The 
corresponding profiles obtained in a control batch culture are also shown. Error bars represent the 
standard error of duplicate experiments. 
The maximal antibody concentration achieved in high glutamine fed-batch was 327 mg/L, which 
was slightly higher than the low glutamine fed batch (292 mg/L), whereas batch cultures reached 
a maximum of 110 mg/L (Table 6-1). However, the feeding regimes led to significant differences 
in terms of cell specific productivity, as determined by dividing the final antibody titer by the 
integral of viable cells.  While the cell specific productivity of the high glutamine fed-batch was 
similar to the one obtained in batch, the low glutamine fed-batch exhibited a two-fold greater 
specific recombinant protein expression rate (Table 6-1).  
Overall, this set of experiments demonstrated the potential to significantly enhance either the 
growth or the productivity of an inducible expression system through fed-batch operation. 
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However, an increase in growth was at the expense of productivity (and vice versa). Moreover, 
these results suggested the apparent sensitivity of CHO cell metabolism to glutamine levels.  
6.3.3.2 Semi-Continuous Cultures and Isotopomer Analysis 
To further investigate the metabolic response to varying levels of glutamine in the culture 
medium, a comprehensive 
13
C-metabolic flux analysis was conducted. Given the ever-changing 
conditions observed in batch and fed-batch cultures, the analysis was performed by growing cells 
under a semi-continuous mode of operation so as to obtain reliable kinetic rates corresponding to 
a defined metabolic pseudo-steady state. The effects of glutamine were investigated by using 
basal medium supplemented with either low and high concentration of this amino acid in the 
feed. For each condition, five parallel cultures containing different labeled substrates were 
maintained in a similar physiological state to allow reliable intracellular flux estimation (Crown 
& Antoniewicz, 2013; Olivier Henry & Durocher, 2011). The resulting cell density profiles are 
shown in Figure 6-2, by considering the average and standard deviation from all parallel cultures 
of the same experimental set. Performing a medium exchange on a daily basis was thus able to 
maintain the cells in pseudo-steady state conditions for several days. From the medium exchange 
rates required to maintain a stable cell density, the apparent growth rates were determined to be 
0.7 and 0.5d
-1
 for the high and low glutamine cultures, respectively. Similar to what was 
observed in the fed-batch cultures, the high glutamine condition reached higher cell 
concentrations (4.7± 0.2 ×10
6 
cells/ml) compared to the low glutamine culture (2.9 ± 0.2 ×10
6
 
cells/ml) (Fig 2). The effects of glutamine concentration on antibody production was also 
determined and, consistent with the trend noted in fed-batch cultures,  the highest protein 
productivity was observed in the culture with low glutamine (Table 6-2). 
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Figure  6-2: Time profile of the average viable cell density for induced cells in semi-continuous 
cultures performed with respectively low and high levels of glutamine. Labeled substrates were 
introduced at day 9 and the cultures were maintained for five subsequent days. Standard 
deviations were computed from five parallel cultures in each set 
Cultures were also compared in terms of the main extracellular rates. The 
consumption/production of glucose, lactate, glutamine and other amino acids are shown in Figure 
6-3. While glucose consumption rates were only marginally different between the two culture 
conditions, the lactate production rate was reduced in the low glutamine cultures. Consequently, 
increase in glutamine supply was directly accompanied by an increase in lactate 
production/glucose consumption ratio (1.1 vs. 0.7). Both cultures showed relatively low values 
compared with the typical values reported for mammalian cells in cultures under non-limiting 
glucose concentrations (YLac/Glc ∼= 1–2) indicating that this cell line exhibits a relatively efficient 
glucose metabolism. As shown in Figure 6-3, most of amino acids were consumed by the cells in 
both cultures except glutamate, alanine, glycine and aspartate which all had a net production rate. 
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Figure  6-3: Average cell specific consumption/production rates of amino acids in induced semi-
continuous cultures performed with respectively low and high levels of glutamine 
 
Except for glutamine and alanine, there were no clear trend in the consumption patterns of most 
essential and non-essential amino acids when considering measurement errors. Alanine 
production was significantly augmented as a result of a higher glutamine concentration in the 
feed. This suggests a higher transamination reaction from glutamate to pyruvate (yielding 
alanine), an effective route in preventing ammonia intoxication (Niklas, Priesnitz, Rose, Sandig, 
& Heinzle, 2012). 
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On day 9, after the cultures reached and maintained pseudo-steady state conditions, semi-
continuous operation was continued, but the cultures were fed with specific labeled containing 
media. The feeding was continued for 5 consecutive days, so as to maximize the wash out of 
unlabeled nutrients and metabolites. Cells were then harvested and extraction was performed to 
Figure  6-4: Fractional abundances of labeled mass isotopomers after inductions performed 
respectively at low and high cell densities, for the following metabolites: lactate, alanine, 
succinate and glutamate. Cultures were performed with fresh medium containing 1-
13
C, 6-
13
C 
and U-
13
C  glucose, as well as U-
13
C glutamine 
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measure the labeling pattern of key intracellular metabolites: lactate, alanine, succinate and 
glutamate. As shown in Figure 6-4, cultures at low and high glutamine levels exhibited distinct 
labeling patterns for all measured metabolites and the differences were more pronounced in the 
case of experiments performed with [U-
13
C6] glucose and [U-
13
C5] glutamine. These measured 
fractional abundances reflect the activity of the main intracellular pathways and data inspection 
can provide qualitative information about cell metabolism. For example, in cultures fed with [U-
13
C6] glucose, the higher fractional abundance of M+4 succinate observed for low glutamine 
conditions is indicative of a greater influx of glucose-derived carbons into TCA cycle. When cells 
were fed with [U-
13
C5] glutamine, the fractional abundance of M+3 lactate significantly dropped 
in high glutamine cultures compared to low glutamine conditions, which is clear indication of a 
lower contribution of this substrate towards lactate formation. However useful such information 
may be, a more detailed and quantitative description of cellular metabolism can be obtained using 
13
C-metabolic flux analysis. For both low/high glutamine conditions, the measured mass 
distribution data from the four parallel labeling experiments ([1-
13
C]- glucose, [6-
13
C] glucose, 
[U-
13
C6] glucose and [U-
13
C5] glutamine) were fitted simultaneously together to the same 
metabolic flux model (reaction and carbon transitions shown in Table A1).  
Table  6-2: Comparison between semi-continuous cultures operated with a low and a high 
glutamine feeding regime, respectively. Values are average from n=5 measurements. 
Pseudo-Steady State Measurements 
Low glutamine 
culture 
High glutamine 
culture 
Cell Concentration (×10
6
 cells/mL) 2.9 ± 0.2 4.7 ± 0.2 
Apparent growth rate (d
-1
) 0.49 ± 0.04 0.69 ± 0.05 
Cell specific productivity (pg/cell/d) 9.6 ± 0.3 5.5 ± 0.2 
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* indicates significance at p<0.05. Abbreviations:  AA2 = Leu, Lys, Ile, Tyr, Trp, and Thr; AA4 
= Val, Met, and Ile; AA5 = His, Arg, and Pro. 
 
Figure  6-5 : Metabolic flux maps corresponding to low (A) and high (B) glutamine levels. (C) 
Comparison of key intracellular fluxes. Standard errors were calculated from the upper and 
lower bounds of the 95 % confidence intervals.  
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The metabolic model contained 16 free fluxes to optimize and, by combining the labeling data 
from all parallel cultures, 60 independent mass isotopomer distributions were available for both 
low/high glutamine conditions. The minimum and maximum allowable values for the variance-
weighted sum of squared residuals (WSSR) were 29.8 and 60.5, respectively (chi square test for 
95% level of confidence with 44 degrees of freedom). With the assumed metabolic network, 
statistically acceptable fits were obtained with WSSR values of 45.8 and 47.1 for low and high 
glutamine cultures, respectively. The resulting flux maps corresponding to the two studied 
conditions are shown in Figure 6-5, along with the statistical comparison of key selected 
intracellular fluxes. The complete list of flux values along with the associated 95% confidence 
intervals are reported in Supplementary Material. The main metabolic differences and their 
implication are discussed in the following section. 
6.3.4 Discussion  
Glucose and glutamine are typically the major sources of energy and carbon for cultivated 
mammalian cells. Setting their concentrations in the basal medium and in the feeding solution is 
instrumental in any fed-batch process. Typically, it is desired to maintain low but non-limiting 
nutrient concentrations so as to minimize the accumulation of waste metabolites (ammonia and 
lactate), which are known to affect both cellular growth and productivity (Takeshi Omasa, 
Higashiyama, Shioya, & Suga, 1992; S.S. Ozturk et al., 1992), as well as product quality (Borys, 
Linzer, & Papoutsakis, 1994; Gawlitzek, Valley, & Wagner, 1998). While glucose uptake rate is 
typically varying through the course of a batch culture (decreasing with the concentration), these 
variations are often not associated with changes in cell growth (Pörtner & Schäfer, 1996) until 
limiting concentrations are reached, the excess glucose being essentially diverted towards lactate 
formation (the so called overflow metabolism). The observation in induced batch cultures that 
glutamine is rapidly depleted, quickly followed by a metabolic shift towards lactate consumption 
(Figure 6-1A) strongly suggests that this nutrient is a key determinant of the overall cell 
metabolic activity. In order to determine its impact on cellular growth and productivity, we have 
compared the kinetics of fed-batch cultivations performed with high and low levels of glutamine. 
Our results revealed that varying the availability of glutamine had a profound impact on the 
kinetics of growth, productivity, nutrient consumption and waste metabolite formation.  
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In order to shed more light on the underlying physiological changes associated with glutamine 
concentration and cell metabolism, two sets of CHO cell cultures were studied at different 
glutamine concentrations by performing carbon labeling experiments. This investigation was 
performed by running the cultures in a semi-continuous mode, as the later can provide pseudo-
steady state conditions approaching those of a chemostat system while maintaining the relative 
simplicity of batch culture operation (Olivier Henry et al., 2008). It was previously shown to be 
suitable for conducting reliable tracer studies (Olivier Henry & Durocher, 2011), provided that 
constant cell growth is maintained sufficiently long to meet the requirements for metabolic and 
isotopic pseudo-steady states (Sheikholeslami et al., 2013). Similar to the trends observed in fed-
batch, the semi-continuous cultures were also shown to be affected by the level of glutamine in 
the feed. High glutamine cultures exhibited higher pseudo-steady-state cell concentrations, but 
reduced cell specific productivity. The two culture conditions were also characterized by some 
significant changes in the uptake/production rates of several key nutrients. It is thus not 
surprising that the intracellular flux maps derived from isotopic tracers also revealed significant 
metabolic flux rewiring, which are described in the following sections. 
Glycolytic fluxes 
The main glycolytic fluxes were significantly increased in cultures corresponding to a low 
glutamine concentration in the feed. Hexokinase (HK), fructose-1,6-bisphophate aldolase 
(FBPA), and pyruvate kinase (PK) fluxes were all increased by 15 to 25% compared to high 
glutamine cultures. In most metabolic flux studies of cultivated mammalian cells, high glycolytic 
fluxes are typically associated with high production rates of lactate. However, in our induced 
cultures, this increase was in fact associated with a concomitant 20 % decrease of the lactate 
dehydrogenase (LDH) flux. It could be thought that this reduction is solely due to the lesser 
contribution of glutamine towards lactate formation when the uptake of this substrate is small. 
However, from the mass distribution of lactate in experiments fed with [U-
13
C6] glucose, it is 
found that the percentage of lactate directly metabolized from glucose was relatively similar in 
both cases (86% and 91% for high and low glutamine supplemented cultures, respectively).  
Pentose Phosphate Pathway 
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The increased glycolytic activity of low glutamine cultures was accompanied by a decreased 
oxidative pentose phosphate pathway (0.27±0.07 vs. 0.43±0.04). The split ratio of glucose toward 
PPP was estimated to be 20% for high glutamine cultures, while the value reduced to 11% for 
low glutamine conditions. Oxidative PPP is regarded as a major source of both building blocks 
for nucleotides and reductant (NADPH) for biosynthetic processes, such as fatty acids. The 
observed difference maybe attributable to the reduction in biomass formation, and thus related to 
reduced biosynthetic needs. The obtained splits ratios are within the range of values typically 
reported for cultivated mammalian cells (H. P. Bonarius et al., 2001; C. Goudar et al., 2010). 
Despite the varying biosynthetic rates, the demand in terms of ribose-5-phosphate is quite small 
and the flux through the non-oxidative branch of this pathway (transketolase  activity) was 
consequently also observed to be decreased for the low glutamine feed compared to the high 
glutamine feed (0.08 ± 0.02 vs. 0.12 ± 0.01).  
TCA cycle and anaplerotic reactions 
The main metabolic fluxes around the pyruvate branch point were markedly different for the two 
conditions under investigation. In low glutamine cultures, a higher portion of the intracellular 
pyruvate pool entered TCA (66%), while only 33% was converted to lactate and the remaining 
fraction was converted into amino acids. In contrast, the fluxes were more evenly distributed 
between lactate and the TCA (52 % vs 48%) for cultures with a high uptake rate of glutamine. 
Such even distribution was also reported for CHO cells under high cell density perfusion cultures 
(C. Goudar et al., 2010).  Pyruvate carboxylase (PC) activity can be one of possible ways to 
decrease the ratio of lactate produced per glucose consumed.  While an increase in the PC flux 
was noted for low glutamine cultures, it does not have a great impact on the flux distribution; for 
both culture conditions, the vast majority of pyruvate was channeled into the TCA via the 
pyruvate dehydrogenase flux and the contribution of the pyruvate carboxylase flux remained 
marginal (below 5 %). Owing to the increased oxidative decarboxylation of mitochondrial 
pyruvate to form acetyl-CoA, the main TCA cycle reactions were also significantly increased in 
low glutamine cultures. This increase TCA cycle activity might be related in part to some 
compensatory mechanism for the decreased production of ATP by glycolysis. 
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In low glutamine cultures, 82 % of the total carbon entering the TCA originated from pyruvate, 
while the contribution of glutamine, via ketoglutarate, represented a mere 5 %. In contrast, for 
high glutamine cultures, this amino acid accounted for nearly 40 % of the total carbon intake. 
Conversion of glutamate to ketoglutarate may occur either via glutamate dehydrogenase or 
transaminase reactions. A lower extracellular level of alanine was observed in the low glutamine 
cultures, which is indicative of a decrease in the activity of alanine transaminase. Transaminase 
was reported to be the main pathway for the utilisation of glutamine in mammalian cells based on 
previous studies using enzyme activity measurements or flux analysis (DeBerardinis et al., 2007; 
Neermann & Wagner, 1996).   
While pyruvate is mostly derived from glucose metabolized through glycolysis, 11 and 16 % of 
the intracellular pool originated from the conversion of malate via malic enzyme for low and high 
glutamine cultures, respectively. Such pyruvate recycling is the reason for the presence of 
13
C 
label in lactate produced in the cultures fed with [U-
13
C5] glutamine as the sole source of labeled 
carbon (Figure 6-4). This pathway, together with the oxidative branch of PPP, constitutes a major 
source of reducing agent for the cells.  In total, approximately 0.9 and 1.3 pmol/cell.d of NADPH 
are produced from these pathway for low and high glutamine cultures, respectively, which is 
consistent with the reduction in growth rate and the resulting decrease in biosynthetic 
requirements. 
Overall, the comparative 
13
C -metabolic flux analysis performed in this worked allowed to 
characterize the main physiological changes resulting from supplying cells with either excess or 
limiting amounts of glutamine post-induction. The resulting distinct intracellular flux maps can 
be associated with metabolic states favoring either cell proliferation or recombinant protein 
expression. While this analysis was performed in semi-continuous mode, the effects of glutamine 
on the growth and productivity were consistent with the ones observed in the fed-batch cultures. 
In both cases, higher cell specific productivities were attained when the specific growth rate was 
reduced, perhaps due to the fact that cells are diverting more resources (precursors and energy) 
towards recombinant protein expression. 
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6.3.5 Conclusion  
In this work, we have demonstrated that fed-batch additions performed post-induction can 
significantly enhance the growth and productivity compared to batch cultures. Moreover, 
reducing the amount of glutamine present in the feed was shown to limit cell growth, but 
increased the cell specific productivity. Further improvement can be anticipated by reducing the 
temperature during the production phase to further prolong the culture time, through the addition 
of productivity enhancer (e.g. sodium butyrate) or by employing a dynamic feeding strategy. For 
the latter, the development of a dynamic model to predict the intracellular flux response to 
changing extracellular concentrations will undoubtedly help in that endeavor (Ghorbaniaghdam 
et al., 2013; Ryan P Nolan & Lee, 2011). The results of this study can provide valuable 
information and constraints for guiding the development of such model. 
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Table  6-3 : Biochemical reactions and their corresponding C atom transitions 
Biochemical Reaction Carbon Transition 
Glycolysis   
GLC  G6P abcdef = abcdef 
G6P ↔ F6P abcdef = abcdef 
F6P  2 GAP abcdef = cba + def 
GAP  PYR abc = abc 
PYR  LAC abc = abc 
PYR  PYRm abc = abc 
 Pentose Phosphate Pathway   
G6P  P5P + CO2 abcdef = bcdef + a 
2P5P ↔ S7P + GAP 
abcde + fghij = abfghij + 
cde 
P5P + E4P ↔ F6P + GAP 
abcde + fghi = abfghi + 
cde 
S7P + GAP ↔ F6P + E4P 
abcdefg + hij = abchij + 
defg 
 TCA Cycle   
PYRm  AcCOAm + CO2 abc = bc + a 
AcCOAm + OAAm  CITm ab + cdef = fedbac 
CITm ↔ aKGm + CO2 abcdef = abcde + f 
aKGm  SUCm + CO2 abcde = bcde + a 
SUCm ↔ 0.5 MALm + 0.5 MALm abcd = 0.5 abcd + 0.5 dcba 
MALm ↔ OAAm abcd = abcd 
CITm + MAL  CIT + MALm 
abcdef + ghij = abcdef + 
ghij 
CIT  AcCOAc + OAA abcdef = ed + fcba 
MALm ↔ MAL abcd = abcd 
OAA ↔ MAL abcd = abcd 
PYRm + CO2  OAAm abc + d = abcd 
MALm  PYRm + CO2 abcd = abc + d 
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MAL  PYR + CO2 abcd = abc + d 
 Amino acid reactions   
GLN  GLU abcde = abcde 
GLU ↔ aKGm abcde = abcde 
PYRm + GLU  ALA + aKGm abc = abc  
ASP + aKGm ↔ OAAm + GLU 
abcd + efghi = abcd + 
efghi 
ASN ASP abcd = abcd 
PYR  SER, GLY abc = abc 
CYS  PYR abc = abc 
VAL, MET, ILE  SUCm abcd = abcd 
LEU, LYS, ILE, TYR, TRP, THR  AcCOAm ab = ab 
HIS, ARG, PRO GLU abcde = abcde 
 Biomass and Product Biosynthesis  
0.912 PROTEIN + 0.0315 P5P + 0.0379 G6P + 
0.317 AcCOAc + 0.0151 GAP  BIOMASS 
 
- 
0.0585 ALA + 0.0226 ARG + 0.0449 ASN + 0.0365 
ASP + 0.0252 CYS + 0.0400 GLN + 0.0518 GLU + 
0.0660 GLY + 0.0229 HIS + 0.0329 ILE + 0.0630 
LEU + 0.0608 LYS + 0.0128 MET + 0.0415 PHE + 
0.0717 PRO + 0.0106 SER + 0.1056 THR + 0.0224 
TRP + 0.0288 TYR + 0.0857 VAL  ANTIBODY 
 
- 
0.0811 ALA + 0.0510 ARG + 0.0389 ASN + 0.0485 
ASP + 0.0196 CYS + 0.0435 GLN + 0.0522 GLU + 
0.0727 GLY + 0.0193 HIS + 0.0438 ILE + 0.0763 
LEU + 0.0771 LYS + 0.0187 MET + 0.0296 PHE + 
0.0423 PRO + 0.0581 SER + 0.0522 THR + 0.0059 
TRP + 0.0246 TYR + 0.0562 VAL  PROTEIN 
- 
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6.4 Supplementary data 
 
Figure  6-6: Measured and fitted mass distributions of lactate, alanine, succinate, and glutamate in 
low glutamine feeded cells grown in [1-
13
C]- glucose, [6-
13
C] glucose, [U–13C6] -glucose and [U–
13
C5 ]- glutamine; 
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Figure  6-7: Measured and fitted mass distributions of lactate, alanine, succinate, and glutamate in 
high glutamine fed cells grown in [1-
13
C]- glucose, [6-
13
C] glucose, [U–13C6] -glucose and [U–
13
C5 ]- glutamine; 
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Table  6-4: Calculated fluxes (in pmol/cell.d) and associated confidence intervals for induced 
semi-continuous cultures operated with low and high glutamine concentrations in the feed, 
respectively. 
   
Low glutamine High glutamine 
Biochemical Reaction  Flux  Conf. 95% Flux Conf. 95% 
GLC   G6P 2.40 [ 2.20 , 2.59 ] 2.18 [ 1.99 , 2.38 ] 
LAC  LACex 1.68 [ 1.48 , 1.88 ] 2.13 [ 1.93 , 2.32 ] 
G6P  Biomass 0.04 [ 0.02 , 0.06 ] 0.07 [ 0.05 , 0.09 ] 
P5P  Biomass 0.04 [ 0.02 , 0.06 ] 0.06 [ 0.04 , 0.08 ] 
AcCOAc  Biomass 0.37 [ 0.17 , 0.56 ] 0.47 [ 0.28 , 0.67 ] 
GAP  Biomass 0.02 [ 0.00 , 0.21 ] 0.03 [ 0.00 , 0.05 ] 
GLNex  GLN 0.11 [ 0.00 , 0.31 ] 0.88 [ 0.68 , 1.08 ] 
His/Arg/Pro  GLU 0.14 [ 0.00 , 0.54 ] 0.11 [ 0.00 , 0.27 ] 
VAL/MET/ ILE  SUCm 0.10 [ 0.00 , 0.35 ] 0.09 [ 0.00 , 0.28 ] 
Leu/Lys/Ile/Tyr/
Trp/Thr  AcCOAm 0.32 [ 0.00 , 0.71 ] 0.10 [ 0.00 , 0.30 ] 
ALA  ALAex 0.09 [ 0.00 , 0.48 ] 0.59 [ 0.39 , 0.78 ] 
ASP  ASPex 0.04 [ 0.00 , 0.19 ] 0.17 [ 0.00 , 0.37 ] 
               GLUin  GLUex 0.12 [ 0.00 , 0.30 ] 0.21 [ 0.00 , 0.41 ] 
PYR  AA3 0.05 [ 0.00 , 0.40 ] 0.00 [ 0.00 , 0.20 ] 
ASNex  ASP 0.17 [ 0.00 , 0.36 ] 0.00 [ 0.00 , 0.20 ] 
G6P ↔ F6P net 2.09 [ 1.95 , 2.22 ] 1.69 [ 1.63 , 1.76 ] 
 
  exch 0.00 [ 0.00 , inf ] 40.8 [ 1.87 , inf ] 
F6P  GAP + GAP 2.24 [ 2.19 , 2.28 ] 1.93 [ 1.91 , 1.96 ] 
GAP  PYR 4.54 [ 4.49 , 4.58 ] 3.96 [ 3.94 , 3.98 ] 
PYR  LAC 1.68 [ 1.48 , 1.88 ] 2.13 [ 1.93 , 2.32 ] 
G6P  P5P+CO 0.27 [ 0.14 , 0.41 ] 0.43 [ 0.35 , 0.49 ] 
P5P +P5P ↔ S7P + GAP net 0.08 [ 0.04 , 0.10 ] 0.12 [ 0.10 , 0.14 ] 
 
  exch 0.85 [ 0.06 , 1.42 ] 0.00 [ 0.00 , 0.10 ] 
P5P + E4P ↔ F6P + GAP net 0.08 [ 0.04 , 0.10 ] 0.12 [ 0.10 , 0.14 ] 
 
  exch 0.00 [ 0.00 , 2.07 ] 29.9 [ 0.00 , inf ] 
S7P + GAP ↔ F6P + E4P net 0.08 [ 0.04 , 0.10 ] 0.12 [ 0.10 , 0.14 ] 
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  exch 11.8 [ 0.07 , inf ] 35.2 [ 0.00 , inf ] 
PYR  PYRm net 3.22 [ 2.80 , 3.48 ] 2.27 [ 1.81 , 2.55 ] 
   
exch 6.78 [ 0.00 , inf ] 6.68 [ 0.00 , inf ] 
PYRm  AcCOAm + CO 3.12 [ 3.10 , 3.16 ] 1.94 [ 1.92 , 1.96 ] 
AcCOAm + 
OAAm  CITm 3.44 [ 3.42 , 3.49 ] 2.04 [ 2.02 , 2.07 ] 
CITm ↔ aKGm + CO2 net 3.07 [ 3.03 , 3.12 ] 1.57 [ 1.55 , 1.60 ] 
 
  exch 29..1 [ 0.00 , inf ] 12.9 [ 2.60 , inf ] 
aKGm  SUCm + CO2 3.21 [ 3.18 , 3.25 ] 2.35 [ 2.33 , 2.38 ] 
SUCm ↔ 
0.5MALm 
+0.5MALm net 3.31 [ 3.28 , 3.34 ] 2.44 [ 2.42 , 2.47 ] 
 
 exch 0.77 [ 0.00 , inf ] 0.25 [ 0.00 , 3.24 ] 
MALm ↔ OAAm net 3.14 [ 3.00 , 3.26 ] 2.17 [ 2.10 , 2.24 ] 
 
  exch 31.9 [ 0.00 , inf ] 33.2 [ 0.00 , inf ] 
MALm ↔ MAL net 0.04 [ 0.00 , 0.30 ] -0.03 [ -0.47 , 0.25 ] 
 
  exch 27.5 [ 0.23 , inf ] 38.9 [ 0.26 , inf ] 
CITm  CIT 0.37 [ 0.17 , 0.56 ] 0.47 [ 0.28 , 0.67 ] 
CIT  AcCOAc + OAA 0.37 [ 0.17 , 0.56 ] 0.47 [ 0.28 , 0.67 ] 
OAA ↔ MAL net 0.37 [ 0.17 , 0.56 ] 0.47 [ 0.28 , 0.67 ] 
 
  exch 38.3 [ 0.00 , inf ] 6.30 [ 0.00 , inf ] 
GLN  GLU 0.11 [ 0.00 , 0.31 ] 0.88 [ 0.68 , 1.08 ] 
GLU ↔ aKGm net 0.18 [ 0.17 , 0.18 ] 0.03 [ 0.03 , 0.04 ] 
 
  exch 1.46 [ 0.00 , 4.10 ] 12.4 [ 0.00 , inf ] 
PYRm + GLU  ALA + aKGm 0.09 [ 0.08 , 0.09 ] 0.59 [ 0.58 , 0.59 ] 
OAAm + GLU ↔ ASP+aKGm net -0.13 [ 0.13 , 0.10 ] 0.17 [ 0.00 , 0.17 ] 
 
  exch 1.97 [ 0.13 , 4.60 ] 12.2 [ 0.00 , inf ] 
PYRm + COin  OAAm 0.17 [ 0.06 , 0.29 ] 0.04 [ 0.00 , 0.11 ] 
MALm  PYRm + CO 0.16 [ 0.00 , 0.70 ] 0.30 [ 0.01 , 0.80 ] 
MAL  PYR + CO 0.41 [ 0.00 , 0.67 ] 0.44 [ 0.00 , 0.72 ] 
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CHAPTER 7 GENERAL DISCUSSION 
The present thesis deals with the detailed investigation of an inducible mammalian expression 
system using 
13
C-metabolic flux analysis to examine the implicit relationship between cell 
metabolism and cellular productivity. In line with this general goal, investigations were designed 
and performed aiming at (i) determining the metabolic pathways that are correlated to an 
increased production, (ii) assessing the impact of the timing of induction on the productivity and 
(iii) developing a rational fed-batch strategy pre- and post-induction and analyzing its impact on 
cellular growth and productivity. 
For the first investigation, the aim was to characterize the metabolism of induced/non-induced 
cells in order to quantitatively assess if recombinant protein expression exert a significant 
“burden” (or “metabolic load”) on the cells, as was demonstrated in the cases of yeasts and 
bacteria. More specifically, we sought to identify the main metabolic pathways whose activity is 
associated with increased production, using comparative 
13
C -MFA (Chapter 4). This approach is 
increasingly being applied for the investigation of cultivated mammalian cells, as it allows a more 
accurate quantification of intracellular fluxes. To this end, a recombinant CHO cell line 
producing an antibody and harboring an efficient cumate-inducible expression system was 
employed. The cells were grown in semi-continuous cultures to permit a reliable determination of 
the main cell kinetic rates. Upon addition of a non-toxic concentration of cumate and under mid-
hypothermic conditions (30°C), induced cells exhibited a slight reduction in the apparent specific 
growth rate (~9%) and a concomitant decrease in glucose uptake rate (~8%) compared with 
uninduced cells. It should be stressed that, albeit at a much lower rate, antibody production was 
also measured in the case of uninduced cultures due to minor leaky expression. Our study 
revealed that recombinant protein production correlated with an increase load on the cells. 
Although small in amplitude, significant changes were detected in a number of key intracellular 
pathways related to ATP and NADPH formation, including the pentose phosphate pathway, the 
malic enzyme reaction and the TCA cycle. Since the increase of total cellular protein resulting 
from MAb production is estimated to be at most 15 % of the total cellular protein mass, these 
changes occur presumably to support the additional energy required for protein synthesis and 
other related cellular events (e.g. post-translational modifications and secretion).  
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Irrespective of the level of recombinant protein expression, the percentage of the pyruvate pool 
entering the TCA was relatively high in both cultures (induced and non-induced cells) as 
compared to most published flux distributions of cultivated animal cells. Such highly efficient 
nutrient utilization is most likely related to the mild-hypothermic conditions prevailing in our 
experiments. However, induced cells notably exhibited a more efficient utilization of glucose, 
characterized by a higher fraction of pyruvate entering the TCA cycle (58% vs. 49%) mainly 
through pyruvate dehydrogenase. Conversely, the catabolic rates of most amino acids, including 
glutamine, were small and remained relatively unaffected by the onset of protein expression. The 
results of this study provided a quantitative indication that recombinant protein expression is 
associated with detectable changes in the primary metabolism of CHO cells. A number of 
important points should be emphasized regarding this study. First of all, we did not look at the 
effects of cell density at induction nor at the impact of cumate concentrations, two parameters 
that can potentially greatly affect cell productivity. The former is discussed in the second paper 
but the latter would indeed require more investigation. Preliminary experiments were performed 
with increasing cumate concentrations at induction only to assess any potential cytotoxic effect of 
this compound on the cells. Concentrations up to 5 µg/mL (5 times the concentration used in our 
study) had no detectable impact on the cell specific growth rate (data not shown), but the effects 
on productivity were not evaluated. Besides, as the focus was to evaluate the impact of 
recombinant protein expression, we have not characterized and compared the metabolism of the 
parental cell line (i.e. not harboring the inducible expression system) or clones exhibiting 
different expression levels.   A number of studies have reported that clonal variations can lead to 
significant metabolic changes (Dietmair et al., 2012) that are potentially more important than the 
ones directly attributable to protein expression. Also, at this stage of the work, no efforts were 
done to optimize the production, for example by using better medium formulations. The 
chemically defined medium employed in the study was chosen primarily because it allowed 
conducting more precise labeling experiments.  
Having revealed differences in the primary metabolism of induced and uninduced cells, the goal 
of the subsequent study was to determine the impact of process conditions on productivity and to 
assess if these changes could also be reflected in the primary metabolism, and thereby provide 
some indications to guide further process optimization. More specifically, we studied the impact 
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of the timing of induction, as the latter determines the amount of biomass during the production 
phase, as well as the availability of nutrients. Although it is a commonly studied factor in the case 
of inducible microbial systems, to our knowledge no comprehensive metabolic study has been 
performed to date in the case of induced mammalian cells. Our investigation was performed by 
taking cells at different stages of growth and comparing the main kinetics upon transfer and 
induction in fresh medium (while maintaining the various cell densities prevailing at the time of 
induction). Our study demonstrated that it is not beneficial, in terms of product yield, to induced 
cells at high concentrations, due to an apparent “cell density effect” (whereby the specific 
productivity is negatively correlated with cell density) most likely due to a combination of cell 
age effects, reduced availability of nutrients and/or the presence of waste metabolites. To gain 
more physiological insights, cultures induced respectively at low and high cell densities were 
further characterized by 
13
C -MFA and a number of key intracellular fluxes were found to be 
affected by the cell density at induction and the corresponding availability of nutrients. While 
glucose utilization was more efficient in high cell density cultures, with notably a greater fraction 
of pyruvate entering the TCA cycle (41% vs. 17%), the catabolic rates of most amino acids were 
found to be reduced. The entry of pyruvate into the TCA cycle mostly occurs via pyruvate 
dehydrogenase (PDH), while the anaplerotic conversion of pyruvate to oxaloacetate via pyruvate 
carboxylase (PC) accounted approximately 5 % and 27 % of the total pyruvate entering the TCA 
for cells induced at respectively high and low cell concentrations. On the whole, amino acids 
accounted for approximately 60 % of the total carbon input into the TCA for cells induced at low 
cell concentration, whereas this fraction was reduced down to only 20 % at higher cell densities. 
In the latter case, this is compensated by a greater pyruvate influx into the TCA. It should be 
underlined that, in this study, the metabolic comparison was restricted to the exponential growth 
period immediately following induction of the cultures with cumate. As evident from 
extracellular rate measurements, a significant flux rewiring also occurred at later stage of the 
production phase when cells were still secreting the recombinant product. Obtaining the 
intracellular flux distributions corresponding to these states would however require the 
application of unstationary 
13
C -MFA and hence required additional measurements.  
While valuable information was obtained with the use of isotopic tracers, from a process 
optimization point of view, a key limitation of the aforementioned studies rests on the fact that a 
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complete medium exchange was performed at the time of induction, which is not practical to 
implement at large scale (i.e. in the context of industrial manufacturing). Fed-batch operation 
remains the most prominent mode in industry to avoid the early nutrient limitations encountered 
in batch cultures. For this reason and given the fact that nutrient availability was shown to have a 
significant impact, the next study was focused on investigating the use of feeding strategies for 
maximising the productivity of the inducible expression platform, while retaining a relative ease 
of operation (i.e. without the need for complete medium exchange).  
Compared to induced batch cultures, the use of fed-batch operation allowed to significantly 
enhance both the cell and product concentrations during the production phase. More interestingly, 
varying the amount of glutamine present in the feed led to two distinct metabolic states 
characterized by different cell specific rates of growth and production. Glutamine has long been 
identified as a major source of energy, nitrogen and carbon for cultivated mammalian cells and its 
metabolism can lead to the detrimental accumulation of ammonia in the culture environment. 
Carbon labeling experiments at different glutamine concentrations were thus performed in semi-
continuous cultures to further decipher the impact of this nutrient on the cell metabolism. The 
main glycolytic fluxes were found to increase by 15 to 25% in cultures fed with low glutamine 
levels compared to high glutamine cultures and it was accompanied by a decreased oxidative 
pentose phosphate pathway. Also, fluxes around the pyruvate branch point were markedly 
different for the two conditions under investigation. In low glutamine cultures, a higher portion of 
the intracellular pyruvate pool entered TCA (66%), while the fraction was 48% for cultures with 
a high uptake rate of glutamine. Although pyruvate is mostly derived from glucose metabolized 
through glycolysis, pyruvate recycling from the TCA was also significant, accounting for an 
estimated 11 and 16 % of the intracellular pool originated through the conversion of malate via 
malic enzyme for low and high glutamine cultures, respectively. Overall, our findings of 
physiological impact of glutamine levels on the cells suggest that reducing the amount of 
glutamine present in the feed could increase the specific productivity of cells although it might 
limit the cell growth.  
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It should be emphasized that, unlike the previous two studies, these fed-batch experiments were 
all performed at 37°C. Combined with a fed-strategy, performing a temperature shift at the time 
of induction would in all likelihood further extend the production phase, but the impact on the 
product yield would have to be assessed. 
To perform the various metabolic investigations described above, 
13
C labeling experimental 
procedures had to be adapted or developed throughout this thesis. At the early stage of our work, 
labeling studies were performed in parallel semi-continuous (or repeated batch) cultures, which 
provided a relative ease of operation with good approximation of (pseudo) steady-state 
conditions. However, only the mass isotopomer distributions of extracellular metabolites (three 
excreted amino acids and lactate) could be readily measured and used for the analysis. Since the 
number of measurements was limited, parallel labeling experiments containing various labeled 
glucose and glutamine tracers were conducted to improve the resolution of the calculated 
intracellular fluxes. For each condition under investigation, we conducted 5 parallel experiments 
containing unlabeled, [1-
13
C], [6-
13
C], [U-
13
C6] glucose and [U–
13
C5] glutamine. This selection of 
tracers was motivated by their impact on the identifiability of intracellular flux estimates. The 
main experimental constraint was to maintain all the parallel cultures in a similar physiological 
state, but proved to be achievable with careful culture inoculation/maintenance procedures. 
Although the approach involved repeated feeding of expensive tracers, this was partly 
compensated by the fact that the cultures were operated at relatively small volumes.  
While we were able to quantify the main intracellular fluxes with relatively narrow confidence 
intervals, efforts were subsequently done to optimize the labeling conditions using the prior 
knowledge gained from the first comprehensive labeling study. With the aid of simulations, we 
evaluated 
13
C -tracers that may allow fluxes to be reliably determined by performing a single 
labeling experiment involving a mixture of labeled substrates. The challenge here was to create 
an appropriate precision scoring metric that allows comparing different labeling scenarios more 
efficiently. The simulation results revealed that for a single labeling experiment, using a mixture 
of [1-
13
C] glucose and [U-
13
C5] glutamine will generally be more effective and provide the best 
resolution score. For the second study, analytical methods to measure labeled metabolites had 
also significantly improved and the labeling patterns of three secreted extracellular amino acids 
(aspartate, alanine and glutamate) and three extracellular organic acids (lactate, succinate and α-
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ketoglutarate) could be successfully measured. The first two labeling investigations were carried 
out by assuming that the mass distribution of extracellular metabolites is reflective of their 
corresponding intracellular counterparts. The use of “dilution fluxes” permits to correct any 
potential dilution effects resulting from the presence of unlabeled sources, but will the present the 
drawback of increasing the confidence intervals as more fluxes need to be estimated. For the last 
labeling study, the optimization of cell extraction protocols allowed us to analyse the labeling 
pattern of intracellular metabolites (lactate, alanine, succinate and glutamate) thereby providing 
further confidence in the experimental data used for flux quantification. 
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CHAPTER 8 CONCLUSION AND RECOMMENDATIONS  
 
The main objective of this thesis was to quantitatively characterize the primary metabolism of an 
inducible mammalian expression system. The experimental and mathematical methods developed 
in this thesis allowed to obtain reliable estimation of important intracellular fluxes.  
13
C -
metabolic flux analysis has been recently used by others for the characterization of CHO cells in 
culture, mainly to describe the metabolic flux distributions during the exponential growth or 
stationary phases, on in high cell density perfusion cultures. The main novelty of this work 
resides in its application to investigate and compare different process conditions in an effort to 
further understand the links between the cell metabolism and specific productivity, so as to 
provide a rational basis for process development. We have established that the onset of 
recombinant protein expression is associated with small but detectable changes in the primary 
metabolism of the cells. We have then demonstrated that cultures yielding different levels of 
productivity (due to different process conditions) were also characterized by distinct intracellular 
flux distributions. Finally, we have shown that through different feeding regimes, induced 
cultures can be driven towards metabolic states favoring either cell growth or cellular 
productivity. 
The main original contributions of this work can thus be summarized as follows:  
 The comprehensive metabolic characterization of the “ON” and “OFF” states of an 
inducible mammalian expression system, thereby allowing an assessment of the metabolic 
load exerted by heterologous protein expression on the primary metabolism of cells  
 The 13C-based metabolic characterization of CHO cells under mild hypothermia 
conditions 
 A quantitative assessment of how the timing of induction impacts the metabolism and 
productivity of the cells in a biphasic process 
 The development and application of fed-batch protocols to enhance the yield for an 
inducible expression system  
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 The 13C -MFA based analysis of different feeding regimes having distinct impact on 
cellular growth and productivity 
 
The following outlines some recommendations for future work: 
Characterization of clones with varying expression levels: Given that the work described in this 
thesis was performed on a particular cell line expressing a specific product, the extent to which 
the main findings can be generalized to other mammalian cell expression systems remains an 
open question. To complement our work, it could be interesting to perform a detailed 
13
C -based 
metabolic comparison of distinct cell clones exhibiting different productivity levels. Such work 
could confirm (or refute) the presumed links between specific productivity and the cell primary 
metabolism. Analyzing clones with similar productivity levels would also be important to assess 
the relative importance of metabolic changes solely due to clonal variations. Provided that 
general trends could be inferred and generalized from such analysis, it would bring a valuable 
tool for the selection of clones and speed-up an important step in cell culture process 
development. 
 
Non-stationary 
13
C-MFA: Due to the intrinsic transient nature of many cell culture processes 
(including inducible expression systems), it would be appealing to apply non-stationary 
13
C 
metabolic flux analysis so as to enable the characterization at any point during a culture. 
Non‐stationary 13C‐flux analysis has been applied in many microbial systems (Noh et al., 2007; 
Schaub et al., 2007), but several aspects have to be taken into account before it can practically be 
applied to mammalian cell systems. Non-stationary labeling experiments require both exact 
quantification of intracellular metabolite concentrations and determination of relative isotopomer 
fractions of the respective intermediates. Nonetheless, recent emerging studies have demonstrated 
the potential of this approach for mammalian cells (Woo Suk Ahn & Antoniewicz, 2011). The 
main challenge lies in the establishment of proper procedures for sample preparation, including 
inactivation of metabolism and efficient extraction of the required metabolites, as well as 
analytical methods for quantification of these metabolites and determination of the isotopic 
distributions must also be established.  
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Substitution of glutamine in fed-batch cultures: Glutamine level in the feed was shown to have 
a determinant impact on the growth/productivity of the cells. Several studies have demonstrated 
that glutamine can be substituted by pyruvate (Genzel, Ritter, König, Alt, & Reichl, 2005) or 
glutamate (Altamirano et al., 2000). These strategies could be explored in the context of 
induction. One strategy could involve the complete replacement of glutamine (both in the basal 
medium and in the concentrated feed) and another one would study partial replacement of 
glutamine (replacement in the feed only). The effects of those substitutions would be 
comprehensively characterized using 
13
C-labeling experiment. Furthermore, fed-batch cultures 
could potentially be enhanced with a dynamic feeding protocol, with the feed adjusted based on 
the specific uptake rate of a reference nutrient. 
 
Integrative “omics” analysis: There are several potential bottlenecks limiting recombinant 
protein production in mammalian cells. The most important limitations can potentially be at the 
transcription, translation and/or post-translation processing levels. Our studies were strictly based 
on metabolic flux analysis, but the application of other ‘omics’ approaches  (transcriptomics, 
proteomics, metabolomics) could potentially provide useful and complementary information to 
the present work.  
  
147 
 
 
 
REFERENCES 
Ahn, W. S., & Antoniewicz, M. R. (2011). Metabolic flux analysis of CHO cells at growth and 
non-growth phases using isotopic tracers and mass spectrometry. Metabolic Engineering, 
13(5), 598-609.  
Ahn, W. S., & Antoniewicz, M. R. (2012). Towards dynamic metabolic flux analysis in CHO cell 
cultures. Biotechnology Journal, 7(1), 61-74.  
Ahn, W. S., & Antoniewicz, M. R. (2013). Parallel labeling experiments with [1,2-13C]glucose 
and [U-13C]glutamine provide new insights into CHO cell metabolism. Metabolic 
Engineering, 15(0), 34-47.  
Al-Rubeai, M., Emery, A., Chalder, S., & Jan, D. (1992). Specific monoclonal antibody 
productivity and the cell cycle-comparisons of batch, continuous and perfusion cultures. 
Cytotechnology, 9(1-3), 85-97.  
Al Zaid Siddiquee, K., Arauzo-Bravo, M. J., & Shimizu, K. (2004). Metabolic flux analysis of 
pykF gene knockout Escherichia coli based on 13C-labeling experiments together with 
measurements of enzyme activities and intracellular metabolite concentrations. Applied 
Microbiology and Biotechnology, 63(4), 407-417.  
Altamirano, C., Illanes, A., Becerra, S., Cairo, J. J., & Godia, F. (2006). Considerations on the 
lactate consumption by CHO cells in the presence of galactose. Journal of 
Biotechnololgy, 125(4), 547-556.  
Altamirano, C., Illanes, A., Casablancas, A., Gamez, X., Cairo, J. J., & Godia, C. (2001). 
Analysis of CHO cells metabolic redistribution in a glutamate-based defined medium in 
continuous culture. Biotechnology Progress, 17(6), 1032-1041.  
Altamirano, C., Paredes, C., Cairo, J. J., & Godia, F. (2000). Improvement of CHO cell culture 
medium formulation: simultaneous substitution of glucose and glutamine. Biotechnology 
Progress, 16(1), 69-75.  
Altamirano, C., Paredes, C., Illanes, A., Cairo, J. J., & Godia, F. (2004). Strategies for fed-batch 
cultivation of t-PA producing CHO cells: substitution of glucose and glutamine and 
rational design of culture medium. Journal of Biotechnology, 110(2), 171-179.  
Amribt, Z., Niu, H., & Bogaerts, P. (2013). Macroscopic modelling of overflow metabolism and 
model based optimization of hybridoma cell fed-batch cultures. Biochemical Engineering 
Journal, 70(0), 196-209.  
Antoniewicz, M. R., Kelleher, J. K., & Stephanopoulos, G. (2006). Determination of confidence 
intervals of metabolic fluxes estimated from stable isotope measurements. Metabolic 
Engineering, 8(4), 324-337.  
Antoniewicz, M. R., Kelleher, J. K., & Stephanopoulos, G. (2007). Accurate assessment of amino 
acid mass isotopomer distributions for metabolic flux analysis. Analytical Chemistry, 
79(19), 7554-7559.  
148 
 
 
Antoniewicz, M. R., Kelleher, J. K., & Stephanopoulos, G. (2007). Elementary metabolite unites 
(EMU): a novel framwork for modeling isotopic distributions. Metabolic Engineering, 
9(1), 68-86.  
Aoyama, T., & Chua, N. H. (1997). A glucocorticoid‐mediated transcriptional induction system 
in transgenic plants. The Plant Journal, 11(3), 605-612.  
Baughman, A. C., Huang, X., Sharfstein, S. T., & Martin, L. L. (2010). On the dynamic modeling 
of mammalian cell metabolism and mAb production. Computers & Chemical 
Engineering, 34(2), 210-222.  
Becerra, S., Berrios, J., Osses, N., & Altamirano, C. (2012). Exploring the effect of mild 
hypothermia on CHO cell productivity. Biochemical Engineering Journal, 60, 1-8.  
Bi, J.-X., Shuttleworth, J., & Al-Rubeai, M. (2004). Uncoupling of cell growth and proliferation 
results in enhancement of productivity in p21CIP1-arrested CHO cells. Biotechnology 
and Bioengineering, 85(7), 741-749.  
Bibila, T. A., & Robinson, D. K. (1995). In pursuit of the optimal fed-batch process for 
monoclonal antibody production. Biotechnology Progress, 11, 1-13.  
Blum, J. J., & Stein, R. B. (1982). On the analysis of metabolic networks. Goldberger RF (Eds). 
In Biological Regulation and Development. New York: Plenum Press; 1982:99-124. 
Boghigian, B. A., Seth, G., Kiss, R., & Pfeifer, B. A. (2010). Metabolic flux analysis and 
pharmaceutical production. Metabolic Engineering, 12(2), 81-95.  
Bonarius, H. P., Hatzimanikatis, V., Meesters, K. P., de Gooijer, C. D., Schmid, G., & Tramper, 
J. (1996). Metabolic flux analysis of hybridoma cells in different culture media using 
mass balances. Biotechnology and Bioengineering, 50(3), 299-318.  
Bonarius, H. P., Ozemre, A., Timmerarends, B., Skrabal, P., Tramper, J., Schmid, G., & Heinzle, 
E. (2001). Metabolic-flux analysis of continuously cultured hybridoma cells using 
(13)CO(2) mass spectrometry in combination with (13)C-lactate nuclear magnetic 
resonance spectroscopy and metabolite balancing. Biotechnology and Bioengineering, 
74(6), 528-538.  
Bonarius, H. P., Schmid, G., & Tramper, J. (1997). Flux analysis of underdetermined metabolic 
networks: the quest for the missing constraints. Trends in Biotechnology, 15, 308-314.  
Bonarius, H. P., Timmerarends, B., de Gooijer, C. D., & Tramper, J. (1998). Metabolite-
balancing techniques vs. 13C tracer experiments to determine metabolic fluxes in 
hybridoma cells. Biotechnology and Bioengineering, 58(2-3), 258-262.  
Borys, M. C., Linzer, D. I., & Papoutsakis, E. T. (1994). Ammonia affects the glycosylation 
patterns of recombinant mouse placental lactogen‐I by chinese hamster ovary cells in a 
pH‐dependent manner. Biotechnology and Bioengineering, 43(6), 505-514.  
Brown, I. R., & Rush, S. J. (1990). Expression of heat shock genes (hsp70) in the mammalian 
brain: Distinguishing constitutively expressed and hyperthermia-inducible mRNA 
species. Journal of Neuroscience Research, 25(1), 14-19.  
Burdon, R. H. (1986). Heat shock and the heat shock proteins. Biochemical Journal, 240(2), 313.  
149 
 
 
Burleigh, S., van de Laar, T., Stroop, C., van Grunsven, W., O'Donoghue, N., Rudd, P., & Davey, 
G. (2011). Synergizing metabolic flux analysis and nucleotide sugar metabolism to 
understand the control of glycosylation of recombinant protein in CHO cells. BMC 
Biotechnology, 11(1), 95.  
Butler, M., & Meneses-Acosta, A. (2012). Recent advances in technology supporting 
biopharmaceutical production from mammalian cells. Applied Microbiology and 
Biotechnology, 96(4), 885-894.  
Chen, F., Kou, T., Fan, L., Zhou, Y., Ye, Z., Zhao, L., & Tan, W.-S. (2011). The combined effect 
of sodium butyrate and low culture temperature on the production, sialylation, and 
biological activity of an antibody produced in CHO cells. Biotechnology and Bioprocess 
Engineering, 16(6), 1157-1165.  
Chen, P., & Harcum, S. W. (2005). Effects of amino acid additions on ammonium stressed CHO 
cells. Journal of Biotechnology, 117(3), 277-286.  
Choi, J. H., Keum, K. C., & Lee, S. Y. (2006). Production of recombinant proteins by high cell 
density culture of Escherichia coli. Chemical Engineering Science, 61(3), 876-885.  
Chon, J. H., & Zarbis-Papastoitsis, G. (2011). Advances in the production and downstream 
processing of antibodies. New Biotechnology, 28(5), 458-463.  
Christensen, B., & Nielsen, J. (2000a). Metabolic network analysis of Penicillium chrysogenum 
using (13)C-labeled glucose. Biotechnology and Bioengineering, 68(6), 652-659.  
Christensen, B., & Nielsen, J. (2000b). Metabolic network analysis. A powerful tool in metabolic 
engineering. Advances in Biochemical Engineering/Biotechnology, 66, 209-231.  
Chun, B.-H., Park, S.-Y., Chung, N., & Bang, W.-G. (2003). Enhanced production of 
recombinant B-domain deleted factor VIII from Chinese hamster ovary cells by propionic 
and butyric acids. Biotechnology Letters, 25(4), 315-319.  
Costenoble, R., Muller, D., Barl, T., van Gulik, W. M., van Winden, W. A., Reuss, M., & 
Heijnen, J. J. (2007). 13C-Labeled metabolic flux analysis of a fed-batch culture of 
elutriated Saccharomyces cerevisiae. FEMS Yeast Res, 7(4), 511-526.  
Craig Seamans, T., & Hu, W.-S. (1990). Kinetics of growth and antibody production by a 
hybridoma cell line in a perfusion culture. Journal of fermentation and bioengineering, 
70(4), 241-245.  
Crown, S. B., Ahn, W. S., & Antoniewicz, M. R. (2012). Rational design of 13C-labeling 
experiments for metabolic flux analysis in mammalian cells. BMC Systems Biology, 
6(43).  
Crown, S. B., & Antoniewicz, M. R. (2013). Parallel labeling experiments and metabolic flux 
analysis: Past, present and future methodologies. Metabolic Engineering, 16(0), 21-32.  
Cruz, H. J., Freitas, C. M., Alves, P. M., Moreira, J. L., & Carrondo, M. J. T. (2000). Effects of 
ammonia and lactate on growth, metabolism, and productivity of BHK cells. Enzyme and 
Microbial Technology, 27(1-2), 43-52.  
150 
 
 
Cruz, H. J., Moreira, J. L., & Carrondo, M. J. T. (2000). Metabolically optimised BHK cell fed-
batch cultures. Journal of Biotechnology, 80(2), 109-118.  
Dalm, M. C. F., Lamers, P. P., Cuijten, S. M. R., Tjeerdsma, A. M., Grunsven, W. M. J., 
Tramper, J., & Martens, D. E. (2007). Effect of Feed and Bleed Rate on Hybridoma Cells 
in an Acoustic Perfusion Bioreactor: Metabolic Analysis. Biotechnology Progress, 23, 
560-569.  
Datta, P., Linhardt, R. J., & Sharfstein, S. T. (2013). An 'omics approach towards CHO cell 
engineering. Biotechnology and Bioengineering, 110(5):1255-71 
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, 
C. B. (2007). Beyond aerobic glycolysis: Transformed cells can engage in glutamine 
metabolism that exceeds the requirement for protein and nucleotide synthesis. 
Proceedings of the National Academy of Sciences, 104(49), 19345-19350.  
Deshpande, R., Yang, T. H., & Heinzle, E. (2009). Towards a metabolic and isotopic steady state 
in CHO batch cultures for reliable isotope-based metabolic profiling. Biotechnology 
Journal, 4(2), 247-263.  
Dietmair, S., Hodson, M. P., Quek, L.-E., Timmins, N. E., Gray, P., & Nielsen, L. K. (2012). A 
multi-omics analysis of recombinant protein production in hek293 cells. PloS one, 7(8), 
e43394.  
Dietmair, S., Nielsen, L. K., & Timmins, N. E. (2011). Engineering a mammalian super producer. 
Journal of Chemical Technology & Biotechnology, 86(7), 905-914.  
Dinnis, D. M., & James, D. C. (2005). Engineering mammalian cell factories for improved 
recombinant monoclonal antibody production: lessons from nature? Biotechnology and 
Bioengineering, 91(2), 180-189.  
Dinnis, D. M., Stansfield, S. H., Schlatter, S., Smales, C. M., Alete, D., Birch, J. R., . . . James, 
D. C. (2006). Functional proteomic analysis of GS-NS0 murine myeloma cell lines with 
varying recombinant monoclonal antibody production rate. Biotechnology and 
Bioengineering, 94(5), 830-841.  
Doverskog, M., Ljunggren, J., Öhman, L., & Häggström, L. (1997). Physiology of cultured 
animal cells. Journal of Biotechnology, 59(1–2), 103-115.  
Dowd, J. E., Kwok, K. E., & Piret, J. M. (2001). Glucose-based optimization of CHO-cell 
perfusion cultures. Biotechnology and Bioengineering, 75(2), 252-256. 
Elmore, S. (2007). Apoptosis: A Review of Programmed Cell Death. Toxicologic Pathology, 
35(4), 495-516.  
Fischer, E., & Sauer, U. (2005). Large-scale in vivo flux analysis shows rigidity and suboptimal 
performance of Bacillus subtilis metabolism. [10.1038/ng1555]. Nature genetics, 37(6), 
636-640.  
Fogolin, M. B., Wagner, R., Etcheverrigaray, M., & Kratje, R. (2004). Impact of temperature 
reduction and expression of yeast pyruvate carboxylase on hGM-CSF-producing CHO 
cells. Journal of Biotechnology, 109(1-2), 179-191.  
151 
 
 
Follstad, B. D., & Stephanopoulos, G. (1998). Effect of reversible reactions on isotope label 
redistribution Analysis of the pentose phosphate pathway. European Journal of 
Biochemistry, 252, 360-371.  
Forster, K., Helbl, V., Lederer, T., Urlinger, S., Wittenburg, N., & Hillen, W. (1999). 
Tetracycline-inducible expression systems with reduced basal activity in mammalian 
cells. Nucleic Acids Research, 27(2), 708-710.  
Fox, S. R., Patel, U. A., Yap, M. G. S., & Wang, D. I. C. (2004). Maximizing interferon-γ 
production by chinese hamster ovary cells through temperature shift optimization: 
Experimental and modeling. Biotechnology and Bioengineering, 85(2), 177-184.  
Fussenegger, M., Morris, R. P., Fux, C., Rimann, M., von Stockar, B., Thompson, C. J., & 
Bailey, J. E. (2000). Streptogramin-based gene regulation systems for mammalian cells. 
[10.1038/81208]. Nature Biotechnology, 18(11), 1203-1208.  
Gaglio, D., Metallo, C. M., Gameiro, P. A., Hiller, K., Danna, L. S., Balestrieri, C., Chiaradonna, 
F. (2011). Oncogenic K-Ras decouples glucose and glutamine metabolism to support 
cancer cell growth. Molecular Systems Biology, 7(1).  
Gaillet, B., Gilbert, R., Amziani, R., Guilbault, C., Gadoury, C., Caron, A. W., Massie, B. (2007). 
High‐Level Recombinant Protein Production in CHO Cells Using an Adenoviral Vector 
and the Cumate Gene‐Switch. Biotechnology Progress, 23(1), 200-209.  
Gaillet, B., Gilbert, R., Broussau, S., Pilotte, A., Malenfant, F., Mullick, A., Massie, B. (2010). 
High‐level recombinant protein production in CHO cells using lentiviral vectors and the 
cumate gene‐switch. Biotechnology and Bioengineering, 106(2), 203-215.  
Gawlitzek, M., Valley, U., & Wagner, R. (1998). Ammonium ion and glucosamine dependent 
increases of oligosaccharide complexity in recombinant glycoproteins secreted from 
cultivated BHK‐21 cells. Biotechnology and Bioengineering, 57(5), 518-528.  
Geisse, S., & Voedisch, B. (2012). Transient Expression Technologies: Past, Present, and Future. 
In V. Voynov & J. A. Caravella (Eds.), Therapeutic Proteins (Vol. 899, pp. 203-219): 
Humana Press. 
Genzel, Y., Ritter, J. B., König, S., Alt, R., & Reichl, U. (2005). Substitution of Glutamine by 
Pyruvate To Reduce Ammonia Formation and Growth Inhibition of Mammalian Cells. 
Biotechnology Progress, 21(1), 58-69.  
Ghorbaniaghdam, A., Henry, O., & Jolicoeur, M. (2013). A kinetic-metabolic model based on 
cell energetic state: study of CHO cell behavior under Na-butyrate stimulation. 
Bioprocess and Biosystems Engineering, 36(4), 469-487.  
Glacken, M. W. (1986). Reduction of Waste Product Excretion via Nutrient Control: Possible 
Strategies for Maximizing Product and Cell yields on Serum in Cultures of Hybridoma 
Cells. Biotechnology and Bioengineering, 28, 1376-1389.  
Glick, B. R. (1995). Metabolic load and heterologous gene expression. Biotechnology Advances, 
13(2), 247-261.  
152 
 
 
Go, E. P., Liao, H.-X., Alam, S. M., Hua, D., Haynes, B. F., & Desaire, H. (2013). 
Characterization of Host-Cell Line Specific Glycosylation Profiles of Early 
Transmitted/Founder HIV-1 gp120 Envelope Proteins. Journal of Proteome Research, 
12(3), 1223-1234.  
Gombert, A. K., & Nielsen, J. (2000). Mathematical modelling of metabolism. Current Opinion 
in Biotechnology, 11(2), 180-186.  
Gossen, M., & Bujard, H. (1992). Tight control of gene expression in mammalian cells by 
tetracycline-responsive promoters. Proceedings of the National Academy of Sciences, 
89(12), 5547-5551.  
Goudar, C., Biener, R., Boisart, C., Heidemann, R., Piret, J., de Graaf, A., & Konstantinov, K. 
(2010). Metabolic flux analysis of CHO cells inperfusion culture by metabolite balancing 
and 2D [13C,1H] Cosy NMR spectroscopy. Metabolic Engineering, 12(2), 138-149.  
Goudar, C., Biener, R., Zhang, C., Michaels, J., Piret, J., & Konstantinov, K. (2006). Towards 
Industrial Application of Quasi Real-Time Metabolic Flux Analysis for Mammalian Cell 
Culture. In W.-S. Hu (Ed.), Cell Culture Engineering (Vol. 101, pp. 99-118): Springer 
Berlin Heidelberg. 
Goudar, C. T., Biener, R., Konstantinov, K. B., & Piret, J. M. (2009). Error propagation from 
prime variables into specific rates and metabolic fluxes for mammalian cells in perfusion 
culture. Biotechnology Progress, 25(4), 986-998.  
Goudar, C. T., Joeris, K., Konstantinov, K. B., & Piret, J. M. (2005). Logistic Equations 
Effectively Model Mammalian Cell Batch and Fed‐Batch Kinetics by Logically 
Constraining the Fit. Biotechnology Progress, 21(4), 1109-1118.  
Han, Y. K., Koo, T. Y., & Lee, G. M. (2009). Enhanced interferon-β production by CHO cells 
through elevated osmolality and reduced culture temperature. Biotechnology Progress, 
25(5), 1440-1447.  
Hendrick, V., Winnepenninckx, P., Abdelkafi, C., Vandeputte, O., Cherlet, M., Marique, T., . . . 
Werenne, J. (2001). Increased productivity of recombinant tissular plasminogen activator 
(t-PA) by butyrate and shift of temperature: a cell cycle phases analysis. Cytotechnology, 
36(1), 71-83.  
Henry, O., & Durocher, Y. (2011). Enhanced glycoprotein production in HEK-293 cells 
expressing pyruvate carboxylase. Metabolic Engineering, 13, 499-507. 
Henry, O., Jolicoeur, M., & Kamen, A. (2010). Unraveling the metabolism of HEK-293 cells 
using lactate isotopomer analysis. Bioprocess and Biosystems Engineering, 34(3), 263-
273. 
Henry, O., Kamen, A., & Perrier, M. (2007). Monitoring the physiological state of mammalian 
cell perfusion processes by on-line estimation of intracellular fluxes Journal of Process 
Control, 17, 241-251.  
Henry, O., Kwok, E., & Piret, J. M. (2008). Simpler noninstrumented batch and semicontinuous 
cultures provide mammalian cell kinetic data comparable to continuous and perfusion 
cultures. Biotechnology Progress, 24(4), 921-931.  
153 
 
 
Henry, P. G., Adriany, G., Deelchand, D., Gruetter, R., Marjanska, M., Oz, G., . . . Ugurbil, K. 
(2006). In vivo 13C NMR spectroscopy and metabolic modeling in the brain: a practical 
perspective. Magnetic Resonance Imaging, 24, 527-539.  
Heuchel, R., Radtke, F., Georgiev, O., Stark, G., Aguet, M., & Schaffner, W. (1994). The 
transcription factor MTF-1 is essential for basal and heavy metal-induced metallothionein 
gene expression. The EMBO journal, 13(12), 2870.  
Heyland, J., Blank, L. M., & Schmid, A. (2011). Quantification of metabolic limitations during 
recombinant protein production in Escherichia coli. Journal of Biotechnology, 155(2), 
178-184.  
Heyland, J., Fu, J., Blank, L. M., & Schmid, A. (2010). Quantitative physiology of Pichia pastoris 
during glucose‐limited high‐cell density fed‐batch cultivation for recombinant protein 
production. Biotechnology and Bioengineering, 107(2), 357-368.  
Heyland, J., Fu, J., Blank, L. M., & Schmid, A. (2011). Carbon metabolism limits recombinant 
protein production in Pichia pastoris. Biotechnology and Bioengineering, 108(8), 1942-
1953.  
Hofmann, U., Maier, K., Niebel, A., Vacun, G., Reuss, M., & Mauch, K. (2008). Identification of 
metabolic fluxes in hepatic cells from transient 13C-labeling experiments: Part I. 
Experimental observations. Biotechnology and Bioengineering, 100(2), 344-354.  
Holmes, W., Darby, R., Wilks, M., Smith, R., & Bill, R. (2009). Developing a scalable model of 
recombinant protein yield from Pichia pastoris: the influence of culture conditions, 
biomass and induction regime. Microbial Cell Factories, 8(1), 35.  
Hoppe, U. C., Marban, E., & Johns, D. C. (2000). Adenovirus-Mediated Inducible Gene 
Expression in Vivo by a Hybrid Ecdysone Receptor. Molecular Therapy, 1(2), 159-164.  
Huang, E. P., Marquis, C. P., & Gray, P. P. (2004). Process development for a recombinant 
Chinese hamster ovary (CHO) cell line utilizing a metal induced and amplified 
metallothionein expression system. Biotechnology and Bioengineering, 88(4), 437-450.  
Huber, R., & Buchs, J. (2011). Utilizing high-throughput experimentation to enhance specific 
productivity of an E.coli T7 expression system by phosphate limitation. BMC 
Biotechnology, 11(22).  
Irani, N., Wirth, M., van den Heuvel, J., & Wagner, R. (1999). Improvement of the primary 
metabolism of cell cultures by introducing a new cytoplasmic pyruvate carboxylase 
reaction. Biotechnology and Bioengineering, 66(4), 238-246.  
Jain, E., & Kumar, A. (2008). Upstream processes in antibody production: Evaluation of critical 
parameters. Biotechnology Advances, 26(1), 46-72.  
Jardon, M. A., Sattha, B., Braasch, K., Leung, A. O., Côté, H. C. F., Butler, M., . . . Piret, J. M. 
(2012). Inhibition of glutamine-dependent autophagy increases t-PA production in CHO 
Cell fed-batch processes. Biotechnology and Bioengineering, 109(5), 1228-1238.  
Jayapal, K., Wlaschin, K., Hu, W.-S., & Yap, M. (2007). Recombinant Protein Therapeutics from 
Cho Cells - 20 Years and Counting. CHO Consortium: SBE Special Edition, 40-47.  
154 
 
 
Jeong, D., Kim, T. S., Lee, J. W., Kim, K. T., Kim, H. J., Kim, I. H., & Kim, I. Y. (2001). 
Blocking of acidosis-mediated apoptosis by a reduction of lactate dehydrogenase activity 
through antisense mRNA expression. Biochem Biophys Res Commun, 289(5), 1141-1149.  
Kaufmann, H., Mazur, X., Fussenegger, M., & Bailey, J. E. (1999). Influence of low temperature 
on productivity, proteome and protein phosphorylation of CHO cells. Biotechnology and 
Bioengineering, 63(5), 573-582.  
Kaufmann, H., Mazur, X., Marone, R., Bailey, J. E., & Fussenegger, M. (2001). Comparative 
analysis of two controlled proliferation strategies regarding product quality, influence on 
tetracycline‐regulated gene expression, and productivity. Biotechnology and 
Bioengineering, 72(6), 592-602.  
Kelleher, J. K. (2001). Flux Estimation Using Isotopic Tracers: Common Ground for Metabolic 
Physiology and Metabolic Engineering. Metabolic Engineering, 3, 100-110.  
Kim, J., Kim, Y.-G., & Lee, G. (2012). CHO cells in biotechnology for production of 
recombinant proteins: current state and further potential. Applied Microbiology and 
Biotechnology, 93(3), 917-930.  
Kim, N. S., & Lee, G. M. (2002). Response of recombinant Chinese hamster ovary cells to 
hyperosmotic pressure: effect of Bcl-2 overexpression. J Biotechnol, 95(3), 237-248.  
Kim, S. H., & Lee, G. M. (2007). Down-regulation of lactate dehydrogenase-A by siRNAs for 
reduced lactic acid formation of Chinese hamster ovary cells producing thrombopoietin. 
Appl Microbiol Biotechnol, 74(1), 152-159.  
Klamt, S., & Schuster, S. (2002). Calculating as Many Fluxes as Possible in Underdetermined 
Metabolic Networks. Molecular Biology Reports, 29(1-2), 243-248. 
Klapa, M. I., Park, S. M., Sinskey, A. J., & Stephanopoulos, G. (1999). Metabolite and 
isotopomer balancing in the analysis of metabolic cycles: I. Theory. Biotechnology and 
Bioengineering, 62(4), 375-391.  
Kleijn, R. J., Geertman, J. M., Nfor, B. K., Ras, C., Schipper, D., Pronk, J. T., van Winden, W. A. 
(2007). Metabolic flux analysis of a glycerol-overproducing Saccharomyces cerevisiae 
strain based on GC-MS, LC-MS and NMR-derived C-labelling data. FEMS Yeast 
Research, 7(2), 216-231.  
Kochanowski, N., Blanchard, F., Cacan, R., Chirat, F., Guedon, E., Marc, A., & Goergen, J. L. 
(2008). Influence of intracellular nucleotide and nucleotide sugar contents on recombinant 
interferon-γ glycosylation during batch and fed-batch cultures of CHO cells. 
Biotechnology and Bioengineering, 100(4), 721-733.  
Kou, T.-C., Fan, L., Zhou, Y., Ye, Z.-Y., Liu, X.-P., Zhao, L., & Tan, W.-S. (2011). Detailed 
understanding of enhanced specific productivity in Chinese hamster ovary cells at low 
culture temperature. Journal of Bioscience and Bioengineering, 111(3), 365-369. 
Kumar, N., Gammell, P., Meleady, P., Henry, M., & Clynes, M. (2008). Differential protein 
expression following low temperature culture of suspension CHO-K1 cells. BMC 
Biotechnology, 8(1), 42.  
155 
 
 
Kurokawa, H., Park, Y. S., Iijima, S., & Kobayashi, T. (1994). Growth characteristics in fed-
batch culture of hybridoma cells with control of glucose and glutamine concentrations. 
Biotechnology and Bioengineering, 44(1), 95-103.  
Kuystermans, D., Krampe, B., Swiderek, H., & Al-Rubeai, M. (2007). Using cell engineering and 
omic tools for the improvement of cell culture processes. Cytotechnology, 53(1-3), 3-22.  
Langdom, S. P. (2008). Mammalian cell culture. In: Walker, JM, Rapley, R (Eds). Molecular 
Biomethods Handbook, pp. 861–873. 
Lee, F. W., Elias, C. B., Todd, P., & Kompala, D. S. (1998). Engineering Chinese hamster ovary 
(CHO) cells to achieve an inverse growth-associated production of a foreign protein, β-
galactosidase Cell Culture Engineering VI (pp. 73-80): Springer. 
Lee, K., Berthiaume, F., Stephanopoulos, G., & Yamush, M. L. (1999). Metabolic Flux Analysis: 
A Powerful Tool for Monitoring Tissue Function. Tissue Engineering, 5(4), 347-368.  
Lee, M. S., Kim, K. W., Kim, Y. H., & Lee, G. M. (2003). Proteome analysis of antibody-
expressing CHO cells in response to hyperosmotic pressure. Biotechnol Prog, 19(6), 
1734-1741.  
Li, F., Vijayasankaran, N., Shen, A., Kiss, R., & Amanullah, A. (2010). Cell culture processes for 
monoclonal antibody production. MAbs, 2(5), 466-477.  
Libourel, I. G. L., Gehan, J. P., & Shachar-Hill, Y. (2007). Design of substrate label for steady 
state flux measurements in plant system using the metabolic network of Brassica napus 
embryos. Phytochemistry, 68(16-18), 2211-2221.  
Lim, Y., Wong, N. S. C., Lee, Y. Y., Ku, S. C. Y., Wong, D. C. F., & Yap, M. G. S. (2010). 
Engineering mammalian cells in bioprocessing – current achievements and future 
perspectives. Biotechnology and Applied Biochemistry, 55(4), 175-189.  
Lipscomb, M. L., Mowry, M. C., & Kompala, D. S. (2004). Production of a secreted glycoprotein 
from an inducible promoter system in a perfusion bioreactor. Biotechnology Progress, 
20(5), 1402-1407.  
Ljunggren, J., & Haggstrom, L. (1992). Glutamine Limited Fed-Batch Culture Reduces the 
Overflow Metabolism of Amino Acids in Myeloma Cells. Cytotechnology, 8, 45-56.  
Ljunggren, J., & Häggström, L. (1994). Catabolic control of hybridoma cells by glucose and 
glutamine limited fed batch cultures. Biotechnology and Bioengineering, 44(7), 808-818.  
Llaneras, F., Pic, amp, & Jes. (2007). A procedure for the estimation over time of metabolic 
fluxes in scenarios where measurements are uncertain and/or insufficient. BMC 
Bioinformatics, 8(1), 421.  
Llaneras, F., & Pico, J. (2008). Stoichiometric modelling of cell metabolism. Journal of 
Bioscience and Bioengineering, 105(1), 1-11.  
Luo, J., Vijayasankaran, N., Autsen, J., Santuray, R., Hudson, T., Amanullah, A., & Li, F. (2012). 
Comparative metabolite analysis to understand lactate metabolism shift in Chinese 
hamster ovary cell culture process. Biotechnology and Bioengineering, 109(1), 146-156.  
156 
 
 
Maier, K., Hofmann, U., Reuss, M., & Mauch, K. (2008). Identification of metabolic fluxes in 
hepatic cells from transient 13C-labeling experiments: Part II. Flux estimation. 
Biotechnology and Bioengineering, 100(2), 355-370.  
Mancuso, A., Sharfstein, S. T., Fernandez, E. J., Clark, D. S., & Blanch, H. W. (1998). Effect of 
extracellular glutamine concentration on primary and secondary metabolism of a murine 
hybridoma: an in vivo 13C nuclear magnetic resonance study. Biotechnology and 
Bioengineering, 57(2), 172-186.  
Mancuso, A., Sharfstein, S. T., Tucker, S. N., Clark, D. S., & Blanch, H. W. (1994). Examination 
of primary metabolic pathways in a murine hybridoma with carbon-13 nuclear magnetic 
resonance spectroscopy. Biotechnology and Bioengineering, 44(5), 563-585.  
Maranga, L., & Goochee, C. F. (2006). Metabolism of PER.C6TM cells cultivated under fed-
batch conditions at low glucose and glutamine levels. Biotechnology and Bioengineering, 
94(1), 139-150.  
Martens, D. E. (2007). Metabolic Flux Analysis of Mammalian Cells. In M. Al-Rubeai & M. 
Fussenegger (Eds.), Systems Biology (Vol. 5, pp. 275-299): Springer Netherlands. 
Martens, D. E., de Gooijer, C. D., van der Velden-de Groot, C. A. M., Beuvery, E. C., & 
Tramper, J. (1993). Effect of dilution rate on growth, productivity, cell cycle and size, and 
shear sensitivity of a hybridoma cell in a continuous culture. Biotechnology and 
Bioengineering, 41(4), 429-439.  
Martial, A., Dardenne, M., Engasser, J. M., & Marc, A. (1991). Influence of Inoculum Age on 
Hybridoma Culture Kinetics. Cytotechnology, 5, 165-171.  
Martinez, V. S., Dietmair, S., Quek, L. E., Hodson, M. P., Gray, P., & Nielsen, L. K. (2013). Flux 
balance analysis of CHO cells before and after a metabolic switch from lactate production 
to consumption. Biotechnol Bioeng, 110(2), 660-666.  
Marx, A., de Graaf, A. A., Wiechert, W., Eggeling, L., & Sahm, H. (1996). Determination of the 
fluxes in the central metabolism of Corynebacterium glutamicum by nuclear magnetic 
resonance spectroscopy combined with metabolite balancing. Biotechnology and 
Bioengineering, 49(2), 111-129.  
Matasci, M., Hacker, D. L., Baldi, L., & Wurm, F. M. (2008). Recombinant therapeutic protein 
production in cultivated mammalian cells: current status and future prospects. Drug 
Discovery Today: Technologies, 5(2–3), e37-e42.  
McMurray-Beaulieu, V., Hisiger, S., Durand, C., Perrier, M., & Jolicoeur, M. (2009). Na-
butyrate sustains energetic states of metabolism and t-PA productivity of CHO cells. 
Journal of Bioscience and Bioengineering, 108(2), 160-167.  
Meleady, P., Doolan, P., Henry, M., Barron, N., Keenan, J., O'Sullivan, F., . . . Leonard, M. 
(2011). Sustained productivity in recombinant Chinese Hamster Ovary (CHO) cell lines: 
proteome analysis of the molecular basis for a process-related phenotype. BMC 
Biotechnology, 11(1), 78.  
157 
 
 
Mercille, S., Johnson, M., Lanthier, S., Kamen, A. A., & Massie, B. (2000). Understanding 
factors that limit the productivity of suspension-based perfusion cultures operated at high 
medium renewal rates. Biotechnology and Bioengineering, 67(4), 435-450.  
Metallo, C. M., Walther, J. L., & Stephanopoulos, G. (2009). Evaluation of 13C isotopic tracers 
for metabolic flux analysis in mammalian cells. Journal of Biotechnology, 144(3), 167-
174.  
Miller, W. M., Blanch, H. W., & Wilke, C. R. (1988). A kinetic analysis of hybridoma growth 
and metabolism in batch and continuous suspension culture: Effect of nutrient 
concentration, dilution rate, and pH. Biotechnology and Bioengineering, 32(8), 947-965.  
Mohan, C., Kim, Y.-G., Koo, J., & Lee, G. M. (2008). Assessment of cell engineering strategies 
for improved therapeutic protein production in CHO cells. Biotechnology Journal, 3(5), 
624-630. 
Mollney, M., Wiechert, W., Kownatzki, D., & de Graaf, A. A. (1999). Bidirectional reaction 
steps in metabolic networks: IV. Optimal design of isotopomer labeling experiments. 
Biotechnology and Bioengineering, 66(2), 86-103.  
Morgan, J. A., & Rhodes, D. (2002). Mathematical Modeling of Plant Metabolic Pathways 
Metabolic Engineering, 4, 80-89.  
Mullick, A., Xu, Y., Warren, R., Koutroumanis, M., Guilbault, C., Broussau, S., . . . Lo, R. 
(2006). The cumate gene-switch: a system for regulated expression in mammalian cells. 
BMC Biotechnology, 6(1), 43.  
Mulukutla, B. C., Gramer, M., & Hu, W.-S. (2012). On metabolic shift to lactate consumption in 
fed-batch culture of mammalian cells. Metabolic Engineering, 14(2), 138-149.  
Munger, J., Bennett, B. D., Parikh, A., Feng, X. J., McArdle, J., Rabitz, H. A., . . . Rabinowitz, J. 
D. (2008). Systems-level metabolic flux profiling identifies fatty acid synthesis as a target 
for antiviral therapy. Nature Biotechnology, 26(10), 1179-1186.  
Nam, J. H., Ermonval, M., & Sharfstein, S. T. (2009). The effects of microcarrier culture on 
recombinant CHO cells under biphasic hypothermic culture conditions. Cytotechnology, 
59(2), 81-91.  
Neermann, J., & Wagner, R. (1996). Comparative analysis of glucose and glutamine metabolism 
in transformed mammalian cell lines, insect and primary liver cells. Journal of Cellular 
Physiology, 166(1), 152-169.  
Niklas, J., & Heinzle, E. (2012). Metabolic Flux Analysis in Systems Biology of Mammalian 
Cells. In W. S. Hu & A.-P. Zeng (Eds.), Genomics and Systems Biology of Mammalian 
Cell Culture (Vol. 127, pp. 109-132): Springer Berlin / Heidelberg. 
Niklas, J., Priesnitz, C., Rose, T., Sandig, V., & Heinzle, E. (2012). Primary metabolism in the 
new human cell line AGE1.HN at various substrate levels: increased metabolic efficiency 
and α1-antitrypsin production at reduced pyruvate load. Applied Microbiology and 
Biotechnology, 93(4), 1637-1650.  
158 
 
 
Niklas, J., Sandig, V., & Heinzle, E. (2011). Metabolite channeling and compartmentation in the 
human cell line AGE1.HN determined by 13C labeling experiments and 13C metabolic 
flux analysis. Journal of Bioscience and Bioengineering, 112(6), 616-623.  
No, D., Yao, T. P., & Evans, R. (1996). Ecdysone-inducible gene expression in mammalian cells 
and transgenic mice. Proceedings of the National Academy of Sciences, 93(8), 3346-3351.  
Noguchi, Y., Young, J. D., Aleman, J. O., Hansen, M. E., Kelleher, J. K., & Stephanopoulos, G. 
(2009). Effect of anaplerotic fluxes and amino acid availability on hepatic lipoapoptosis. 
Journal of Biological Chemistry, 284(48), 33425-33436.  
Noh, K., Gronke, K., Luo, B., Takors, R., Oldiges, M., & Wiechert, W. (2007). Metabolic flux 
analysis at ultra short time scale: isotopically non-stationary 13C labeling experiments. 
Journal of Biotechnology, 129(2), 249-267.  
Noh, K., Wahl, A., & Wiechert, W. (2006). Computational tools for isotopically instationary 13C 
labeling experiments under metabolic steady state conditions. Metabolic Engineering, 
8(6), 554-577.  
Noh, K., & Wiechert, W. (2006). Experimental design principles for isotopically instationary 13C 
labeling experiments. Biotechnology and Bioengineering, 94(2), 234-251.  
Nolan, R. P., & Lee, K. (2011). Dynamic model of CHO cell metabolism. Metabolic 
Engineering, 13(1), 108-124.  
Nolan, R. P., & Lee, K. (2012). Dynamic model for CHO cell engineering. Journal of 
Biotechnology, 158(1-2), 24-33.  
Nyberg, G. B., Balcarcel, R. R., Follstad, B. D., Stephanopoulos, G., & Wang, D. I. C. (1999). 
Metabolism of peptide amino acids by Chinese hamster ovary cells grown in a complex 
medium. Biotechnology and Bioengineering, 62(3), 324-335.  
Nyberg, G. B., Balcarcel, R. R., Follstad, B. D., Stephanopoulos, G., & Wang, D. I. C. (2000). 
Metabolic Effects on Recombinant Interferon; Glycosylation in Continuous Culture of 
Chinese Hamster Ovary Cells. IBM Journal of Research and Development, 44(5), 770-
783.  
O'Callaghan, P. M., & James, D. C. (2008). Systems biotechnology of mammalian cell factories. 
Briefings in Functional Genomics & Proteomics, 7(2), 95-110.  
Omasa, T., Furuichi, K., Iemura, T., Katakura, Y., Kishimoto, M., & Suga, K. (2010). Enhanced 
antibody production following intermediate addition based on flux analysis in mammalian 
cell continuous culture. Bioprocess and Biosystems Engineering, 33(1), 117-125.  
Omasa, T., Higashiyama, K. I., Shioya, S., & Suga, K. i. (1992). Effects of lactate concentration 
on hybridoma culture in lactate‐controlled fed‐batch operation. Biotechnology and 
Bioengineering, 39(5), 556-564.  
Ozturk, S. S., & Hu, W. S. (2005). Cell culture technology for pharmaceutical and cell-based 
therapies: Taylor & Francis. 
159 
 
 
Ozturk, S. S., & Palsson, B. O. (1991). Growth, metabolic, and antibody production kinetics of 
hybridoma cell culture: 2. Effects of serum concentration, dissolved oxygen 
concentration, and medium pH in a batch reactor. Biotechnology Progress, 7(6), 481-494.  
Ozturk, S. S., Riley, M. R., & Palsson, B. O. (1992). Effects of ammonia and lactate on 
hybridoma growth, metabolism, and antibody production. Biotechnology and 
Bioengineering, 39(4), 418-431.  
Panda, A. (2003). Bioprocessing of Therapeutic Proteins from the Inclusion Bodies of 
Escherichia coli. In T. Ghose, P. Ghosh, S. Chand, S. K. Gupta, B. B. Lohray, K. 
Mazumdar-Shaw, P. Mishra, S. Nath, A. K. Panda & S. Suryanarayan (Eds.), 
Biotechnology in India II (Vol. 85, pp. 43-93): Springer Berlin Heidelberg. 
Paredes, C., Sanfeliu, A., Cardenas, F., Cairó, J. J., & Gòdia, F. (1998). Estimation of the 
intracellular fluxes for a hybridoma cell line by material balances. Enzyme and Microbial 
Technology, 23(3–4), 187-198.  
Park, J. H., Lee, S. Y., Kim, T. Y., & Kim, H. U. (2008). Application of systems biology for 
bioprocess development. Trends in Biotechnology, 26(8), 404-412.  
Park, S. M., Klapa, M. I., Sinskey, A. J., & Stephanopoulos, G. (1999). Metabolite and 
isotopomer balancing in the analysis of metabolic cycles: II. Applications. Biotechnology 
and Bioengineering, 62(4), 392-401.  
Petersen, S., de Graaf, A. A., Eggeling, L., Mollney, M., Wiechert, W., & Sahm, H. (2000). In 
vivo quantification of parallel and bidirectional fluxes in the anaplerosis of 
Corynebacterium glutamicum. Journal of Biological Chemistry, 275(46), 35932-35941.  
Peuhkurinen, K. J., Hiltunen, J. K., & Hassinen, I. E. (1983). Metabolic compartmentation of 
pyruvate in the isolated perfused rat heart. Biochemical Journal, 210(1), 193-198.  
Pörtner, R., & Schäfer, T. (1996). Modelling hybridoma cell growth and metabolism—a 
comparison of selected models and data. Journal of Biotechnology, 49(1), 119-135.  
Provost, A., & Bastin, G. (2004). Dynamic metabolic modelling under the balanced growth 
condition. Journal of Process Control, 14(7), 717-728.  
Quek, L.-E., Dietmair, S., Krömer, J. O., & Nielsen, L. K. (2010). Metabolic flux analysis in 
mammalian cell culture. Metabolic Engineering, 12(2), 161-171.  
Quek, L.-E., Wittmann, C., Nielsen, L., & Kromer, J. (2009). OpenFLUX: efficient modelling 
software for 13C-based metabolic flux analysis. Microbial Cell Factories, 8.  
Rajendra, Y., Kiseljak, D., Baldi, L., Hacker, D., & Wurm, F. (2012). Reduced glutamine 
concentration improves protein production in growth-arrested CHO-DG44 and HEK-
293E cells. Biotechnology Letters, 34(4), 619-626.  
Rita Costa, A., Elisa Rodrigues, M., Henriques, M., Azeredo, J., & Oliveira, R. (2010). 
Guidelines to cell engineering for monoclonal antibody production. European Journal of 
Pharmaceutics and Biopharmaceutics, 74(2), 127-138.  
160 
 
 
Rühl, M., Rupp, B., Nöh, K., Wiechert, W., Sauer, U., & Zamboni, N. (2012). Collisional 
fragmentation of central carbon metabolites in LC-MS/MS increases precision of 13C 
metabolic flux analysis. Biotechnology and Bioengineering, 109(3), 763-771.  
Sanderson, C. S., Phillips, P. J., & Barford, J. P. (1996). Structured modelling of animal cells. 
Cytotechnology, 21(2), 149-153.  
Sauer, P. W., Burky, J. E., Wesson, M. C., Sternard, H. D., & Qu, L. (2000). A high-yielding, 
generic fed-batch cell culture process for production of recombinant antibodies. 
Biotechnology and Bioengineering, 67(5), 585-597.  
Sauer, U. (2006). Metabolic networks in motion: 13C-based flux analysis. Molecular Systems 
Biology, 2, 1-10.  
Schaub, J., Mauch, K., & Reuss, M. (2007). Metabolic flux analysis in Enscherichia coli by 
integrating isotopic dynamic and isotopic stationary 13C labeling data. Biotechnology and 
Bioengineering, 99(5), 1170-1185.  
Schmidt, K., Carlsen, M., Nielsen, J., & Villadsen, J. (1997). Modeling isotopomer distributions 
in biochemical networks using isotopomer mapping matrices. Biotechnology and 
Bioengineering, 55(6), 831-840.  
Schmidt, K., Nielsen, J., & Villadsen, J. (1999). Quantitative analysis of metabolic fluxes in 
Encherichia coli, using two-dimentional NMR spectrometry and complete isotopomer 
models. Journal of Biotechnology, 71, 175-190.  
Schneider, M., Marison, I. W., & von Stockar, U. (1996). The importance of ammonia in 
mammalian cell culture. Journal of Biotechnology, 46(3), 161-185.  
Schützendübel, A., & Polle, A. (2002). Plant responses to abiotic stresses: heavy metal‐induced 
oxidative stress and protection by mycorrhization. Journal of Experimental Botany, 
53(372), 1351-1365. 
Selvarasu, S., Ho, Y. S., Chong, W. P. K., Wong, N. S. C., Yusufi, F. N. K., Lee, Y. Y., . . . Lee, 
D.-Y. (2012). Combined in silico modeling and metabolomics analysis to characterize 
fed-batch CHO cell culture. Biotechnology and Bioengineering, 109(6), 1415-1429.  
Sengupta, N., Rose, S. T., & Morgan, J. A. (2011). Metabolic Flux Analysis of CHO Cell 
Metabolism in the Late Non-Growth Phase. Biotechnology and Bioengineering, 108(1), 
82-92.  
Seth, G., Hossler, P., Yee, J. C., & Hu, W. S. (2006). Engineering cells for cell culture 
bioprocessing--physiological fundamentals Cell Culture Engineering (Vol. 101): Springer 
Berlin. 
Sheikh, K., Förster, J., & Nielsen, L. K. (2005). Modeling Hybridoma Cell Metabolism Using a 
Generic Genome-Scale Metabolic Model of Mus musculus. Biotechnology Progress, 
21(1), 112-121.  
Sheikholeslami, Z., Jolicoeur, M., & Henry, O. (2013). Probing the metabolism of an inducible 
mammalian expression system using extracellular isotopomer analysis. Journal of 
Biotechnology, 164(4), 469-478.  
161 
 
 
Shen, J., Petersen, K. F., Behar, K. L., Brown, P., Nixon, T. W., Mason, G. F., . . . Rothman, D. 
L. (1999). Determination of the rate of the glutamate/glutamine cycle in the human brain 
by in vivo 13C NMR. Proceedings of the National Academy of Sciences, 96(14), 8235-
8240.  
Sidoli, F. R., Mantlaris, A., & Asprey, S. P. (2004). Modelling of mammalian cells and cell 
culture processes. Cytotechnology, 44, 27-46.  
Sidorenko, Y., Wahl, A., Dauner, M., Genzel, Y., & Reichl, U. (2008). Comparison of Metabolic 
Flux Distributions for MDCK Cell Growth in Glutamine- and Pyruvate-Containing 
Media. Biotechnology Progress, 24(2), 311-320.  
Simpson, N. E., & Constantinidis, I. (2007). 13C NMR  isotopomeric analysis and its application 
in the study of endocrine cell metabolism and function. Acta Bio-medica, 78, 99-112.  
Stephanopoulos, G. (1999). Metabolic Fluxes and Metabolic Engineering. Metabolic 
Engineering, 1, 1-11.  
Stephanopoulos, G., Aristidou, A. A., & Nielsen, J. (1998). Metabolic engineering: principles 
and methodologies: Academic Press. 
Sun, Z., Zhou, R., Liang, S., McNeeley, K. M., & Sharfstein, S. T. (2004). Hyperosmotic stress 
in murine hybridoma cells: effects on antibody transcription, translation, posttranslational 
processing, and the cell cycle. Biotechnol Prog, 20(2), 576-589.  
Sunley, K., & Butler, M. (2010). Strategies for the enhancement of recombinant protein 
production from mammalian cells by growth arrest. Biotechnology Advances, 28(3), 385-
394.  
Suthers, P. F., Burgard, A. P., Dasika, M. S., Nowroozi, F., Van Dien, S., Keasling, J. D., & 
Maranas, C. D. (2007). Metabolic flux elucidation for large-scale models using 13C 
labeled isotopes. Metabolic Engineering, 9, 387-405.  
Suthers, P. F., Chang, Y. J., & Maranas, C. D. (2010). Improved computational performance of 
MFA using elementary metabolite units and flux coupling. Metabolic Engineering, 12(2), 
123-128.  
Takuma, S., Hirashima, C., & Piret, J. M. (2007). Dependence on glucose limitation of the pCO2 
influences on CHO cell growth, metabolism and IgG production. Biotechnology and 
Bioengineering, 97(6), 1479-1488.  
Taschwer, M., Hackl, M., Hernández Bort, J. A., Leitner, C., Kumar, N., Puc, U., . . . Borth, N. 
(2012). Growth, productivity and protein glycosylation in a CHO EpoFc producer cell 
line adapted to glutamine-free growth. Journal of Biotechnology, 157(2), 295-303.  
Templeton, N., Dean, J., Reddy, P., & Young, J. D. (2013). Peak antibody production is 
associated with increased oxidative metabolism in an industrially relevant fed-batch CHO 
cell culture. Biotechnol Bioeng, 110(7), 2013-2024.  
Trummer, E., Fauland, K., Seidinger, S., Schriebl, K., Lattenmayer, C., Kunert, R., . . . Katinger, 
H. (2006a). Process parameter shifting: Part I. Effect of DOT, pH, and temperature on the 
162 
 
 
performance of Epo‐Fc expressing CHO cells cultivated in controlled batch bioreactors. 
Biotechnology and Bioengineering, 94(6), 1033-1044.  
Trummer, E., Fauland, K., Seidinger, S., Schriebl, K., Lattenmayer, C., Kunert, R., . . . Katinger, 
H. (2006b). Process parameter shifting: Part II. Biphasic cultivation—A tool for 
enhancing the volumetric productivity of batch processes using Epo‐Fc expressing CHO 
cells. Biotechnology and Bioengineering, 94(6), 1045-1052.  
Tsao, Y. S., Cardoso, A. G., Condon, R. G. G., Voloch, M., Lio, P., Lagos, J. C., . . . Liu, Z. 
(2005). Monitoring Chinese hamster ovary cell culture by the analysis of glucose and 
lactate metabolism. Journal of Biotechnology, 118, 316- 327.  
Tuttle, S., Stamato, T., Perez, M. L., & Biaglow, J. (2000). Glucose-6-phosphate dehydrogenase 
and the oxidative pentose phosphate cycle protect cells against apoptosis induced by low 
doses of ionizing radiation. Radiat Res, 153(6), 781-787.  
van Winden, W., Schipper, D., Verheijen, P., & Heijnen, J. (2001). Innovations in generation and 
analysis of 2D [(13)C,(1)H] COSY NMR spectra for metabolic flux analysis purposes. 
Metabolic Engineering, 3(4), 322-343.  
van Winden, W. A., van Dam, J. C., Ras, C., Kleijn, R. J., Vinke, J. L., van Gulik, W. M., & 
Heijnen, J. J. (2005). Metabolic-flux analysis of Saccharomyces cerevisiae CEN.PK113-
7D based on mass isotopomer measurements of (13)C-labeled primary metabolites. 
FEMS Yeast Research, 5(6-7), 559-568.  
Walsh, G. (2010). Biopharmaceutical benchmarks 2010. Nature Biotechnology, 28, 917-924.  
Walther, J. L., Metallo, C. M., Zhang, J., & Stephanopoulos, G. (2012). Optimization of 13C 
isotopic tracers for metabolic flux analysis in mammalian cells. Metabolic Engineering, 
14(2), 162-171.  
Wang, X.-h., Xu, J., Zhang, Y., Li, L., Feng, Q., Mi, L., & Chen, Z.-n. (2004). Inducible 
expression of Bcl-XLinhibits sodium butyrate-induced apoptosis in hybridoma, resulting 
in enhanced antibody production. Cell Biology International, 28(3), 185-191.  
Weuster-Botz, D., Altenbach-Rehm, J., & Arnold, M. (2001). Parallel substrate feeding and pH-
control in shaking-flasks. Biochemical Engineering Journal, 7(2), 163-170.  
Wiechert, W. (2001). 13C metabolic flux analysis. Metabolic Engineering, 3(3), 195-206.  
Wiechert, W., & de Graaf, A. A. (1997). Bidirectional reaction steps in metabolic networks: I. 
Modeling and simulation of carbon isotope labeling experiments. Biotechnology and 
Bioengineering, 55(1), 101-117.  
Wiechert, W., Mollney, M., Isermann, N., Wurzel, M., & de Graaf, A. A. (1999). Bidirectional 
reaction steps in metabolic networks: III. Explicit solution and analysis of isotopomer 
labeling systems. Biotechnology and Bioengineering, 66(2), 69-85.  
Wiechert, W., & Noh, K. (2005). From stationary to instationary metabolic flux analysis. 
Advances in Biochemical Engineering/Biotechnology, 92, 145-172.  
163 
 
 
Wiechert, W., Siefke, C., de Graaf, A. A., & Marx, A. (1997). Bidirectional reaction steps in 
metabolic networks: II. Flux estimation and statistical analysis. Biotechnology and 
Bioengineering, 55(1), 118-135.  
Wilkens, C., Altamirano, C., & Gerdtzen, Z. (2011). Comparative metabolic analysis of lactate 
for CHO cells in glucose and galactose. Biotechnology and Bioprocess Engineering, 
16(4), 714-724.  
Wittmann, C. (2002). Metabolic flux analysis using mass spectrometry. Advances in Biochemical 
Engineering/Biotechnology, 74, 39-64.  
Wittmann, C. (2007). Fluxome analysis using GC-MS. Microbial Cell Factories, 6, 6.  
Wong, D. C. F., Wong, N. S. C., Goh, J. S. Y., May, L. M., & Yap, M. G. S. (2010). Profiling of 
N-glycosylation gene expression in CHO cell fed-batch cultures. Biotechnology and 
Bioengineering, 107(3), 516-528.  
Woodside, S., Bowen, B., & Piret, J. (1998). Mammalian cell retention devices for stirred 
perfusion bioreactors. Cytotechnology, 28(1-3), 163-175.  
Xie, L., & Wang, D. I. (1996). Material balance studies on animal cell metabolism using a 
stoichiometrically based reaction network. Biotechnology and Bioengineering, 52(5), 
579-590.  
Xie, L., & Wang, D. I. C. (1996). Energy metabolism and ATP balance in animal cell cultivation 
using a stoichiometrically based reaction network. Biotechnology and Bioengineering, 
52(5), 591-601.  
Xie, L., & Wang, D. I. C. (1996). High Cell Density and High Monoclonal Antibody Production 
Through Medium Design and Rational Control in a Bioreactor. Biotechnology and 
Bioengineering, 51, 725-729.  
Xie, L., & Wang, D. I. C. (2006). Fed-batch cultivation of animal cells using different medium 
design concepts and feeding strategies. Biotechnology and Bioengineering, 95(2), 270-
284.  
Xing, Z., Kenty, B., Koyrakh, I., Borys, M., Pan, S.-H., & Li, Z. J. (2011). Optimizing amino 
acid composition of CHO cell culture media for a fusion protein production. Process 
Biochemistry, 46(7), 1423-1429.  
Yallop, C. A., Nørby, P. L., Jensen, R., Reinbach, H., & Svendsen, I. (2003). Characterisation of 
G418-induced metabolic load in recombinant CHO and BHK cells: effect on the activity 
and expression of central metabolic enzymes. Cytotechnology, 42(2), 87-99.  
Yang, M., & Butler, M. (2000). Enhanced erythropoietin heterogeneity in a CHO culture is 
caused by proteolytic degradation and can be eliminated by a high glutamine level. 
Cytotechnology, 34(1), 83-99.  
Yang, M., & Butler, M. (2002). Effects of ammonia and glucosamine on the heterogeneity of 
erythropoietin glycoforms. Biotechnology Progress, 18(1), 129-138.  
164 
 
 
Yoon, S. K., Hwang, S. O., & Lee, G. M. (2004). Enhancing Effect of Low Culture Temperature 
on Specific Antibody Productivity of Recombinant Chinese Hamster Ovary Cells: Clonal 
Variation. Biotechnology Progress, 20(6), 1683-1688.  
Young, J. D., Shastri, A. A., Stephanopoulos, G., & Morgan, J. A. (2011). Mapping 
photoautotrophic metabolism with isotopically nonstationary 13C flux analysis. 
Metabolic Engineering, 13(6), 656-665.  
Young, J. D., Walther, J. L., Antoniewicz, M. R., Yoo, H., & Stephanopoulos, G. (2007). An 
Elementary Metabolite Unit (EMU) Based Method of Isotopically Nonstationary Flux 
Analysis. Biotechnology and Bioengineering, 99(3), 686-699.  
Zagari, F., Jordan, M., Stettler, M., Broly, H., & Wurm, F. M. (2013). Lactate metabolism shift in 
CHO cell culture: the role of mitochondrial oxidative activity. New Biotechnology, 30(2), 
238-245.  
Zamboni, N. (2011). (13)C metabolic flux analysis in complex systems. Current Opinion in 
Biotechnology, 22(1), 103-108. 
Zamorano, F., Vande Wouwer, A., & Bastin, G. (2009). Metabolic Flux Interval Analysis of 
CHO cells. Proceedings of the 6th mathmod conference, Vienna, Austria.  
Zamorano, F., Wouwer, A. V., & Bastin, G. (2010). A detailed metabolic flux analysis of an 
underdetermined network of CHO cells. Journal of Biotechnology, 150(4), 497-508.  
Zeng, A. P. (1996). Quantitative assessment of cell density effect on the metabolism and antibody 
production rate of hybridoma cells at high cell density. Journal of Biotechnology, 45(3), 
243-251.  
Zhu, J. (2012). Mammalian cell protein expression for biopharmaceutical production. 
Biotechnology Advances, 30(5), 1158-1170.  
Zupke, C., & Stephanopoulos, G. (1994). Modeling of isotope distributions and intracellular 
fluxes in metabolic networks using atom mapping matrices. Biotechnology and 
Bioengineering, 10(5), 489-498.  
Zupke, C., & Stephanopoulos, G. (1995). Intracellular flux analysis in hybridomas using mass 
balances and in vitro (13)C NMR. Biotechnology and Bioengineering, 45(4), 292-303.  
 
 
